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Abstract 
 
Nakadomarin A is a polycyclic marine alkaloid of the manzamine family. It was first isolated 
from the marine sponge Haliclona sp. collected off Manzamo, (Okinawa, Japan) and was 
characterised by Kobayashi and co-workers in 1997. The structure of this unprecedented 
compound was elucidated by exhaustive spectroscopic studies which showed that the 
natural product has a unique hexacyclic skeleton. In terms of biological activity, this 
natural product displays cytotoxicity against murine lymphoma L1210 cells (IC50 1.3 μg/mL), 
inhibitory activity against cyclin-dependent kinase 4 (IC50 9.9 μg/mL), anti-microbial 
activity against the fungus Trichophyton mentagrophytes (MIC 23 μg/mL) and anti-bacterial 
activity against the Gram-positive bacterium Corynebacterium xerosis. 
The complex structure of nakadomarin A combined with its biological activities has made it 
a highly attractive synthetic target. The work described herein displays the most recent 
contribution to this field from our research group. 
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The first chapter of this thesis gives a general introduction to nakadomarin A, its isolation 
and biological activities, followed by a summary of the efforts previously made towards its 
preparation. 
The Clark group has been interested in the synthesis of manzamines, and the objective of 
the work described in the second chapter of this thesis is to carry on the strategy 
previously followed towards the formation of the ABD core of nakadomarin A. The second 
part of this chapter also describes the efforts towards the formation of the furan ring C. 
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Chapter 1: Introduction to 
nakadomarin A 
 
he total synthesis of natural products is one of the most challenging 
problems that chemists face because nature is a never-ending source of 
new and complex targets. Natural compounds are derived from plants, 
microorganisms, or marine organisms.1 They are the subject of interest, not 
only in their natural forms, but also because they can serve as templates for synthetic 
modifications.2 The most obvious proof of this is the number of well-known drug molecules 
derived from natural products. For millennia, natural products extracted from plants 
reigned supremely in medicine throughout the world as therapeutic agents (e.g. aspirin and 
morphine, which are two of the oldest drugs known to mankind).3-4 Approximately 87% of 
all categorised human pathologies, including cancer and cardiovascular diseases, are 
treated using natural products and drugs related to them.2  
The purpose of the work described in this thesis is the total synthesis of the polycyclic 
marine alkaloid nakadomarin A (1), a member of the manzamine family of natural 
products. This first chapter provides a general introduction to nakadomarin A ― its isolation 
and biological activities ― followed by a summary of the previous efforts to synthesise it. 
The second chapter will focus on the results achieved over the past three years and the 
final chapter will detail the experimental procedures carried out. 
T 
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1.1 Nakadomarin A and members of the manzamine 
family 
1.1.1 Nakadomarin A, a member of the manzamine family 
Nakadomarin A (1) is a polycyclic marine alkaloid of the manzamine family (Figure 1.1).5 
The first manzanine alkaloid, manzamine A (2), was isolated from the marine sponge 
Haliclona sp. collected off Manzamo, (Okinawa, Japan) and characterised by Higa and co-
workers in 1986.6 Since then, more than 70 compounds of this family have been 
discovered.7-10  
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Figure 1.1: Selected compounds from the manzamine family  
1.1.2 Isolation and biological activities of nakadomarin A 
Nakadomarin A was first isolated from the sponge Amphimedon sp., collected off the 
Kerama Islands (Okinawa, Japan), by Kobayashi and co-workers in 1997.11 This natural 
product displays cytotoxicity against murine lymphoma L1210 cells (IC50 1.3 μg/mL), 
inhibitory activity against cyclin-dependent kinase 4 (IC50 9.9 μg/mL), anti-microbial 
activity against the fungus Trichophyton mentagrophytes (MIC 23 μg/mL) and anti-bacterial 
activity against the Gram-positive bacterium Corynebacterium xerosis.11 The structure of 
this unprecedented compound was elucidated by exhaustive spectroscopic studies and 
shown to have a unique hexacyclic skeleton. Nakadomarin A contains 6 rings, one of which 
is a piperidine, and is the only compound of the mazamine family that contains a furan 
ring. It also possesses three different heterocycles and 4 stereogenic centres. 
Unfortunately, the limited availability of natural material (6 mg isolated from 1 kg of wet 
sponge) has prevented exhaustive screening of the compound. 
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1.1.3 Biosynthesis of nakadomarin A 
Knowledge of the biosynthesis is important when planning a total synthesis and an efficient 
biomimetic pathway can be a great source of inspiration when working on the total 
synthesis of complex molecules.12 The complex structures of the manzamines were 
unprecedented in nature, making, as Higa said: ―the provenance of manzamines B and C, 
like that of A, biogenetically problematic‖.6 The preliminary sketch of the answer was 
made six years after the isolation of manzamine A (Scheme 1.1). This first theory was 
proposed by Baldwin and Whitehead in 1992 and is based on the assumption that the 
manzamines are derived in vivo from three simple building blocks: tryptophan (4), two 
units of a symmetrical dialdehyde 5 and two units of acrolein 6.1,13 With these three 
compounds in hand, a reductive coupling with ammonia gives the simple manzamine C (3).  
O
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N
H
OHC CHO
N
N N
H
Manzamine C (3)
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Scheme 1.1: Biosynthesis of manzamine C.  
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Baldwin and Whitehead were able to explain the biosynthesis of more complex 
manzamines, such as manzamine A (2) and B (7) (Scheme 1.2).13 Indeed, manzamine A (2) 
could be derived from manzamine B (7)  through a trans-eliminative opening of the 
epoxide, followed by allylic hydroxylation of a double bond and ring closure of the 
macrocycle. Manzamine B (7) is then obtained from aminoaldehyde 8 by oxygenation and 
introduction of the tryptophan unit 4. Aldehyde 8 is simplified to 9 by hydrolysis, and redox 
exchange between the two piperidine rings gives 10. Iminium ion 10 is clearly the product 
of an intramolecular endo Diels Alder reaction of 11; its conjugate acid 12 could be easily 
obtained from the same units 5, 6 and ammonia, as described for manzamine C (3).13 
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H
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O
H NH3
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Scheme 1.2: The Baldwin-Whitehead hypothesis for the biosynthesis of manzamine A (2) 
and B (7). 
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In 1992, Kobayashi and co-workers discovered and isolated another key compound of the 
manzamine family, ircinal A (13).14 The Japanese group provided the first experimental 
proof of Baldwin’s hypothesis by achieving the first semi-synthesis of manzamine A (2), 
converting ircinal A (13) to manzamine A (2) through a Pictet-Spengler cyclisation with 
tryptamine (14), which formed manzamine D (15) (Scheme 1.3). Subsequent DDQ 
oxidation of 15 led to manzamine A (2).14-15 
N
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H
H
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H OH
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H OH
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a b
 
Scheme 1.3: First semi synthesis of manzamine A. Conditions: a) TFA, toluene, rt, 37%; b) 
DDQ, CHCl3, rt, 54%. 
The validity of this proposed pathway was further re-affirmed, when Baldwin published his 
studies on the biomimetic synthesis of keramaphidin B (16),16-17 a pentacyclic alkaloid, 
isolated independently by Kobayashi and Andersen (Scheme 1.4).18-19 The macrocyle 12, a 
common precursor to compounds of the manzamine family, was prepared not from the 
original four building blocks, but from the pyridine derivative 17 to achieve an efficient 
synthesis in 37% yield over 11 steps. Intermolecular Diels-Alder reaction of 12, followed by 
treatment with sodium borohydride afforded a small quantity of keramaphidin B (16), 
confirming the validity of the proposal. However, the authors realise an enzymatic process 
is almost certainly involved in the Diels Alder reaction.16,20 
N+
N+
1217
N
OH
11 steps
Diels Alder
then NaBH4
N
N
0.3%
37%
Keramaphidin B (16) 
Scheme 1.4: Synthesis of keramaphidin B (16).  
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This proposed biogenetic route to manzamine A (2) and ircinal A (13) allowed a possible 
biosynthetic link to nakadomarin A (1). Indeed, nakadomarin A (1) is very likely to come 
from ircinal A (13) via a biotransformation process (Scheme 1.5).21 The biosynthesis of 
nakadomarin A (1) could be explained mechanistically by ircinal A (13) undergoing a retro-
Mannich reaction, leading to the tetracyclic compound 18, followed by a Mannich reaction 
to close the cyclopentane ring (compound 19) and dehydration then giving nakadomarin A 
(1). 
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H
NH
N
H
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Scheme 1.5: Biosynthesis of nakadomarin A from ircinal A.  
 
1.2 Total synthesis of nakadomarin A 
Due to its unique structure and biological activity, nakadomarin A (1) has been the subject 
of much interest from the synthetic organic chemistry community over the last decade. 
Efforts have resulted in a total of 8 total syntheses of both natural (—) and non-natural (+) 
nakadomarin A. Nakagawa,22-23 Kerr,24 Dixon,25-28 Funk,29 and Zhai published the total 
synthesis of this natural product or its enantiomer,30 and this list is completed by two 
formal syntheses, accomplished by Mukai and Magnus.31-32 The synthesis of the natural 
product has also held the attention of several other groups, such as Fürstner,33-34 
Williams,35 and Winkler,36 and their work towards the target will be described at the end of 
the section.   
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1.2.1 Nakagawa’s  strategy: the first total synthesis of nakadomarin A  
Nakagawa and co-workers published their first work concerning nakadomarin A in 2001 with 
the synthesis of the central tetracyclic core of this natural product.37 A novel 
intramolecular Mannich-type cyclisation was the key reaction, following the biogenetic 
pathway.21 Using this approach, they described the first total synthesis of non-natural ent-
(+)-nakadomarin A (20) in 2003, only six years after its isolation.22 A year later they 
published the first asymmetric total synthesis of natural (—)-nakadomarin A.23 The 2003 
retrosynthetic analysis (Scheme 1.6) started with the reduction of the two amides of 21 to 
the corresponding amines, leading to ent-nakadomarin A (20). This compound could be 
obtained by employing ring-closing metathesis reactions to form both the 15- and 8-
membered rings, the precursor of which was molecule 22. At this point, the ABCD core 
could be obtained by an intramolecular Mannich-type cyclisation reaction, following in this 
respect their previous work regarding the elucidation of the biogenetic pathway,37 and 
leading to 23. The iminium compound 23 could be derived from spirolactam 24, which 
could be prepared via Suzuki-Miyaura coupling from 25 and 26. Finally, 25 could be 
prepared from the unsaturated ester 27.38 
 
O
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O
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H
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H
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N
H
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O
N
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H
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O
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NPG
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O
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NPG
O
COEt2
20 21 22
23
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O
O
O
O
EtO2C
reduction RCM
Suzuki-Miyaura
 
Scheme 1.6: Nakagawa’s retrosynthesis analysis.  
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Their forward synthesis commenced with the use of readily available piperidine 27 
(Scheme 1.7).37 This compound was resolved to afford (R)-27 in 99.6% ee using (+)-
cinchonine. However, isolation of the opposite (S)-isomer, leading to the natural 
enantiomer, was not possible at this stage. Thus Nakagawa began with the racemic 
material and progressed to the enantioselective syntheses of the non-natural enantiomer 
but could not prepare (―)-nakadomarin A (1). Condensation of (R)-27 with benzylamine 
was followed by catalytic dihydroxylation with osmium tetroxide to provide the 
corresponding diol, which was then cleaved to provide aldehyde 28. Wittig olefination of 
aldehyde 28, and subsequent intramolecular Michael addition provided the desired 
spirolactam 29, as an inseparable 3.3:1 mixture of diastereoisomers.39-40 Resolution and 
purification was performed by hydrolysis to the acids, allowing the removal of the 
phosphine oxide, and re-esterification to give back 29. Subsequent reduction of 29 allowed 
the separation of the alcohols and the isolation of the desired isomer 30 in 58% yield from 
over 6 steps. The synthesis continued with the removal of the ketal group leading to keto 
alcohol 31, which was subsequently protected using a THP group to prevent intermolecular 
acetal formation. Conversion of the ketone 32 into the enol triflate provided 33 in 87% 
yield.  
N
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Bs CO2H
N
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OTf
N
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OTHP
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N
Bs
N
O
CO2Et
Bn
N
O
O
Bs
CHO
O
H
N Bn
30  X = O(CH2)2O, R = CH2OH
31  X = O, R = CH2OH
32  X = O, R = CH2OTHP
N
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N
O
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N
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N
O
H
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X
R-27 28 29
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b-d e, f
g, h i -k l, m
O
O
O
O
N
O
O
Bs CO2H
27
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impure
 
Scheme 1.7. Forward strategy. Conditions: a) resolution using (+)-cinchonine, MeOH, then 
HCl, 44%; b) BnNH2, EDC, HOBt, DMF, 91%; c) cat. OsO4, NMO, aq THF; d) NaIO4, CH2Cl2, 
H2O; e) Ph3P=CHCO2Et, CH2Cl2; f) DBU, EtOH; g) NaOH, MeOH; h) AcCl, EtOH, 59% over 6 
steps; i) LiBH4, MeOH, THF, 99%; j) HClO4, CH2Cl2, 91%; k) DHP, cat. CSA, 91%; l) LiHMDS, 
THF; m) PhNTf2, 87% over 2 steps.  
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Suzuki-Miyaura coupling of 33 with furan-3-boronic ester 26, provided the furan 34 in a 
95% yield (Scheme 1.8). Subsequent stereoselective hydrogenation occurred from the      
β-side (in a 5.7:1 ratio) as expected from previous studies, and the two isomers of 35 were 
separated.37 Subsequent reduction of the ester side chain with lithium borohydride 
afforded 36, and a deprotection-protection procedure provided 37. Reduction of the 
lactam with concomitant selective unmaking of the Boc protected alcohol, by treatment 
with DIBAL-H, was followed by alcohol acylation using Ac2O/pyridine to yield ester 38 in 
80% yield over these two steps. Treatment of 38 with pTSA, followed by removal of the 
THP group gave tetracyclic 39 in 87% yield. Selenation of 39 followed by oxidation of the 
selenide and thermal elimination of the resulting selenoxide formed 40. Finally, removal of 
the Boc group followed by N-acylation using 5-hexenoic acid provided 41, in a 73% yield 
over 4 steps. The diene 41 was treated with the Grubbs second generation metathesis 
catalyst to form 42 in 70% yield.41 
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Scheme 1.8: Nakagawa’s approach. Conditions: a) 26, PdCl2(dppf), K3PO4, 95%; b) i) H2, 
Pd-C, MeOH, 71%; ii) PPTS, EtOH; iii) sep diastereomers; iv) DHP, cat CSA, 69%; c) LiBH4, 
MeOH, THF, 99%; d) Li, liq. NH3; e) PhSO2Cl, aq NaHCO3, 80% over 2 steps; f) (Boc)2O, Et3N, 
cat. DMAP, 98%; g) DIBAL-H, CH2Cl2; h) Ac2O, pyr., 80% over 2 steps; i) pTSA, CH2Cl2; j) HCl, 
THF, 87% over 2 steps; k) 2-nitrophenylselenocyanate, nBu3P; l) mCPBA, aq K2HPO4; m) TFA, 
CH2Cl2; n) 5-hexenoic acid, EDC, HOBt, 73% over 4 steps, o) Grubbs II, CH2Cl2, 70%. 
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The synthesis continued with the removal of the acetate, in the furan side chain of 42, 
followed by Dess-Martin oxidation of the resulting alcohol to form aldehyde 43, which was 
then converted to 44 by a Wittig olefination in 53% yield (Scheme 1.9).42 Removal of the 
sulfonamide protecting group, followed by N-acylation using 5-hexenoic acid gave 45 in two 
steps, in 77% yield. Triene 45 underwent RCM, with the Grubbs ruthenium catalyst, to give 
a separable mixture of E and Z products, from which the desired Z isomer 46 was isolated 
in 26% yield.43 Finally, reduction of the Z-bislactam, using Red-Al, provided the target 
molecule 20 in 86% yield. This completed the first total synthesis of ent-(+)-nakadomarin A, 
from readily available carboxylic acid 27, in 34 steps. The major drawbacks of this first 
synthesis were its length and the inability to form of the desired enantiopure starting 
material. 
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Scheme 1.9: Nakagawa’s endgame. Conditions: a) NaOH, MeOH, 91%; b)DMP, 80%; c) 
Ph3P=CH2, 72%; d) Na, naphthalene; e) 5-hexenoic acid, EDC, 77% over 2 steps; f) Grubbs I 
(Z: 26% - E: 44%), g) Red Al, toluene, 86%. 
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1.2.2 Strategy for the natural enantiomer 
To achieve the first total synthesis of the naturally occurring enantiomer, (—)-nakadomarin 
A, Nakagawa and co-workers needed an appropriate starting material. They achieved this 
goal in 2004 and published a new route to the ABCD core, leading to the successful first 
total synthesis of (—)-nakadomarin A (1) (Scheme 1.10).23 The starting point of this 
retrosynthetic analysis shows similarity with that of the non-natural compound.22 
Disconnection of both 15- and 8-membered macrocycles leads to 47. The furan ring could 
be obtained from aldehyde 48, itself prepared from ketone 49.Tricyclic lactam 49 could be 
synthesised from bisketone 50, which could be constructed from a Diels-Alder reaction 
between siloxydiene 52 and dienophile 51. The unsaturated lactam 51 would be a 
derivative from natural amino acid L-serine. 
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Scheme 1.10: Retrosynthesis – strategy for the natural enantiomer. 
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Nakagawa’s synthesis started with the Diels-Alder reaction of diene 52 with the L-serine 
derived dienophile 51 (Scheme 1.11). This was followed by Luche reduction of the ketone 
to give a mixture of alcohols 53, which were the intermediates for the key SN2’ reaction, 
performed in a 70% yield by treatment with HCl to remove the acetonide group, leading to 
54.44 Subsequent protection of the hydroxyl group as a TBDPS ether allowed the removal of 
the N-benzenesulfonyl group, leading to 55 (74% over 2 steps). The six-membered ring was 
then cleaved by ozonolysis and recyclised by aldol condensation to give the desired 5-
membered ring and deliver aldehyde 56 in 75% over 2 steps.45  
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Scheme 1.11: Forward synthesis. Conditions: a) i) neat; ii) TFA, CH2Cl2, 52%; b) NaBH4, 
CeCl3•7H2O, CH2Cl2, MeOH, 98% (d.r = 2:1); c) HCl, benzene, 70%; d) TBDPSCl, imidazole; e) 
Na/anthracene, 1,2-ethanediol, 74% over 2 steps; f) O3, CH2Cl2, Me2S; g) N-methylanilinium 
trifluoroacetate, THF, 75% over 2 steps. 
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The resulting aldehyde 56 underwent a Wittig olefination, to install the side chain 
necessary for the synthesis of the furan system (compound 57) (Scheme 1.12). Treatment 
with singlet oxygen formed the peroxide 58, which was treated with tBuOK, then with acid 
to provide furan 59 in a 88% yield (this sequence also removed the TBDPS group).46 The 
tetracyclic compound 59 corresponded to the complete chiral ABCD-ring system of 
nakadomarin A. Oxidation of the alcohol to the aldehyde using the Dess-Martin-periodinane 
(90% yield) was followed by a Peterson olefination, and the TMS protecting group of the 
alkyne was removed, leading to the enyne 60.47 The protection of the nitrogen with a Boc 
group allowed the reduction of the lactam carbonyl group to give carbamate 61.  
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Scheme 1.12: Towards 61. Conditions: a) Ph3PCH2CH2CH2CCTMS, NaH, THF, 76%; b) O2, 
Rose bengal, h , CH2Cl2/MeOH, quant, (α/β adducts = 1.2:1); c) tBuOK, THF, HCl, 88%; d) 
DMP, CH2Cl2 90%; e) TMSCH2MgCl, Et2O, 83% (d.r. = 2:1); f) BF3.Et2O, CH2Cl2; g) K2CO3, 
MeOH, 81% over 2 steps; h) Boc2O, DMAP, Et3N, 93%; i) DIBAL-H, toluene; j) Et3SiH, 
BF3.Et2O, CH2Cl2, 84% over 2 steps. 
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The final steps in this synthesis were similar to those employed for the preparation of the 
non-natural compound and allowed the first total synthesis of natural nakadomarin A 
(Scheme 1.13).48 This sequence provided the natural (―)-nakadomarin A in 26 steps, from 
dienophile 51. 
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Scheme 1.13: Endgame. Conditions: a) Na/naphtalene, DME; b) 5-hexenoyl chloride, Et3N, 
CH2Cl2, 92% over 2 steps; c) Co2(CO)8, CH2Cl2, 91%; d) Grubbs II, CH2Cl2, 83%; e) nBu3SnH, 
benzene, 75%; f) TFA, CH2Cl2; g) 5-hexenoyl chloride, Et3N, CH2Cl2 92%; h) Grubbs I, CH2Cl2, 
83%, Z isomer: 26%, E isomer: 46%; i) Red-Al, toluene, 92%.  
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1.2.3 Kerr’s approach (2007) 
The second synthesis of nakadomarin A (1) was reported in 2007, when Kerr published his 
approach to the unnatural enantiomer 20.24 In this respect, he was able to improve his 
previous work published in 2005 regarding the synthesis of the tetracyclic core of this 
molecule using a nitrone/cyclopropane cycloaddition as the key step.49-50 Kerr’s 
retrosynthetic analysis began with the disconnection of the two macrocycles by RCM 
leading to 68, followed by excision of the piperidine ring, leading to 69 (Scheme 1.14).  In 
turn, this molecule could be prepared from 70 via a pyrrolidine synthesis including a N-O 
bond cleavage and ring closure.49 This Heck substrate would derive from oxazine 71, made 
from the three-component coupling of 72, 73, and 74.51 The chirality of 73, establishing 
the stereogenicity of the target molecule, comes from D-mannitol. However, preparation of 
the corresponding enantiomer was difficult which meant that the natural product could not 
be accessed readily.52  
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Scheme 1.14: Kerr’s retrosynthetic analysis. 
The key step in this synthesis was the three-component cycloaddition of the hydroxylamine 
75, aldehyde 76 and cyclopropane 77 to afford a highly functionalised tetrahydro-1,2-
oxazine 78 (Scheme 1.15).49 Mono-reduction of the equatorial ester in 78 using DIBAL-H 
(via an empirical method), followed by a Horner-Wadsworth-Emmons olefination afforded 
80.53 Subsequent Heck cyclisation provided 81 as an undetermined, but single isomer 
around the alkene. Removal of the PMB protecting group and acylation of nitrogen afforded 
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83. Subsequent conversion of the oxazine to the pyrrolidine was the second key step in this 
synthesis: cleavage with SmI2, followed by selective O-mesylation and subsequent 
treatment with base delivered the desired pyrrolidine 85. It is interesting to note that this 
sequence had an unexpected consequence of isomerising the enoate moiety.54-55 With 
intermediate 85 in hand, 14 further steps were required to complete the synthesis. 
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Scheme 1.15: Kerr’s total synthesis. Conditions: a) Yb(OTf)3, 4 Å MS, 87%; b) DIBAL-H, 
CH2Cl2, 87%; c) (MeO)2P(O)CH2CO2Me, tBuOK, THF, 93%; d) Pd(PPh3)4, Ag2SO4, Et3N, DMF, 
82%; e) DDQ, CH2Cl2/H2O, 56%; f) ClC(O)(CH2)4OBn, Et3N, CH2Cl2, 89%; g) SmI2, THF; h) MsCl, 
Et3N, DMAP, CH2Cl2; i) tBuOK, THF, 65% over 3 steps.  
The α,β-unsaturated ester in the tricyclic compound 85 was reduced with nickel boride, 
which afforded 86 (Scheme 1.16). Subsequent reduction of the carbomethoxy groups and 
mesylation of the resulting primary alcohols provided bis mesylate 87 in 79% yield over 2 
steps. Subsequent formation of the piperidine ring in 88 was achieved by treatment of 87 
with ammonia, followed by reaction the corresponding acyl chloride. Double debenzylation 
to the diol 89 was followed by oxidation to the bis aldehyde 90 and the subsequent double 
Wittig reaction provided diene 91. Treatment of diene 91 with Grubbs’ second generation 
catalyst resulted in RCM and afforded the pentacyclic compound 92.43 Removal of the silyl 
groups, oxidation to the bis-aldehyde and Wittig olefination provided Nishida’s 
intermediate 66. Analogous to Nakagawa’s synthetic approach, treatment of 66 with 
Grubbs first generation catalyst, and subsequent reduction of the lactams to give the 
corresponding cyclic amines provided ent(+)-nakadomarin A 20.22  
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 Scheme 1.16: Kerr’s Endgame. Conditions: a) NiCl2•6H2O, NaBH4, Na2CO3, MeOH/THF, 67% 
(14:1 dr); b) LiAlH4, THF; c) MsCl, Et3N, DMAP, CH2Cl2, 79% over 2 steps; d) NH3, EtOH/THF, 
reflux; e) ClC(O)(CH2)4OTBDPS, Et3N, CH2Cl2, 77% over 2 steps; f) BCl3, CH2Cl2, 71%; g) IBX, 
DMSO; h) tBuOK, MePPh3I, THF/toluene, 45% over 2 steps; i) Grubbs II, CH2Cl2, 84%; j) 
TBAF, THF; k) DMP, CH2Cl2, 70% over 2 steps; l) tBuOK, MePPh3Br, THF/toluene; m) Grubbs 
I, CH2Cl2, 28% of E-isomer; n) Red-Al, toluene, 20% of Z-isomer over 2 steps. 
Overall, this route yielded the unnatural nakadomarin A in 28 linear steps. Although shorter 
than Nakagawa’s strategy, this route has the major drawback of only allowing access to (+)-
nakadomarin A. 
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1.2.4 Dixon’s syntheses of (—)-nakadomarin A (2009 & 2011) 
In 2009, Dixon and co-workers published the second total synthesis of (—)-nakadomarin A.25 
Two years later, they published two further syntheses of this molecule and one 
modification, solving the major drawbacks of their first pathway.26-28 Dixon’s first 
retrosynthetic analysis shows that (—)-nakadomarin A (1) can be obtained by a ring-closing 
metathesis of 95 (Scheme 1.17). The triene 95 would by created by reduction of the nitro 
group and reductive manipulation of both carbonyl groups followed by a diastereoselective 
iminium ion cyclisation of 96. Intermediate 96 would be constructed via a 
diastereoselective multicomponent nitro-Mannich/lactamisation cascade of nitro ester 99 
and the imine formed in situ from commercial amine 97 and formaldehyde 98. Finally, 99 
could be obtained from nitro olefin 100 via a Michael addition with aza-bicyclic pro-
nucleophile 101. 
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Scheme 1.17: Dixon’s retrosynthetic analysis. 
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In Dixon’s initial approach to the natural product, the first target was bicyclic compound 
101, which was prepared in 6 steps and in 24% overall yield (Scheme 1.18). Nucleophilic 
substitution of pyroglutamol 102, with sodium thiolate 103 afforded sulfide 104. This was 
followed by N-alkylation to afford 105 and oxidation of the sulfide to the sulfone 106. 
Following deprotection to unveil aldehyde 107, an intramolecular Julia-Kocienski 
olefination was used to provide the desired bicyclic lactam 108 in a good yield.56 Finally, C-
acylation with dimethyl carbonate provided the desired fragment 101 in 82% yield. 
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Scheme 1.18: Dixon’s preparation of 101. Conditions: a) THF, reflux, 96%; b) 2-(4-
bromobutyl)-1,3-dioxalane, NaH, Bu4NI, DMSO, 71%; c) mCPBA, CH2Cl2, 78%; d) HCl, THF, rt, 
98%; e) CsCO3, DMF, THF, H2O, 56%; f) dimethylcarbonate, LHMDS, THF, 82%. 
The second fragment, furanyl nitro olefin 100, was synthesised in 4 steps and 21% yield 
(Scheme 1.19). Allylation of ketophosphonate 109, followed by a Horner-Wadsworth-
Emmons reaction using diacetyl dihydroxyacetone 110 afforded enone 111. Subsequent 
acid hydrolysis provided alcohol 112, which, after a Swern oxidation and Henry-type 
condensation, afforded the desired nitro olefin 100.57  
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Scheme 1.19: Dixon’s preparation of 100. Conditions: a) NaH, BuLi, THF, allylbromide, 
then 2-oxopropane-1,3-diyl diacetate, THF, 42%; b) HCl, EtOH, 69%; c) (COCl)2, DMSO, Et3N, 
CH2Cl2, 82%; d) MeNO2, KOH, 88%. 
20 
 
With the two key fragments in hand, it was possible to combine them via a 
diastereoselective Michael addition, with the use of the bifunctional cinchona catalyst 114 
(Figure 1.2). Submission of the resulting compound 99 to a three-component nitro-
Mannich/lactamisation cascade provided 96 in 68% yield (Scheme 1.20).58 Reduction of the 
nitro group was then achieved in 70% yield, and providing 115 as a single diastereoisomer.59 
The δ-lactam was reduced using lithium aluminium hydride at —20 °C, without reducing the 
less reactive γ-lactam. The piperidine 116 was thus isolated in 86% yield. Treatment of this 
compound with DIBAL-H, followed by acidification promoted cyclisation, which established 
the pentacyclic core of the natural target. Finally, olefin metathesis was achieved using 
Grubbs first generation catalyst, in the presence of camphor sulfonic acid, providing 
natural (—)-nakadomarin A (1) in 62% yield, and with a 63:37 Z/E ratio.60  
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Figure 1.2: catalyst 114 
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Scheme 1.20: Dixon’s Endgame. Conditions: a) 114, toluene, 57%, 91:9 dr; b) hex-5-
enamine, CH2=O, 68%; c) AIBN, Bu3SnH, toluene, 70%; d) LiAlH4, toluene, then HCOOH, 86%; 
e) DIBAL-H, toluene, HCl, 41%; f) Grubbs I, (+)-CSA, CH2Cl2, 62%, 63:37 Z/E. 
This impressive 16-steps synthesis (longest linear sequence 12 steps) provided the natural 
enantiomer of nakadomarin A. Although the ratio of alkene isomers was better than 
Nakagawa’s, the major drawback of this route was the poor selectivity (63:37 Z/E) in the 
final ring-closing metathesis reaction. To solve this issue, Dixon published two alternative 
routes to the natural product, employing diyne ring-closing metathesis.26-27 The second 
synthesis, whilst containing an increased 19 synthetic steps, was a significant improvement: 
the ring closure was achieved using a diyne RCM/syn-reduction sequence thus avoiding the 
poor selectivity of the first diene RCM. The next improvement in Dixon’s synthesis was 
highlighted in a further publication in the same year, which described a shorter third 
generation synthesis that built on the success of the two previous routes.27 The initial 
retrosynthetic analysis of this final sequence deviated from the first generation synthesis 
mainly with regard to the initial disconnection. Nakadomarin A would be prepared from 
118 via an alkyne RCM and a final hydrogenation step (Scheme 1.21). The continuation of 
the retrosynthesis is subsequently very similar to the group’s earlier work. 
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Scheme 1.21: Dixon’s final retrosynthetic analysis 
The bicyclic pro-nucleophile 101 was prepared using the route described in Scheme 1.18. 
The novel furanyl nitro olefin 120 was obtained in 22% yield over 4 steps, following a 
sequence that was similar to the pathway used to prepare 100. As shown in Scheme 1.22, 
bis-alkyne 121 was obtained in 7% overall yield. Following preparation of 118, Dixon 
observed a very low reactivity for the envisaged ring-closing metathesis reaction. This 
finding resulted in alteration of the originally proposed pathway. 
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Scheme 1.22: Towards 117. Dixon’s Endgame. Conditions: a) 114, toluene, 58%, 90:10 dr; 
b) hex-5-enamine, CH2=O, MeOH, 63%; c) AIBN, Bu3SnH, toluene, 64%; d) LiAlH4, toluene, 
then HCOOH, 86%; e) DIBAL-H, toluene, HCl, 35%; f) Mo(CO)6, 4-fluorophenol, PhCl, 0%; g) 
(tBuo)3WCCMe3, toluene, 0%; h) [(pyridine)(Ph3SiO)3MoN],toluene, 0%. 
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In order to solve the ring closure problem issue, the alkyne RCM reaction was performed 
earlier in the synthesis, by RCM of 121 to provide 122 (Scheme 1.23). This reaction was 
followed by a syn-selective partial hydrogenation leading to 123. Subsequent reduction 
with DIBAL-H transformed the piperidinone to piperidine 124. Lactam 124 was then 
treated with 2,6-di-tBuPy to form the desired final product. This short and highly 
stereoselective synthesis (13 steps longest linear sequence) allowed the preparation of (—)-
nakadomarin A from commercially available starting materials.  
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Scheme 1.23: Conditions: a) Mo(CO)6, 2-fluorophenol, PhCl, 36%; b) Lindlar’s catalyst, H2, 
quinoline, EtOAc, 86%; c) DIBAL-H, toluene, 57%; d) Tf2O, 2,6-di-tBuPy, CH2Cl2, then NaBH4, 
MeOH, 41%. 
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Finally, in 2011 Dixon published an ultimate improvement of his work toward Nakadomarin 
A. Indeed, using a tungsten based complex (Figure 1.3), he improved the Z/E ratio of the 
alkene RCM to 94:7.28 This development also solved a major drawback of several previous 
syntheses, as Nakagawa and Kerr were facing the same challenge.  
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Scheme 1.24: Conditions: tungsten complex, toluene, 63%, 94:6 Z/E. 
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Figure 1.3: Hoveyda Schrock tungsten catalyst. 
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1.2.5 Mukai’s formal synthesis of (+)-nakadomarin A (2010)  
In 2010, the group of Mukai published the formal synthesis of (+)-nakadomarin A (20) using 
a strategy based on a Pauson-Khand reaction.31 According to Mukai’s reterosynthetic 
analysis, nakadomarin A would be prepared from 45, as previously described by Nishida and 
Kerr (Scheme 1.25).22,24 The triene 45 could be obtained from 126, by N-acylation with the 
corresponding side chain, deprotection and RCM to form the E ring. The key synthetic 
intermediate, tetracyclic compound 126, might be prepared from the tricyclic compound 
127, itself coming from a Pauson-Khand reaction of precursor the enyne 128. Finally, 128 
would be obtained from 129 and 130.  
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Scheme 1.25: Mukai’s retrosynthetic analysis 
The readily available vinyl iodide 131 was treated with 3-butyn-1-ol 132 to furnish the 
homopropargyl alcohol derivative 133 in 84% yield, through a Sonogashira coupling 
(Scheme 1.26).61-62 This compound was subsequently converted to the primary amine 134 
by treatment with sodium azide and reduction. 
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Scheme 1.26: Preparation of 134. Conditions: a) PdCl2(PPh3)2, CuI, iPr2NH, THF, 84%; b) 
MsCl, Et3N, CH2Cl2; c) NaN3, DMF; d) PPh3, H2O, Et2O, 84% over 3 steps. 
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In addition to this, aldehyde 136 was prepared from the protected lactam 135 (derived 
from L-pyroglutamic acid),63 in 3 steps and an with overall yield of 59% (Scheme 1.27). 
Subsequent reductive amination of 136 with the previously prepared amine 134, followed 
by treatment with TsCl provided the enyne 137 in 69% yield.   
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Scheme 1.27: Preparation of 137. Conditions: a) LiHMDS, ClCO2Me, THF; b) DIBAL-H, THF; 
c) CSA, toluene, 59% over 3 steps; d) 134, MgSO4, MeOH, then NaBH4; e) TsCl, pyr., CH2Cl2, 
69% over 2 steps. 
The next step involved formation of the key tricyclic intermediate 138 via a Pauson-Khand 
reaction (Scheme 1.28). This was achieved in 60% yield by treatment of 137 with dicobalt 
octacarbonyl and n-butylmethyl sulfide, in a refluxing toluene/ether solution. In order to 
prepare the furan ring, exchange of the PMB group for a benzoyl group (molecule 139) was 
followed by dihydroxylation to afford 140. Subsequent ring closure, under acidic 
conditions, provided the desired tetracyclic compound 141. The Boc protecting group was 
also cleaved under these conditions. 
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Scheme 1.28: Key Pauson-Khand reaction. Conditions: a) Co2(CO)8, Et2O, toluene, nBuSMe, 
100%; b) DDQ, CH2Cl2; c) BzCl, pyridine, CH2Cl2, 90% over 2 steps; d) OsO4 aq, NMO, 
THF/H2O; e) CSA, toluene, 80% over 2 steps. 
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In order to prepare the natural product, the double bond present in 141 required removal. 
Following Fmoc protection of the free amine, hydrogenation provided compound 143 as 
shown in Scheme 1.29. Finally, the Fmoc group was removed, to provide the desired 
tetracyclic amine 144. 
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Scheme 1.29: Conditions: a) FmocCl, NaHCO3, THF/H2O, 90%; b) 20% Pd/C, H2 (10 atm), 
EtOAc, 51%; c) piperidine, DMF, quant. 
To prepare the southern 8-membered lactam, acylation of amine 144 was performed, 
followed by deprotection of the TBDPS group with TBAF afforded 145 in a 55% yield 
(Scheme 1.30). Subsequent Dess-Martin oxidation and Wittig olefination was followed by 
RCM using Grubbs 2nd generation catalyst to provide 146 in a 84% yield over 3 steps. Alkyne 
147 was prepared from benzoate 148 in 73% yield via debenzoylation, oxidation and 
treatment with the Ohira-Bestmann reagent.64 Removal of the tosyl group, followed by 
amide formation with 5-hexenoic acid provided 148, in a 69% yield. Finally, hydrogenation 
of 148 with Lindlar’s catalyst provided 45.65 This intermediate had been transformed to 
(+)-nakadomarin A by Nishida and Kerr.22,24  
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Scheme 1.30: Mukai’s Endgame. Conditions: a) 5-hexenoyl chloride, Et3N, CH2Cl2; b) TBAF, 
THF, 55% over 2 steps; c) DMP, CH2Cl2; d) tBuOK, MePPh3Br, THF; e) Grubbs II, CH2Cl2, 84% 
over 3 steps; f) NaOH, MeOH; g) IBX, DMSO/THF; h) PO(Me)2CHN2, K2CO3, MeOH, 73% over 3 
steps; i) Na/naphtalene, 1,2-ethandiol; j) 5-hexenoic acid, EDC, HOBt, THF, 69% over 2 
steps; k) Lindlar’s catalyst, quinoline, H2, MeOH, 83%. 
1.2.6 Magnus’ strategy (2010): formal synthesis of ent-nakadomarin A 
Magnus’ 2010 approach towards nakadomarin A was a formal synthesis and involved 
synthesis of the ent-intermediate 149 in 49% yield form L-pyroglutamic acid 151 (Scheme 
1.31).32 In comparison to Dixon’s approach towards the opposite enantiomer (29% of 108), 
this was a much improved synthetic sequence in terms of overall yield.25 In terms of the 
retrosynthetic analysis, Magnus proposed that 149 would be obtained from lactam 150, 
which, in turn, would derive from L-pyroglutamic acid 151. 
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Scheme 1.31: Magnus’ retrosynthetic analysis. 
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The synthetic sequence began with esterification of L-pyroglutamic acid 151, followed by 
Boc protection of the free nitrogen to form 153 in 82% yield over 2 steps (Scheme 1.32). 
Subsequent reduction of the lactam functionality led to alcohol 154. Treatment with 
ethanol, followed by reduction of the ester afforded the aldehyde 156, which underwent a 
Wittig reaction to give the alkene 157 in an excellent 98% yield and with excellent 
stereoselectivity.  
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Scheme 1.32: Conditions : a) SOCl2, MeOH, 92%; b) Boc2O, DMAP, Et3N, CH2Cl2, 89%; c) 
DIBAL-H, THF, toluene, 98%; d) EtOH, pTSA, 96%; e) DIBAL-H, toluene, 89%, f) 
PPh3CH(CH2)4OTBDPS, KHMDS, toluene, 98%. 
Subsequent Jones oxidation of 157 with chromium trioxide resulted in the formation of 
free lactam 150, which, after TBDPS removal furnished compound 158 in an excellent yield 
over the two steps (Scheme 1.33). Conversion of the primary alcohol functionality of 158 
into the tosylate 159 allowed the eight-membered ring-closure to the lactam 149 upon 
treatment with potassium tert butoxide in 98% yield. From 149, only 7 steps are necessary, 
according to Dixon’s synthesis, to prepare (—)-nakadomarin A.25 Although Magnus only 
described an improvement in the synthesis of a fragment of nakadomarin A, his method 
would allow large amounts of non natural enantiomer to be prepared. 
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Scheme 1.33: Conditions : a) CrO3, AcOH; b) TFA, CH2Cl2, 84% over 2 steps; c) HF, MeCN, 
90%; d) TsCl, Me3N•HCl, Et3N, CH2Cl2, 99%; e) tBuOH, THF, 98%. 
1.2.7 Funk’s total synthesis (2010)  
In 2010, Funk and co-workers published the synthesis of (―)-nakadomarin A, achieving in 
this regard the third total synthesis of the natural compound in 21 steps from D-
pyroglutamic acid.29 In his route, Funk employed previous methodology he had developed in 
2006 involving the generation of an N-acyliminium ion via intramolecular conjugate 
addition.66 His retrosynthetic analysis started with the disconnection of the macrocycles. 
He envisaged that a diene RCM reaction could provide the eight membered ring and a 
closure using diyne RCM/semihydrogenation strategy would be used to construct the Z-
cycloalkene isomer (Scheme 1.34). Compound 160 is the product from the key cyclisation 
reaction previously described by Funk, where compound 162 is the starting precursor. In 
turn, 162 would be obtained as the product of a Knoevenagel condensation of furaldehyde 
164 and amido-ester 163.67  
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Scheme 1.34: Funk’s retrosynthetic analysis. 
The synthesis started with the preparation of the first fragment, furaldehyde 164, which 
was prepared following Maldonado’s methodology (Scheme 1.35).68 Reaction between 
methyl 4-hexynoate 165 and dimethylphosphonate 166 provided 167 in 54% yield. 
Subsequent Horner-Wadsworth-Emmons olefination of diacetoxyacetone using phosphonate 
167 afforded diacetoxyenone 168. Acid-catalysed cyclisation of 168 formed furan 169, 
which was in turn converted into the furaldehyde 164 using standard Swern oxidation 
conditions. 
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Scheme 1.35: Synthesis of furaldehyde 164. Conditions: a) nBuLi, THF, 54%; b) NaH, 1,3-
diacetoxyacetone, THF, 82%; c) HCl, MeOH, 82%; d) (COCl)2, DMSO, Et3N, CH2Cl2, 75% 
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The second fragment, amido-ester 163, was obtained in 8 steps from 170 (Scheme 1.36). 
The sequence started with the preparation of Boc-protected lactam 171 from D-
pyroglutaminol 170. Subsequent reduction of 171 following Yu’s protocol, afforded to 172 
in 88% yield.69 Vilsmeier-Haack formylation of 172 provided 173, from which reductive 
amination and N-acylation with methyl malonyl chloride afforded the desired 1,3-
dicarbonyl compound 163.70  
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Scheme 1.36: Synthesis of fragment 163. Conditions: a) imidazole, TIPSCl, CH2Cl2, DMF, 
88%; b) Boc2O, DMAP, MeCN, 90%; c) LiBHEt3, iPr2NEt, DMAP, TFAA, toluene, 88%; d) DMF, 
(COCl)2, CH2Cl2, 87%; e) CHCC(CH2)4NH2, NaBH4, MeOH; f) methyl malonyl chloride, Et3N, 
CH2Cl2, 66% over 2 steps.  
The sequence continued with the Knoevenagel condensation of aldehyde 164 and amido-
ester 163 to provide 162, with exclusively E-geometry, in 87% yield (Scheme 1.37).71 
Subsequent cyclisation of 162 to 160 using InCl3 allowed the whole ABCD core of the 
molecule to be constructed in a single key step. Saponification and decarboxylation of 160 
afforded lactam 174. Diyne RCM, employing conditions developed by Fürstner, and alkyne 
reduction with Lindlar’s catalyst provided 175.72 Subsequent TIPS deprotection led to the 
desired pentacyclic compound 176. It is worth noting that Funk was the first chemist to 
successfully use the diyne RCM strategy, developed by Fürstner, to prepare nakadomarin A 
(see section 1.3.1).33  
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Scheme 1.37: Synthesis of pentacycle 176. Conditions: a) PhCO2H, piperidine, benzene, 
87%; b) InCl3, CH2Cl2, 79%; c) KOH, H3O
+, MeOH; d) toluene, 80% over 2 steps; e) 
[(pyridine)(Ph3SiO)3MoN], toluene, 80%; f) H2, Lindlar’s cat., MeOH; g) TBAF, 80% over 2 
steps.  
34 
 
The synthesis concluded with the formation of the final E ring. Oxidation of the alcohol 176 
with IBX was followed by Tebbe olefination to afford the alkene 177 (Scheme 1.38).73 
Subsequent removal of the Boc and N-acylation with 5-hexenoyl chloride provided 178. 
Finally, RCM of 178 followed by reduction of the bis-lactam 179 afforded nakadomarin A 
(1).  
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Scheme 1.38: End game: a) IBX, DMSO; b) Cp2TiCH2AlClMe2, THF, 68% over 2 steps; c) TFA, 
CH2Cl2; d) 5-hexenoyl chloride, Et3N, benzene, 74% over 2 steps; e) Grubbs I, CH2Cl2; f) 
AlCl3, LiAlH4, THF, 58% over 2 steps. 
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1.2.8 Zhai’s total synthesis (2011)  
In 2011, Zhai and co-workers accomplished the fourth total synthesis of natural 
nakadomarin A.30 Zhai’s retrosynthetic analysis started with the disconnection of both 
macrocycles, to provide the tetracyclic intermediate 180 (Scheme 1.39). This compound 
would come from the alkene 181, the product of a PtII-promoted cascade reaction of the 
alkyne 182.74 Alkyne 182 would result from a Sonogashira coupling between 183 and the 
corresponding furan partner. Finally, 183 would be obtained from aldehyde 184. 
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Scheme 1.39: Retrosynthetic analysis 
The synthesis started with the preparation of the coupling partner for the Sonogashira 
coupling reaction, furan 188, which was easily obtained in four steps (Scheme 1.40). The 
THP ether of propargyl alcohol (185) was deprotonated and treated with γ-butyrolactone 
to afford the ynone 186. Subsequent iodination/cyclisation provided the alcohol 187.75 The 
desired furan (188) was finally obtained after TBDPS protection. 
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Scheme 1.40: Conditions: a) γ-butyrolactone, BuLi, BF3.Et2O, THF; b) HI, toluene; c) pTSA, 
MeOH, 53% over 3 steps; d) TBDPSCl, imidazole, CH2Cl2, 89%. 
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For the second fragment, readily available aldehyde 184 underwent reductive amination, 
followed by N-sulfonylation to provide the akyne 183 (Scheme 1.41).69 A Sonogashira 
coupling with the previously prepared iodo furan 188 afforded 182. Subsequent PtII-
promoted cascade reaction, employing Dake’s conditions, provided tetracyclic compound 
181 in a regiospecific (6-endo vs. 5-exo) and stereospecific fashion.76 This compound was 
then subjected to stereoselective hydroboration followed by oxidation to afford 189. 
Subsequent Barton-McCombie deoxygenation, with prior xanthate ester formation, yielded 
180.77 Finally, reduction of the ester within 180 to the aldehyde, followed by Wittig 
olefination afforded the alkene 190. 
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Scheme 1.41: Conditions: a) propargylamine•HCl, Et3N, tBuOH, NaBH4, MeOH; b) BsCl, 
Et3N, DCM, 54% over 2 steps; c) 188, [Pd(PPh3)2Cl2], CuI, Et3N, DMF, 87%; d) PtCl2, MePh, 
81%; e) BH3•SMe2, THF, H2O2, NaOH, 81%; f) NaH, CS2, MeI, THF; g) Bu3SnH, AIBN, toluene, 
94% over 2 steps; h) DIBAL-H, DCM; i) CH3PPh3Br, tBuOK, THF, 74% over 2 steps. 
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Boc removal and N-acylation with 5-hexenoyl chloride of the resulting free amine was 
followed by removal of the TBDPS group, to provide 191 (Scheme 1.42). Subsequent RCM 
with Grubbs’ second generation catalyst afforded pentacyclic compound 192. Standard 
Swern oxidation and Wittig olefination led to compound 193, from which the Bs group was 
removed and the resulting secondary amine was treated with 6-bromo-1-hexene to provide 
the triene 194. Subsequent RCM and reduction of the lactam afforded the nakadomarin A 
(1) but only with a 2:1 ratio of Z and E isomers.  
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Scheme 1.42: Conditions: a) ZnBr2, CH2Cl2; b) 5-hexenoyl chloride, Et3N, DMAP, CH2Cl2; c) 
TBAF, THF, 70% over 3 steps; d) Grubbs II, CH2Cl2; e) (COCl)2, DMSO, Et3N, CH2Cl2, f) 
CH3PPh3Br, K2CO3, CH2Cl2, 70% over 3 steps; g) Na, naphthalene, THF; h) 6-bromo-1-hexene, 
K2CO3, EtOH, 91% over 2 steps; i) Grubbs I, CSA, CH2Cl2, Z/E 2:1, 65% (E+Z), 31% pure Z; j) 
Red-Al, toluene, 85%. 
 
1.3 Other approaches towards nakadomarin A 
Several other research groups have also been working toward the total synthesis of 
nakadomarin A and have developed the synthesis of various ring systems present within the 
target. The following paragraphs describe such approaches and highlight many elegant 
chemical transformations.  
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1.3.1 Fürstner strategies (1999 & 2001) 
The first publication towards the synthesis of the main core of nakadomarin A was 
presented in 1999 by Fürstner and co-workers.33 The Fürstner group developed an diyne 
RCM method, and tested it on the synthesis of the 15-membered ring of nakadomarin A. As 
previously described, this work was great inspiration to other groups working on the 
synthesis of this natural product. The synthesis of the model system started with the 
deprotonation of readily available 196, followed by trapping of the resulting sulfur ylide 
with 4-hexynal to deliver vinylepoxide 197 (Scheme 1.43).78 Subsequent treatment with 
methyl (phenylsulfonyl)acetate, in the presence of Pd(0), followed by THP protection of 
the hydroxyl group provided the alkyne 198. 
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Scheme 1.43: Conditions: a) tBuLi, THF; b) CH3CCCH2CH2CHO, THF, 70% over 2 steps; c) 
PhSO2CH2COOMe, Pd(Ph3)4, THF, 81%; d) DHP, PPTS, CH2Cl2, 89%.  
The sequence continued with the TBAF removal of the TBS group which triggered 
spontaneous lactonisaton to afford 199 (Scheme 1.44). Treatment of this lactone with 1-
amino-5-heptyne led to the formation of diyne 200. 
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Scheme 1.44: Conditions: a) TBAF, NH4F, THF, 81%; b) CHCC(CH2)4NH2, NaCN, MeOH, 96%. 
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Oxidation of the primary alcohol 200, followed by cleavage of the THP protecting group 
resulted in the formation of the 2,4-disubstituted furan 201 (Scheme 1.45). Subsequent 
treatment of diyne 201 with catalytic amounts of Schrock’s tungsten alkylidyne complex 
resulted in the formation of the desired cycloalkyne 202 in 90% yield. Lindlar reduction of 
202 provided (Z)-alkene 203 in 97% yield, which constituted the fully functionalised 15-
membered ring of nakadomarin A. 
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Scheme 1.45: Conditions: a) MnO2, CH2Cl2; b) HCl, EtOAc, 96% over 2 steps; c) 
(tBuO)3WCCMe3, PhCl, 90%; d) H2, Lindlar’s cat., quinoline, CH2Cl2, 97%. 
In 2001, Fürstner and co-workers also reported the synthesis of a fully functionalised ADE 
ring system in which the quaternary centre was set with the correct absolute 
stereochemistry (Scheme 1.46).34 Starting from (R)-(+)-pyroglutaminic ester 204, 
conversion of this compound into the thioester 205 was followed by treatment with the 
corresponding amine to provide amide 206 in two steps and 70% yield.79 
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Scheme 1.46: Conditions: a) LiHMDS, THF, ClC(O)SEt, 96%; b) PMBNH(CH2)2CCCOOtBu, 
AgOTf, (iPr)2NEt, CH3CN, 73%. 
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With 206 in hand, Fürstner performed an intramolecular Michael addition reaction. 
Subsequent hydrogenation provided spirocycle bis-lactam 207 in 80% yield as a single 
isomer (Scheme 1.47). Removal of the N-Boc group and selective reduction of the methyl 
ester delivered 208. Oxidation of the resulting primary alcohol with Dess-Martin-
periodinane afforded the required aldehyde 209. Methylenation of this material followed 
by N-alkylation with 6-iodo-1-hexene provided the precursor 210 required for diene RCM. 
The phenylindenylidene complex 212 was employed as a pre-catalyst (Figure 1.4). The 
product was obtained in a nearly quantitative yield (98%). The final compound 211 was 
obtained by cleavage of the tbutyl ester and conversion of the free acid to the methyl 
ester. This compound represents a fully functionalised ADE segment of nakadomarin A. 
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Scheme 1.47: Preparation of 220. Conditions: a) (iPr)2NEt, MeCN; b) H2, Pd-C, MeOH, 80% 
over 2 steps; c) Mg(ClO4)2 MeCN, 99%; d) LiBH4, THF, 82%; e) DMP, H2O, CH2Cl2, 78%; f) 
CH2I2, Ti(OiPr)4, Zn, THF, 84%; g) NaH, DMF, then 6-iodo-1-hexene, 88%; h) catalyst 212, 
CH2Cl2, 98%; i) F3CCOOH, then Me3SiCHN2, toluene, MeOH, 85%. 
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Figure 1.4: Complex 212.  
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1.3.2 Magnus’ original approach (2002) 
Before publishing the formal synthesis presented section 1.2.6, Magnus published a 
synthesis of the tricyclic ABD ring structure of nakadomarin A employing an intramolecular 
Pauson–Khand reaction as the key step.80 The synthesis started with the treatment of 
lactam 213 with LiHMDS followed by treatment with methyl chloroformate (Scheme 1.48). 
Reduction of the resulting ester 214 with DIBAL-H followed by dehydration using 
quinolinium camphor sulfonic acid, provided 215 in 77% yield. Reductive amination of 215 
with 1-amino-3-butyne afforded the alkyne 216 and was followed by protection of the free 
amine with TsCl to provide 217, the precursor for the Pauson-Khand reaction. Enyne 217 
was subsequently subjected to cobalt-mediated Pauson-Khand reaction conditions to afford 
218 in 69% yield. Finally, hydrogenation of the double bond and removal of the Boc group 
provided the tricyclic ketone 219, in 95% yield.  
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Scheme 1.48: Magnus’ approach. Conditions: a) LiHMDS, THF, ClCO2Me, 85%; b) iBu2AlH, 
THF, PhMe; c) quinolinium camphor sulfonic acid, 77% over 2 steps; d) CC(CH2)2NH3Cl, Et3N, 
MeOH, NaBH4; e) TsCl, 75% over 2 steps; f) Co2(CO8), nBuSMe, 1,2-DCE, 69%; g) H2, Pd/C, 
65%. 
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1.3.3 Williams’ strategy (2004) 
In 2004, Williams and co-workers reported an asymmetric synthesis of the ADE-ring 
system,35 using an elegant azomethine ylide 1,3-dipolar cycloaddition reaction as the key 
step in the synthesis (Scheme 1.49). The key three component condensation of 220, 221 
and 222 allowed the formation of 224 as a single diastereomer in 35% yield. With 
compound 224 in hand, the removal of the chiral template was accomplished by 
hydrogenolysis using Pearlman’s catalyst leading to 225 in 93% yield. The pyrrolidine was 
then N-acylated with 5-hexenoyl chloride in 75% yield. Treatment of the carboxylic acid 
with trimethylsilyl diazomethane followed by SnCl2 yielded the diol 226 (80% yield over two 
steps), which was subsequently converted into the olefin 227.81 Ring-closing metathesis of 
227 with Grubbs’ second-generation catalyst afforded the ADE intermediate 228 in 65% 
yield. In this pathway, the asymmetric synthesis of the ADE fragment of nakadomarin A was 
accomplished in just nine steps from commercially available materials.  
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Scheme 1.49: Williams’ approach. Conditions: a) 228, 229, 230, toluene, 35%; b) H2, 
Pd(OH)2/C, MeOH, EtOAc, 92%; c) CH2CH(CH2)3COCl, Et3N, CH2Cl2, 75%; d) i) TMSCHN2, 
MeOH ii) SnCl2, CH3NO2/H2O, 80%; e) PPh3, imidazole, I2, toluene, 60%; f) Grubbs II, CH2Cl2, 
65%. 
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1.3.4 Winkler’s approach (2010)  
Finally, in 2010 Winkler published work towards nakadomarin A.36 Reaction between the 
known acid 229 and amine 230, followed by a deprotection/protection sequence provided 
benzoate 231 (Scheme 1.50).82 Subsequent cyclisation using DMTSF and treatment with 
CbzCl to reprotect the amine functionality led to the lactam 232. Finally, ester cleavage 
and cyclisation to give the cyclic urethane 233 was performed in 75% yield. 
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Scheme 1.50: Conditions: a) HATU, DIPEA, 83%; b) TBAF; c)  pBrPhCOCl, Et3N, DMAP, 89% 
over 2 steps; d) DMTSF, MeNO2, 50%; e) CbzCl, DIPEA, DMAP, 62%; f) K2CO3, MeOH, 75%. 
 
1.4 Contribution from the Clark group 
As described in the preceding section, nakadomarin A (1) is a member of the manzanine 
family of marine alkaloids. The Clark research group has already targeted this class of 
compound and in particular manzamine A (2). The strategy is to develop a route for both 
the syntheses of manzamine A (2) and nakadomarin A (1). This section will present the 
relevant work achieved previously towards these targets. 
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1.4.1 Towards manzanine A 
The strategy developed by the Clark group was based on a Pauson-Khand reaction and 
cuprate conjugate addition. The retrosynthetic analysis of mazanamine A (2) is depicted 
Scheme 1.51. Ircinal A 13 can be converted to manzamine A (2) in a two-step process, 
according to Kobayashi and co-workers.14 Indeed, intermediate 13 could be derived from 
234 by deprotection, oxidation of the aldehyde functionality and reduction of the lactam 
functionality. Retrosynthetic ring-closing diyne metathesis reveals 235. Removal of the 
alkyne side chains along with the hydroxyl side chain provides 236. The lactam 236 could 
be prepared by formation of the N-C bond and RCM of the bis-alkene. 237 would be formed 
by ring expansion of 238. Finally, 238 would be obtained from cuprate addition to the 
Pauson-Khand product 240. 
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Scheme 1.51: Clark’s strategy towards manzamine A. 
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1.4.2 Development of the key steps  
This approach started from commercially available propargylamine 241 (Scheme 1.52). 
Treatment of 241 with tosyl chloride followed by alkylation using 4-bromo-1-butene 
provided 242 in 95% yield over 2 steps. Subsequent Pauson-Khand reaction, using a 
catalytic amount of dicobalt octacarbonyl and under a carbon monoxide atmosphere, 
afforded the desired bicyclic enone 240 in high yield.83 
241
NTs
H2N
a, b
242 240
c
N
Ts
O
 
Scheme 1.52: Condition : a) TsCl, pyr., THF, 100%; b) 4-bromo-1-butene, K2CO3, acetone, 
95%; c) Co2(CO)8, TMTU, toluene, CO, 70 C, 6 h, 87%.  
The next step in this synthesis was the introduction of the side chain between the A and B 
ring via a cuprate addition (Scheme 1.53). Extensive screening of conditions was 
performed, and variations in copper source, temperatures, and solvents were explored.84 
After solving problems such as the competitive 1,2-addition reaction, improved conditions 
were identified, which provided the desired 1,4-product 243 in a modest 37% yield.  
N
Ts
O
N
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O +
N
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OH
240 243 244
H
 
Scheme 1.53: Optimised conditions of the cuprate addition. Conditions: AllylMgBr, CuI, 
THF, 40%, 5.8:1 ratio of 243:244. 
 
In an attempt to obtain a more suitable substrate for the following synthetic steps, an 
alternative side chain was tested. However, employing 1-bromo-2-butyne failed to deliver 
the desired alkyne 245 (Scheme 1.54). Indeed, the formation of the Grignard reagent was 
not as straightforward as expected, thus, the 1,4 addition product was not observed.85  
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Scheme 1.54: Towards 245. Conditions: 1-bromo-2-butyne, Mg, CuI, THF, 0%.  
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Instead of the unstable 2-butynylmagnesium bromide, the enyne side-chain was introduced 
using 1-iodo-4-(triisopropylsilyl)-3-butyne 247 (Scheme 1.55).86 The desired alkyne species 
247 was prepared from alcohol 246 in five steps and an excellent overall yield.  
a -e
OH I
TIPS
246 247  
Scheme 1.55: Formation of the side chain. Conditions: a) TMSCl, Et3N, CH2Cl2, 85%; b) 
nBuLi, Et2O, TIPSOTf, used crude; c) AcOH, THF, H2O, 82% over 2 steps; d) MsCl, Et3N, 
CH2Cl2; e) NaI, acetone, reflux, 90% over 2 steps.  
 
 Alkyne 247 was submitted to a lithium-halogen exchange with tBuLi, and treatment with 
copper iodide resulted in the formation of dialkyl cuprate 248 (Scheme 1.56). Enone 240 
was added in the presence of TMSCl and DMS which resulted in the formation of the desired 
enol ether 249. Due to the sensitivity of this intermediate, it was used immediately 
without full characterisation. However, the corresponding ketone 250, obtained after 
treatment of the crude enol ether 249 with acid, was fully characterised to confirm its 
structure. The expected cis configuration of the side chain was confirmed by X-ray studies 
of 250.  
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Scheme 1.56: Cuprate addition. Conditions: a) tBuLi, DMS, CuI, Et2O, THF, ―78 ºC to 0 ºC, 
45 min, used directly; b) 240, TMSCl, THF, 0 ºC, 2 h, used crude or 79% of 250. 
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1.4.3 Attempted formation of the C ring        
  
Studies directed towards the introduction of the second side chain using a Mukaiyama aldol 
condensation were explored with moderate success (Scheme 1.57). Treatment of silyl enol 
ether 249 with TiCl4 and valeraldehyde did not provide the alcohol 251 as expected. 
Instead, alkenes 252 and 253 were obtained, resulting from the dehydration of the alcohol 
251. Despite extensive efforts to avoid this outcome, the desired product was never 
obtained. 
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Scheme 1.57: Towards 251. Conditions: TiCl4, CH2Cl2 then (CH2)4CHO, 1:1 of 252:253, 
15%. 
 
To avoid the dehydration problem encountered during Mukaiyama aldol condensation, a 
route involving the alkylation of the TMS enol ether 254 with chloromethyl phenyl sulfide 
to form 255 was investigated (Scheme 1.58). Aldehyde 256 could then be obtained 
through oxidation and Pummerer rearrangement, and would be converted to the desired 
diene 257.87 Unfortunately, attempts to alkylate 254 did not deliver the desired product. 
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Scheme 1.58: Towards 257. Conditions: PhSCH2Cl, TiCl4, CH2Cl2, 0%. 
 
Alternatively, a pathway involving the intramolecular Mukaiyama aldol condensation was 
investigated. Starting from 240 and 258, a 1,4-conjugated addition followed by an 
intramolecular Mukaiyama aldol condensation would have ultimately led to tricyclic 
compound 260 (Scheme 1.59). Unfortunately, the precursor for the condensation reaction, 
ketone 259, was not obtained. Indeed, cuprate addition of allylic bromide 258 to enone 
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240 only resulted in an undesired 1,2-addition reaction. Introduction of various side chains 
was attempted but the desired compound could not be obtained. 
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Scheme 1.59: Intramolecular Mukaiyama aldol condensation. Conditions: tBuLi, CuI, DMS, 
TMSCl.  
 
In an additional attempt to form the C ring of manzamine A, electrophilic aminations were 
explored. An example is depicted in Scheme 1.60 with the unsuccessful use of 
hydroxylamine-O-sulfonic acid. 
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Scheme 1.60: Amination attempt. Conditions: hydroxylamine-O-sulfonic acid, TiCl4. 
 
In an alternative route, the Clark group also investigated Carreira’s methodology towards 
the direct introduction of N-trifluoroacetyl group using a manganese complex, such as 
(salen)Mn(N) 262 or (saltmen)Mn(N) 263 (Scheme 1.61 and Figure 1.5).88 The employment 
of such nitromanganese (V) complexes can result in nitrogen transfer when activated with 
trifluoroacetic anhydride, allowing direct introduction of a N-trifluoroacetyl group. 
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Scheme 1.61: Carreira’s strategy. Conditions: 264 or 265, (CF3CO)2O, pyr., CH2Cl2. 
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Figure 1.5: Manganese complexes. 
 
Both (salen)Mn(N) 264 and (saltmen)Mn(N) 265 complex were prepared, following reported 
precedent.88 Unfortunately, when employing these complexes on the TMS enol ether 249, 
the reactions failed to deliver the desired product 266 (Scheme 1.62).  
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Scheme 1.62: Conditions: 264 or 265, (CF3CO)2O, pyr., CH2Cl2, 0% 
 
Although the success towards the synthesis of the manzamine family of natural products 
was modest, numerous strategies have been eliminated. 
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Chapter 2: Results and discussion  
 
his chapter will focus on the approaches elaborated by the Clark group towards the 
synthesis of nakadomarin A. The chapter is divided into two main sections starting 
with the proposed retrosynthetic analysis followed by presentation of the synthetic 
progress.  
2.1 Retrosynthetic analysis  
As presented in an earlier section, the retrosynthetic approach taken by the Clark group 
towards nakadomarin A initially involved disconnection of the trisubstituted amine (ring D) 
leading to amide 267 (Scheme 2.1). This molecule could be accessed from the 
corresponding bisalkyne 268, which itself could be formed by a double alkyne ring-closing 
metathesis reaction of 269. Removal of the side chain on the trisubstituted nitrogen of the 
piperidine ring followed by disconnection of the furan ring leads to the bicyclic ketone 270. 
Removal of the side chains, on both A and B rings, gives the simplied bicyclic enone 240. 
This enone could then be obtained by the Pauson-Khand reaction of 271, prepared from 
commercially available propargylamine 241.  
T 
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Scheme 2.1: Retrosynthetic analysis of nakadomarin A. 
2.2 Results and discussion 
2.2.1 Towards the preparation of enone 240 
As depicted in section 1.4, the synthesis of nakadomarin A starts with the preparation of 
the enyne precursor 242 for the Pauson-Khand reaction (Scheme 2.2). Commercially 
available propargylamine 241 was treated with tosyl chloride under basic conditions to 
afford tosylated derivative 272 in 88% yield. Following this, treatment with 4-bromo-1-
butene delivered the required enyne precursor 242 in excellent yield.89 The bicyclic enone 
240 was then prepared by a Pauson-Khand reaction in 71% yield, using a catalytic amount 
of dicobalt octacarbonyl and tetramethyl thiourea under a carbon monoxide atmosphere.83  
240241
NH NTsH2N
a b c
N
Ts
O
272 242
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Scheme 2.2: Formation of enone 240. Condition: a) TsCl, THF, pyr, 0 ºC to rt, 16 h, 88%; 
b) 4-bromo-1-butene, K2CO3, acetone, reflux, 17 h, 91%; c) Co2(CO)8, TMTU, toluene, CO, 
70 C, 6 h, 71%.  
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2.2.2 Synthesis of the side chain 
With the synthesis of the AB core of nakadomarin A established, attention focused on 
preparation of the side chain required for the impending conjugate addition reaction. 
Following a literature protocol, this side chain was prepared from alcohol 246 (Scheme 
2.3).86 TMS protection of the hydroxyl group was followed by TIPS protection of the alkyne 
to provide 274. Susequent deprotection of the hydroxyl group, mesylation and 
displacement with iodine provided the desired alkyne species 247 in an excellent overall 
yield. 
a b
c
OH OTMS OTMS
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246 273 274
275 276 247  
Scheme 2.3: Preparation of the side chain. Conditions: a) TMSCl, Et3N, CH2Cl2, 0 C to rt, 
15 h, 73%; b) nBuLi, Et2O, TIPSOTf, ―40 C to rt, 16 h, used crude; c) AcOH, THF, H2O, rt, 
24 h, 85% over 2 steps; d) MsCl, Et3N, CH2Cl2, 0 C to rt, 17 h, 98%; e) NaI, acetone, reflux, 
24 h, 93%. 
With the desired side chain in hand, conjugate addition, via the corresponding cuprate 
derivative, was attempted (Scheme 2.4). The 1,4 addition of 248 to enone 240 took place 
under anhydrous conditions and the resulting enolate was trapped using TMSCl to afford 
silyl enol ether 249.90 Due to the sensitivity of this intermediate, it was used immediately 
without full characterisation, although a characteristic peak at 4.5 ppm was observed in 
the crude 1H NMR spectrum, corresponding to the enol ether hydrogen. Moreover, the 
corresponding ketone 250, obtained after treatment of the crude enol ether 249 with acid, 
was fully characterised to confirm its structure. The relative configuration was established 
by comparison with previously acquired data.84  
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Scheme 2.4: Cuprate addition. Conditions: a) tBuLi, DMS, CuI, Et2O, THF, ―78 ºC to 0 ºC, 
45 min, used directly; b) 240, TMSCl, THF, 0 ºC, 2 h, used crude or 96% of 250. 
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With the required alkyne chain in place, the next step involved the introduction of a 
nitrogen-containing group α to the ketone moiety. Several studies to explore this 
functionalisation have been undertaken within the group, with moderate success.84 The 
next section describes new strategies employed to install this requisite nitrogen atom.  
2.2.3 Radical cyclisation 
The initial strategy involved the deprotection of alkyne 250, followed by treatment with 
thiophenol and AIBN, to form the tricyclic ketone 278 (Scheme 2.5).91 Elimination of 
phenyl sulfide followed by reduction and protection of the ketone functionality would 
provide compound 279. Ozonolysis of the alkene would provide 280, which is the precursor 
for a Beckmann rearrangement to afford lactam 281. Further manipulation would then 
form the amino alcohol 282, with the desired functionality in place. 
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Scheme 2.5: Radical strategy. 
The mechanism of the key cyclisation is depicted Scheme 2.6.92 The addition of radical 
species PhS• to the alkyne 277 is followed by a 1,5-hydrogen transfer to deliver compound 
284. Subsequent 5-exo-trig radical cyclisation would lead to the formation of the tricyclic 
system 285. The radical formed will then be quenched to reveal the desired the tricyclic 
ketone 278. The formation of the cis product would be expected because the newly formed 
5-membered ring should be favoured compared to the trans fused product for ring-strain 
reasons.  
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Scheme 2.6: Anticipated mechanism of the radical cyclisation. 
The sequence commenced with removal of the TIPS group to afford bicyclic ketone 277 in 
84% yield (Scheme 2.7). However, subsequent attempts to perform at the radical 
cyclisation reaction using this species proved unsuccessful and resulted in the formation of 
an undesired product.91 Although the by-product formed under these conditions was not 
fully characterised, analysis of the 1H NMR spectrum suggested that addition of thiophenol 
to the alkyne functionality (compound 286), without continuing the radical cyclisation 
pathway, had occured.  
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Scheme 2.7: Attempts to perform the radical reaction. Conditions: a) TBAF, THF, ―78 ºC to 
rt, 17 h, 84%; b) AIBN, PhSH, toluene, 70 ºC, 16 h, 0% (formation of a by-product). 
In addition to the above, alternative conditions, described by Beaufils et al., were applied 
(Scheme 2.8).93 Unfortunately this reaction was also unsuccessful and the starting material 
decomposed, and so an alternative approach was explored. 
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Scheme 2.8: Conditions: AIBN, PhSH, tBuOH, benzene, reflux, (decomposition of SM). 
55 
 
2.2.4 Alternative route 
At this point, the synthesis of the desired α-amino ketone was explored using a simpler 
model substrate in order to test and optimise future steps. More specifically, a methyl 
cuprate addition was performed on enone 240 (Scheme 2.9). This reaction showed greater 
reproducibility and was more competitive in terms of cost, due to the commercial 
availability of the Grignard reagent. As encountered in the case of the initial target, the 
enol ether intermediate 287 could not be fully characterised due to its poor stability, and 
was directly used in the following reactions without purification. As before, the crude 1H 
NMR spectrum showed the presence of the characteristic enol ether signal. Also, after an 
acidic treatment, the corresponding ketone 288 was isolated and fully characterised to 
confirm its structure. 
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Scheme 2.9: Model system. Conditions: MeMgBr, CuI, TMSCl, Et2O, rt, 1 h, used crude or 
96% yield of the corresponding ketone 288 after an acidic work up. 
2.2.5 Introduction of an iodide 
Given the difficulties encountered when attempting direct formation of a third ring, an 
alternative route was considered. Introduction of an iodide, using N-iodosuccinimide (NIS) 
would form the iodo ketone 289 and would be followed by displacement with sodium azide 
to install the nitrogen atom in a more direct fashion (Scheme 2.10). In terms of the 
configuration at the carbon centre bearing the iodine, it is anticipated that a syn 
relationship with the methyl group will be set up due to steric interactions. Subsequent 
displacement with sodium azide will therefore result in an inversion of configuration at this 
centre and undesired compound 290 would result. An epimerisation, under basic 
conditions, would be required to form 291, if the molecule does not rearrange to give the 
cis configuration. 
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Scheme 2.10: Introduction of the iodide and displacement with NaN3.  
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The reaction between enol ether 287 and NIS resulted in an inseparable 1:6 mixture of the 
two isomers 289 and 292 (Scheme 2.11). Unfortunately, the iodides were too unstable to 
be characterised fully and were used crude to the next reaction. The mixture of 289 and 
292 was submitted to an epimerisation under basic conditions, in the hope of forming a 
single isomer, but this set of conditions only resulted in the decomposition of the starting 
material. 
287 289
N
OTMS
Ts
N
O
Ts
I
H H
+
N
O
Ts
I
292
H
a b
N
O
Ts
I
289
H
//
 
Scheme 2.11: Introduction of the iodide. Conditions: a) NIS, THF, ―78 ºC, 1 h, 20%, used 
crude; b) NaOH, H2O, pyr., rt, 10 min (decomposition of the SM). 
Moreover, the treatment of similar iodide substrates with sodium azide or various other 
amines, has been carried out within the group with little success.84 It is speculated the SN2 
displacement of iodide with an amine would have to occur from the more sterically 
hindered top face of the ring, and as a result, the desired product would not have been 
obtained in any case. Following these negative results, this strategy was abandoned.  
2.2.6 Reaction between sodium azide and the enol ether 
Despite the lack of success with the approaches so far, another strategy was pursued. 
Indeed, the direct reaction between an enol ether and sodium azide in the presence of CAN 
is known to form the resulting α-azido ketone.94-97 Applying this to our target, we envisaged 
the preparation of compound 291, followed by a reduction to afford the desired amine 294 
(Scheme 2.12).  
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Scheme 2.12: Introduction of the azide and subsequent reduction. 
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Unfortunately, when applied to our substrate, the formation of α-azido ketone 291 proved 
to be difficult (Scheme 2.13). In fact, the best result obtained was the formation of an 
inseparable 6:1 mixture of both ketone 288 (the product of the hydrolysis of the silyl enol 
ether) and α-azido ketone 291. 
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Scheme 2.13: Treatment of 287 with NaN3 and CAN. Conditions: NaN3, CAN, MeCN, ―20 ºC, 
1h, 6:1 mixture of 288:291. 
As sodium azide did not seem to react rapidly enough, a new set of conditions involving the 
more reactive triflic azide were investigated (Scheme 2.14).98 Triflyl azide was prepared 
from triflic anhydride and sodium azide directly before addition to the enol ether substrate 
28.99 Unfortunately, this reaction did not provide any of the desired product, and only the 
ketone 37, resulting from enol ether hydrolysis, was observed.  
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Scheme 2.14: Use of triflyl azide. Conditions: N3OTf (formed from NaN3, Tf2O, MeCN, 0 ºC, 
2 h, used directly), MeCN, 0 ºC, 2 h, (only formation of ketone 288). 
At the same time, work carried out within the group has showed that the formation of an 
α-azido ketone was more sucessful when a larger TIPS enol ether was used.84 Thus, it was 
decided to use TIPSCl or TIPSOTf in order to trap the enol ether during the cuprate addition 
(Scheme 2.15). Unfortunately, the only product obtained with this reaction was the ketone 
288, suggesting the enolate was not trapped by the TIPS group. 
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Scheme 2.15: Preparation of compound 296. Conditions: a) MeMgBr, CuI, TIPSCl, THF 0 ºC 
then rt, 2h, (only formation of ketone 288); b) MeMgBr, CuI, TIPSOTf, THF 0 ºC then rt, 2h, 
(only formation of ketone 288). 
Undetered by these results, an alternative strategy was proposed to generate the TIPS enol 
ether 298 (Scheme 2.16). Instead of attempting to trap directly the enolate with the TIPS 
during the cuprate addition, the formation of a lithium enolate could be formed from the 
previously prepared TMS enol ether 287 using methyl lithium. Subsequent trapping of this 
lithium species with TIPSCl should form the desired compound 298.100 Unfortunately, 
despite using TIPSCl or the more reactive TIPSOTf, it was not possible to isolate the desired 
product 298. 
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Scheme 2.16: Switching silyl groups. Conditions: a) MeLi, Et2O, 0 ºC, used directly; b) 
TIPSCl, ―78 ºC to 0 ºC, (only formation of the ketone 288); c) TIPSOTf, ―78 ºC to 0 ºC, 
(only formation of the ketone 288).  
2.2.6 Other electrophilic sources of nitrogen 
At this juncture, attention turned to the use of alternative amination methods. Kobayashi 
and co-workers have demonstrated that it is possible to introduce an amino group at the α 
position of a ketone starting from an enol ether, using the electrophilic DEAD reagent, as 
depicted in Scheme 2.17 for one of their examples.101 
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Scheme 2.17: Use of DEAD. Conditions:  a) AgOTf (10%), DEAD, CH2Cl2, b) HF-THF, 90%. 
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Employing Kobayashi’s conditions on our enol ether 287 in an attempt to form the desired 
compound 300 was unsuccessful (Scheme 2.18) and only ketone 288 was observed. 
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Scheme 2.18: Use of DEAD, AgOTf (10%), DEAD, CH2Cl2, (ketone 288 obtained as the only 
product). 
In the same manner, another attempt to obtain the product by generation and reaction of 
the titanium enolate, following Gennari’s conditions was unsuccessful (Scheme 2.19).102 
Thus, this strategy was abandoned and our attention focused on other types of 
electrophile. 
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Scheme 2.19: Conditions: TiCl4, DIAD, CH2Cl2, rt, 20h, (no reaction). 
Despite the negative results obtained above, our attention turned to the use of another N-
electrophile that could be used for the preparation of α amino ketone: N-
tosyliminobenzyliodinane (PhI=NTs). This reagent has been used by Lim and co-workers to 
aminate cyclic ketones as depicted Scheme 2.20. For example, TMS enol ether 302 was 
treated with PhI=NTs to give the desired α-amino ketone 303 in 67% yield.103 
OTMS O
NHTs
302 303  
Scheme 2.20: Amination of silyl enol ether. Conditions: PhI=NTs, MeCN, rt, 67%. 
N-Tosyliminobenzyliodinane (305) is not commercially available and so was prepared by 
treatment of p-toluenesulfonamide with iodobenzene diacetate 304 in methanol following 
the procedure of Heuss and co-workers.104 The desired product was obtained in a 16% yield 
following this protocol (Scheme 2.21).  
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Scheme 2.21. Preparation of N-Tosyliminobenzyliodinane. Conditions: TsNH2, KOH, MeOH, 
0 ºC to rt, 16%. 
Despite the low yield obtained from the formation of the N-tosyliminobenzyliodinane, there 
was sufficient material to screen various sets of reaction conditions with our substrate 
(Scheme 2.22 and Table 2.1). When the reaction was performed using Lim’s conditions, it 
failed to deliver the desired product (Entry 1). Thus, our attention turned to other sets of 
conditions, particularly those employing copper catalysis, because numerous groups have 
employed this strategy with success.104-107 The copper catalysts used in Entries 2―4 were 
commercially available,106-107 but Cu(MeCN)4ClO4 (Entry 5) had to be prepared and was used 
directly.105-106 Unfortunately, in every case, our attempt to prepare the amino ketone 306 
led to hydrolysis of the enol ether and ketone 288 was isolated instead of the desired 
product. Thus, aziridination of the TMS enol ether 287 did not seem to be a feasible 
approach to progress the synthesis.   
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Scheme 2.22: Use of PhI=NTs. Conditions: PhI=NTs, catalyst, ligand, solvent, ―20 ºC to rt 
(see Table 2.1). 
Entry Catalyst Ligand Solvent Time Results 
1 - - MeCN 17 h SM + Ketone 288 
2 Cu(acac)2 - MeCN 20 h SM + Ketone 288 
3 Cu(MeCN)4PF6 - CH2Cl2 20 h SM + Ketone 288 
4 Cu(MeCN)4PF6 TMEDA CH2Cl2 20 h SM + Ketone 288 
5 Cu(MeCN)4ClO4 - MeCN 18 h Ketone 288 
Table 2.1: Conditions used to install the tosyl amine. 
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2.2.7 Titanium Chemistry 
Due to the difficulties encountered at this stage, another pathway was investigated. In this 
case, an alternative reagent was employed for cuprate addition to the enone 240. In 1993, 
Paquette and co-workers published the enantioselective total synthesis of (—)-subergorgic 
acid, in the course of which they perform the 1,4 addition of a dioxalane containing 
organocopper reagent to the enone 307. Subsequent treatment of 308 with titanium 
tetrachloride formed the tricyclic ketone 309 as depicted in Scheme 2.23.108 
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Scheme 2.23: Paquette example. Conditions: a) Mg, 2-(2-Bromoethyl)-1,3-dioxolane, 
CuBr•SMe2, TMSCl, DMAP, 90%; b) TiCl4, CH2Cl2, 70% (1:1 mixture of diastereomers).  
It was believed Paquette’s ring construction methodology could be applied to the synthesis 
of the core of nakadomarin A by allowing us to prepare tricyclic ketone 311 (Scheme 
2.24). From this compound, the ketone functionality would be reduced and protected, and 
the ether would be oxidised to form ketone 280 (a key intermediate from our original 
approach cf Scheme 2.5). Subsequent Beckmann rearrangement would reveal the desired 
lactam 281. 
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Scheme 2.24: Strategy following Paquette’s work. 
Initial attempts to perform the reaction following Paquette’s conditions failed to deliver 
the desired 1,4-addition compound 312 and so the reaction had to be modified (Scheme 
2.25 and Table 2.2). The use of CuBr.SMe2 as the copper source, along with DMAP as 
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Paquette suggested, resulted in none of required product and led to the recovery of the 
starting material (Entries 1-3). However, when a catalytic amount of copper iodide was 
employed, reaction did occur, albeit to provide the product 313 arising from undesired   
1,2-addition.109 Upon switching to a super-stoichiometric amount of copper iodide, the 
desired product 312 was obtained in 55% yield (Entry 5).  
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Scheme 2.25: An approach using Paquette’s protocol. Conditions: a) Mg, 2-(2-Bromoethyl)-
1,3-dioxolane, copper source, solvent, additive (see Table 2.2). 
 
Entry Copper source (eq) Solvent Additive T Results 
1 CuBr•SMe2 (1.8) THF DMAP ―78 ºC No reaction 
2 CuBr•SMe2 (1.8) THF - ―20 ºC No reaction 
3 CuBr•SMe2 (1.8) THF DMAP ―20 ºC No reaction 
4 CuI (0.2) THF - ―30 ºC to ―78 ºC 313 (62%) 
5 CuI (1.2) THF - ―30 ºC to―78 ºC 312 (55%) 
Table 2.2: Optimisation of the cuprate addition.  
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Following the successful conjugated addition reaction, conditions were modified in order to 
prepare enol ether 314. TMSCl was added in order to trap the enolate (Scheme 2.26). 
However, subsequent treatment of 314 with titanium tetrachloride did not provide the 
corresponding tricyclic compound 311. Only the formation of the ketone 312 was 
observed. Several attempts were made to accomplish the transformation using various 
temperatures and using TiCl4 as either a 1 M solution in CH2Cl2 or in pure form (see 
conditions).110 
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Scheme 2.26: Conditions: a) Mg, 2-(2-bromoethyl)-1,3-dioxolane, CuI, TMSCl, THF, ―30 ºC 
to ―78 ºC, 2 h, used crude ; b) TiCl4, CH2Cl2, ―78 ºC , 10 min, (obtained only ketone 312, 
53%);  c) TiCl4, CH2Cl2, ―78 ºC to 0 ºC to ―78 ºC , 10 min, (obtained only ketone 312, 54%). 
2.2.8 Rubottom oxidation: formation of the hydroxyketone 316  
At this point in the project, it was clear that functionalisation of the TMS enol ether 287 
was difficult; but another attempt was made to elaborate this compound using Rubottom 
oxidation.111 As a result, our next approach was to prepare the hydroxyketone 316, by 
epoxidation of the silyl enol ether 287, followed by the opening of the epoxide to form 
hydroxyketone 316 (Scheme 2.27). This option would be a way to introduce a hetero 
functionality in the α-position of the ketone. The formation of the hydroxy ketone 316 
would open a new avenue of potential reactions to allow the formation of the α-amino 
ketone 317. 
N
OTMS
Ts
N
Ts
N
O
Ts
OTMS
O
N
Ts
O
OH
H H
H
240 287
316
315
N
Ts
O
NHR
H
317  
Scheme 2.27: Strategy to form the hydroxyketone 316. 
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The initial set of conditions used to perform Rubottom oxidation, involved treatment of 
287 with mCPBA. However this reaction led to decomposition of the starting material and 
only traces of the product 316 were observed. A significant improvement was achieved by 
treatment of the enol ether 287 with milder epoxidation reagent, dimethyldioxirane 
(DMDO).112 The desired hydroxyketone 316 was isolated in 73% yield over 2 steps after 
opening of the epoxy acetal under acidic conditions (Scheme 2.28).  
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Scheme 2.28. Formation of the hydroxyketone. Conditions: a) DMDO, CH2Cl2, 0 ºC, 5 min; 
b) AcOH, H2O, THF, rt, 3 h, 73% over 2 steps. 
Hydroxyketone 316 was obtained as a crystalline solid. In order to confirm its 
stereochemistry, this compound was submitted to X-Ray crystallography. The structure and 
the cis configuration of the methyl group compared to the hydroxyl group were validated 
(Figure 2.1 and Appendix 1). It is worth noting this 3D structure shows a poor accessibility 
to the top face of the molecule. 
 
Figure 2.1: X-Ray Analysis of 316 (see Appendix 1).  
The outcome of the reaction was very gratifying and installation of functionality at the α-
position of ketone 316 was a significant step forward. However, the cis stereochemistry 
obtained using the Rubottom conditions required inversion prior to a displacement with a 
nitrogen containing reagent; i.e. double inversion or net retention of configuration. It was 
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hoped under Mitsunobu conditions, the trans hydroxyketone 319 could be formed and 
mesylated to form the intermediate 320. Subsequent displacement with a nitrogen 
containing nucleophilic reagent (i.e. sodium azide), would produce the desired cis product 
291, which, in turn, could be reduced to give product 294 (Scheme 2.29).113 
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Scheme 2.29: Strategy for the formation of 294. 
Unfortunately, when applying the Mitsunobu strategy to our substrate, using 4-nitrobenzoic 
acid, the selectivity of the α-centre was lost and two inseparable isomers, 318 and 321, 
were formed in 91% yield but only 10:9 dr (Scheme 2.30). Once again, it is suspected the 
problem occurred due to the SN2 displacement being disfavoured when the approaching 
nucleophile comes from the less sterically accessible top face of the molecule. 
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Scheme 2.30: Mitsunobu reaction. Conditions: 4-nitrobenzoic acid, DIAD, PPh3, 0 ºC to rt, 6 
h, 91% yield, 10:9 dr. 
To overcome this steric issue, the next set of conditions investigated for the Mitsunobu 
reaction involved attempted introduction of a smaller acetyl group to form 322 (Scheme 
2.31).114 Unfortunately, this reaction failed and the starting material was not consumed. 
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Scheme 2.31: AcOH in the Mitsunobu reaction. Conditions: AcOH, DIAD, PPh3, Et2O, 0 ºC to 
reflux, 6 days (no reaction).  
In the same manner, it seemed likely that a Mitsunobu reaction could be performed using 
diphenyl phosphoryl azide (DPPA), and thus the nitrogen could be introduced directly at 
this stage, forming 323.115 Regrettably this reaction led to the formation of an unknown 
byproduct and none of the required azide 290 was isolated (Scheme 2.32).  
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Scheme 2.32: DPPA in the Mitsunobu reaction. Conditions: DPPA, DEAD, PPh3, THF, 0 ºC to 
rt, 16 h (by-product). 
Parallel to this work, our attention focused on the hydrolysis of the diastereomeric mixture 
of ester 318 and 321, to provide hydorxyketone 316 and 319. Regrettably, hydrolysis led 
to an unknown by-product. More surprisingly, when submitting the mixture of both isomers 
318 and 321, the formation of a single compound was observed (Scheme 2.33).  
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Scheme 2.33: Attempted hydrolysis of esters 318 and 319. Conditions: K2CO3 , MeOH, THF, 
rt, 17 h. 
To elucidate the structure of the by-product, it was decided to esterify previously prepared 
alcohol 316 under standard conditions to form 321 (Scheme 2.34). This allowed us to work 
with a single isomer, compared to a mixture, in order to screen the conditions for the 
hydrolysis reaction. Several standard basic conditions were used to perform hydrolysis 
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(Table 2.3), but the same by-product, hydroxyketone 323, was obtained in each case.116-
118. The formation and use of the product will be discussed in section 2.2.12 of this chapter. 
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Scheme 2.34: Esterification and hydrolysis. Conditions: 4-nitrobenzoic chloride, DMAP, 
Et3N, CH2Cl2, rt, 3 h, 95%; b) base, solvent (see Table 3). 
Entry Base (eq) Solvent Time T Results 
1 K2CO3 (3.3) MeOH/THF 16 h rt By-Product 316 (18%) 
2 NaOHaq, (1.2) MeCN 16 h rt By-Product 316 (45%) 
3 TMSOK (5) Et2O 2 h rt By-Product 316 (12%) 
4 Et3N (3.1) THF 16 h rt By-Product 316 (17%) 
 
Table 2.3: Attempted formation of 316 via 321.  
Despite the moderate success of the Mitsunobu reaction, another strategy, making use of 
the α-functionalised ketone 316, involved the preparation of bromide 324 before 
displacement with sodium azide (Scheme 2.35).  
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Scheme 2.35: Bromination and displacement. 
Accordingly, the formation of the brominated compound 324 was performed by 
displacement of the alcohol with carbon tetrabromide.119 However, the poor stability of 
this product did not allow for full characterisation and so the crude compound was used 
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directly in the displacement with sodium azide. Unfortunately, this reaction was not 
successful after several attempts (Scheme 2.36 and Table 2.4).120-121 This route was 
eventually abandoned, due to the difficulty in characterising 324 and confirming its 
structure and also determining the stereochemical outcome of the reaction. 
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Scheme 2.36: Bromination and displacement with azide. Conditions: a) CBr4, PPh3, CH2Cl2, 
rt, 2 h, used crude, b) NaN3, solvent, (see Table 2.4). 
 
Entry Solvent Eq NaN3  Time Temperature Results 
1 DMSO 3 2 h rt No reaction 
2 DMSO 3 16 h 35 ºC No reaction 
3 DMSO 3 16 h 50 ºC No reaction 
4 DMF 2 8 h rt No reaction 
5 DMF 4 16 h 35 ºC No reaction 
Table 2.4: Conditions used to displace the bromide  
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At this stage, attention turned to the direct displacement of the hydroxyl group in the 
hydroxyketone 316 with an azide source. The configuration of the hydroxyketone being cis, 
an SN2 displacement should lead to the undesired trans configuration of the azide in 
compound 290 (Scheme 2.37). Despite this, it was hoped the molecule would undergo 
epimerisation to give the more stable cis configuration, otherwise the reduction of the 
azide to the amine, leading to 326, would have to be followed by epimerisation to form 
the desired α-aminoketone 327. 
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Scheme 2.37: Strategy involving SN2 displacement of a leaving group. 
The first attempt to perform the transformation involved mesylation of the hydroxyl group, 
followed by  displacement with sodium azide (Scheme 2.38).113 The mesylation reaction 
proceeded well, as observed by TLC and analysis of the 1H NMR spectrum showed the 
formation of the mesylate 328, which was used crude because it was unstable. For the 
following displacement reaction, several sets of conditions were investigated, but no 
reaction occurred in any case, even when the reaction was heated to 65 ºC for 5 h. Because 
sodium azide can react violently when heated, the temperature was not increased further. 
As before, it can be assumed that attack from the top face of the molecule was not 
straightforward due to the steric encumbrance in this position, caused by the 
conformational preference of the bicyclic mesylate. Consequently, this strategy was 
abandoned. 
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Scheme 2.38: Mesylation and displacement. Condition: MsCl, Et3N, rt, used crude; b) NaN3, 
DMF, from 0 ºC over 2 h to 65 ºC over 5 h, no reaction. 
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2.2.9 Functionalisation at an earlier stage 
In all previous sections, the synthetic strategy has involved functionalisation of the α-
position of the molecule after the cuprate reaction. Due to the lack of success regarding 
this approach, it was decided to explore a different route, in which functionalisation of the 
Pauson-Khand enone product was performed (Route A, Scheme 2.39), or the requisite 
functionality was installed during the Pauson-Khand reaction (Route B, Scheme 2.40). 
Following this idea of introducing a group α to the ketone before the cuprate addition, the 
thought of preparing functionalised enone 329 from 240 was explored (Route A). 
Subsequent cuprate addition to the functionalised enone 329 and displacement of the 
newly installed group with an amine would produce the amino ketone 294.122 
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Scheme 2.39: Route A. 
In Route B, the enone 329 would be obtained directly by the Pauson-Khand reaction of 
alkyne 331. The group X would then be converted into the amino group in 294. 
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Scheme 2.40: Route B. 
Attempts to perform direct bromination of compound 240 resulted only in the formation of 
an undesired by-product. Although it was not possible to isolate and characterise this 
compound, formation of the double bromination product was suspected, as it is an 
intermediate on the pathway to the final product. Increasing the reaction time did not 
change the outcome of the reaction and treatment of the by-product with NaHCO3 resulted 
in the decomposition of the product (Scheme 2.41).123 
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Scheme 2.41: Bromination. Conditions: NaBr, oxone, CH2Cl2, H2O, Et3N, 0 ºC, 16h, then 
NaHCO3, 16h, reflux (decomp). 
Continuing with this new strategy, another set of conditions was explored (Scheme 2.42). 
Epoxidation of enone 240 was followed by treatment with DPPA, to form azide 335 in poor 
yield (12%).124-125 Moreover, the subsequent cuprate addition failed to deliver the required 
keto azide 291. It is also likely that the reaction would afford the non-desired isomer after 
the 1,4 addition, which would then require epimerisation. If the yield had been better 
reduction of the azide functionality in compound 335 to form the amine, and subsequent 
protection as an amide could have been explored, but this route was clearly problematic 
and so was abandoned. 
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Scheme 2.42: Conditions: a) H2O2, NaHCO3; b) DPPA, DMAP, DMF, LiClO4, 12%; c) MeMgBr, 
CuI, THF, rt, 3 h (decomp). 
Despite the problems outlined above, another pathway was investigated, in which a Curtius 
rearrangement reaction was used to install the amine functionality. First described by 
Curtius in 1890, this reaction involves the thermal decomposition of an acyl azide formed 
from an acid chloride, to produce an isocyanate (Scheme 2.43).126 The isocyanate 
intermediate may be isolated, or can be trapped by various nucleophiles to form an amide, 
such as 339. 
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Scheme 2.43: Curtius rearrangement. Conditions: a) NaN3; b) heat; c) R2OH.  
In an attempt to use this transformation to access our desired target, our first goal was to 
install a carboxyl group in place, α to the ketone (340). Subsequent manipulation to the 
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acid chloride 341, followed by formation of the acyl azide 342 would allow the preparation 
of the amide 344 by isocyanide formation and rearrangement (Scheme 2.44). It was hoped 
the acyl azide would rearrange to give the most thermodynamically stable isomer, with the 
cis configuration, otherwise epimerisation would be required. 
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Scheme 2.44: Curtius rearrangement strategy.  
To form the desired compound 340, the route began with reaction of the previously 
prepared enyne 242 with paraformaldehyde, followed by protection of the resulting 
alcohol with a TBS group to provide 346 in 57% yield over two steps (Scheme 2.45). The 
subsequent Pauson-Khand reaction to form the core of our target provided the bicyclic 
enone 347 in modest yield. Unfortunately, attempts to perform the 1,4-addition reaction 
on this enone to give 340 led only to an unidentified by-product.  
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Scheme 2.45: Towards 340. Conditions: a) nBuLi, OH(CH2O)nH, THF, ―78 ºC to rt, 87%; b) 
TBSCl, DMAP, Et3N, CH2Cl2, rt, 66%; c) Co2(CO)8, TMTU, CO, toluene, 70 ºC, 48%; d) MeMgBr, 
CuI, THF. 
An alternative approach was explored, whereby an ester group was introduced prior to the 
Pauson-Khand reaction (Scheme 2.46). The ester cyclisation precursor 350 was prepared in 
34% yield from 242 but the Pauson-Khand reaction of this enyne failed. This result is not 
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without precedent, as previous attempts to perform Pauson-Khand reactions using ynoates 
have delivered mediocre results.127 
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Scheme 2.46: Towards 351. Conditions: ethylchloroformate, CH2Cl2, ―78 ºC to rt, 34%; b) 
Co2(CO)8, TMTU, CO (unknown by-product). 
In a final attempt to utilise the Pauson-Khand reaction with a more highly functionalized 
substrate, ynamide 352 was targeted (Scheme 2.47). Unfortunately, treatment of 350 
with aqueous ammonia failed to deliver the product and a by-product was obtained 
instead. 
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Scheme 2.47: Towards 352. Conditions: NH3/H2O, THF, rt (by-product). 
2.2.10 Neber rearrangement  
At this stage, our attention turned to another strategy, employing the Neber 
rearrangement. The Neber reaction is a powerful reaction in which an oxime (353) is 
converted to an α-amino ketone (357), via the formation of an azirene 356. It was first 
reported by Neber in 1926.128 The general reaction scheme is depicted in Scheme 2.48. 
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Scheme 2.48: Neber rearrangement. Conditions: a) TsCl; b) base; c) H2O. 
In our case, it was anticipated that formation of oxime 358 from enone 240, and 
subsequent treatment with TsCl would deliver tosylated compound 359. Subsequent 1,4-
conjugate addition combined with a Neber rearrangement in presence of HCl would 
ultimately deliver α-amino ketone salt 362 (Scheme 2.49).  
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Scheme 2.49: Neber rearrangement. 
This reaction sequence, in which cuprate addition is combined with a Neber rearrangement 
reaction, has never been described. Neither has a cuprate addition reaction starting from 
an α,β-unsaturated tosylated oxime. However, cuprate addition reaction to N-sulfinyl-α,β 
unsaturated imines has been reported by Ellman and McMahon (Scheme 2.50) with the aim 
of forming 365, via intermediate 364.129  
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Scheme 2.50: MacMahon and Ellman’s model  
In our case, the presence of the N-OTs functionality is crucial because is acts as the leaving 
group. Nevertheless, a similar intermediate to 364 could be reasonably formed in our case 
(366, Figure 2.2). 
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Figure 2.2: Possible intermediate.  
Thus, oxime 358 was prepared in 58% yield as a single isomer (Scheme 2.51). Whilst NOE 
experiments were unsuccessful in determining which isomer was formed, the subsequent 
steps were attempted directly. Protection of the oxime was performed and compound 359 
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was used directly without further purification. Unfortunately, the subsequent cuprate 
addition and Neber reactions failed to deliver the desired product and led to decomposition 
of the starting material.130 
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Scheme 2.51: Conditions: NH2OH.HCl, pyr, EtOH, rt, 24 h, 58%; b) TsCl, pyr, 0 ºC to rt, 4 h, 
24%; c) MeMgBr, CuI THF/Et2O, then HCl(aq), rt, 1 h (decomp). 
In order to probe the potential of this method, we decided to simplify the key reaction. 
Previously prepared ketone 288 was transformed into oxime 363, which was tosylated, to 
form the precursor for the Neber rearrangement (Scheme 2.52). Carrying out the reactions 
in this order, we anticipated the formation of the regioisomers 362 and 365, nevertheless 
the idea was explore the general feasibility of this strategy. The preparation of the oxime 
363 from ketone 288 was performed in 95% yield. Subsequent tosylation was accomplished, 
providing 364. The subsequent Neber reaction failed to deliver the product, and only 
decomposition of the starting material was observed. Consequently, this strategy was 
abandoned.  
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Scheme 2.52: Conditions: a) NH2OH.HCl, pyr, EtOH, rt, 24 h, 95%; c) TsCl, pyr, 0 ºC to rt, 4 
h, used crude; d) tBuOK, EtOH, toluene, 0 ºC to rt, 4 h, then HCl, rt (decomp). 
2.2.11 Cycloaddition 
Regardless of these results, attention turned to the direct formation of the third cycle 
using photocycloaddition chemistry. As early as 1964, Corey and Bass described an enone 
photocyclisation reaction, to form bicyclic compound 368 (Scheme 2.53).131 
Cyclohexenone 366 was treated with allene 367 and irradiated with a mercury arc lamp, in 
pentane to form the product 368. Since this initial study, other examples of reaction have 
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been described mostly with simple propadiene 367, and the head-to-head (HH) 
regioisomers ― where the ketone and alkene are syn ― are generally formed in considerably 
higher yield than the head-to-tail isomers.131-136 
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Scheme 2.53: Corey and Bass’ conditions. 
Moreover, in 1982, Becker and co-workers described the use of 3-methyl-1,2-butadiene 369 
(Scheme 2.54).137 The HH product 370 is also obtained as the major isomer in this case 
(71%), compared to the head-to-tail product 373. 
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Scheme 2.54: Becker’s conditions. 
Applying this method to our substrate, the reaction of the enone 240 with allene 369 
would form the tricyclic ketone 374 (Scheme 2.55). Subsequent reduction and protection 
of the ketone functionality would form 375, which after ozonolysis of the alkene would 
form cyclobutanone 376. Finally, Beckmann rearrangement of compound 376 would form 
the desired lactam 377. 
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Scheme 2.55: Radical cyclisation strategy 
In a practical sense, the use of compound 378 is a good alternative to allene 367 which is a 
highly flammable gas. Whilst 3-methyl-1,2-butadiene (378) is commercially available, it 
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was formed in two steps (Scheme 2.56).138 Treatment of 378 with HCl (conc), 
hydroquinone and CaCl2 provided the desired chlorinated alkyne 379 in 73% yield, which 
was transformed into 369 in 19% yield.  
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Scheme 2.56: Preparation of 125a. Conditions: a) CaCl2, hydroquinone, HCl (conc), 73%, b) 
Zn (granules), nBuOH, 19%. 
With 369 in hand, we screened various sets of conditions in order to form the desired 
tricyclic compound 374 in good yield (Scheme 2.57, Table 2.5). Irradiation of a solution of 
enone 240 and 369 for 2 h was first performed in cyclohexane (Entry 1), but the required 
reaction did not occur. By changing the solvent to a mixture of cyclohexane/acetone, 
traces of a new product were observed on TLC analysis (Entry 2). A dry state adsorption 
technique, using silica gel, was attempted, but this also proved unsuccessful (Entry 3).132 A 
great improvement was achieved, when using a 125 W Hanovia mercuy lamp, and running 
the reaction in cyclohexane (Entry 4).137 As predicted, and despite a decent overall yield 
(54%), the product was formed as an inseparable mixture of regioisomers. The ratio was 
determined by 1H NMR analysis. The yield was increased when the reaction was carried out 
in acetonitrile (Entry 5), but the ratio did not change. The reaction was also performed at 
―30 ºC, but this only resulted in a lower yield without altering the product ratio (Entry 6).  
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Scheme 2.57: Photocycloaddition. Conditions: see Table 2.5.  
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Entry Solvent Lamp 
Typea 
Eq. 
Allene 
Time T Yield Ratio: 
374:381:380 
1 Cyclohexane 1 1 2 h  rt 
No 
reaction 
- 
2 Cyclohexane/acetone  1 1 2 h  rt Traces - 
3 None 2 5 5 h rt 
No 
reaction 
- 
4 Cyclohexane 3 5 6 h rt 54%  3.7:1.4:1 
5 MeCN 3 5 6 h  rt 63%  3.5:1.4:1 
6 MeCN 3 5 10 h  ―30 ºC 34%  4:1.5:1 
a Type 1: LuzChem photoreactor, no cooling supply, 10x8W FL8BL-B lamps (UVA λ=360 nm), Type 2: LuzChem 
photoreactor, no cooling supply, 10x8 W low-pressure germicidal lamps (UVC λ=254 nm), Type 3: 125 W Hanovia 
Mercury Lamp, medium pressure, cooling supply (UVA λ=365 nm).  
b reaction was performed under dry state absorption conditions (silica gel). 
Table 2.5: Photocycloaddition. 
In an attempt to improve the ratio of products, more sterically hindered allenes were 
considered as substrates. Indeed, a bulkier group on the allene functionality should lead 
the reaction to favor of a HH product. The three commercially available compounds shown 
Figure 2.3 were tested. Unfortunately, as depicted Scheme 2.58 and Table 2.6, the ratio 
of the product obtained using 382 could not be determined due to the difficulty in 
interpreting the complex 1H NMR spectrum of the mixture (Entries 1 and 2). The use of 
allene 383 resulted in 2.9:1.1:1 ratio of 385/386/384 (Entry 3), a result that was poorer 
than that obtained using the optimised conditions described in Table 2.5. Finally, 
treatment of 240 with 384 resulted in the decomposition of the starting material (Entry 4) 
and no product was obtained. In this respect, this photocycloaddition pathway was 
abandoned.  
 
79 
 
C
C C
OMe
382 383 384  
Figure 2.3: Allenes used. 
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Scheme 2.58: Photocycloaddition. Conditions: see Table 2.6.  
 
Entrya Solvent Allene 
(eq.) 
Time T Results Ratio  
385/386/387 
1 MeCN 382 (7) 6 h rt 55% 
could not be 
determined 
2 1,2-DCE 382 (7) 6 h rt 60% 
could not be 
determined 
3 MeCN 383 (7) 6 h rt 61% 2.9:1.1:1 
4 MeCN 384 (7) 3 h rt Decomp.  - 
a All experiments were carried out using 125 W Hanovia Mercury Lamp, cooling supply (UVA λ=365 nm). 
Table 2.6: Photocycloaddition reactions of enone 240 with allenes 382-384. 
Despite the moderate success using various allenes as photocycloadditions partners, an 
alternative cycloaddition reaction was considered. Indeed, the cycloaddition reaction of 
dichloroketene to allylic ethers was described as early as 1978, by Malherbe and Bellus 
(Scheme 2.59).139 Simple allylic ether 388 was treated with dichloroketene 389 to form 
the dichlorocyclobutanone 390 in 25% yield. 
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Scheme 2.59: Cycloaddition with dichloroketenes.  
The reacting dichloroketene 389 was formed in situ, by dehalogenation of 
trichloroacetylchloride 391 with Zn-Cu couple, as depicted Scheme 2.60.140 
391 389
Cl
Cl
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Cl
C O
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Scheme 2.60: Formation of dichloroketene 389. Conditions: Zn-Cu couple, Et2O. 
In an attempt to use this transformation to prepare our desired target, our first goal was 
the reduction and protection of the ketone functionality of 240, to provide allylic ether 
393 (Scheme 2.61). Subsequent cyclisation with dichloroketene 389 would be followed by 
a Beckmann rearrangement to form tricylic lactam 395, from which dechlorination would 
provide the desired compound 377.  
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Scheme 2.61: Cycloaddition pathway. 
Thus, our strategy began with the reduction of the enone, using a Luche reduction,44 to 
provide 392 in a 100% yield as a single but undetermined isomer (Scheme 2.62). 
Subsequent TBS protection of the resulting hydroxyl group formed the desired compound 
396. Unfortunately, when following Green’s conditions,140 treatment of 396 with the 
ketene formed in situ failed to deliver the desired tricyclic compound 397 and only an 
uncharacterised by-product was observed. Although it was not possible to fully identify this 
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resulting by-product, 1H NMR spectrum analysis showed the disappearance of the entire 
OTBS group.  
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Scheme 2.62: Attempts to prepare ketone 397. Conditions: a) NaBH4, CeCl3•7H2O, MeOH, 
100%; b) TBSOTf, 2,6 lutidine, CH2Cl2, 100%; c) Cl3COCl, Zn-Cu couple, Et2O (by-product). 
In order to avoid the elimination of the protecting group, the hydroxy group in 134 was 
protected as an acetal (Scheme 2.63). Thus, enone 6 was treated with dimethyl 
propanediol to provide the desired compound 145 in 54% yield. However, subsequent 
treatment of 145 with dichloroketene failed to deliver the desired product 146 and only 
decomposition of the starting material was observed.  
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Scheme 2.63: Conditions: a) 2,2-Dimethyl-1,3-propanediol, oxalic acid, toluene, reflux, 4 
h, 54%; b) Cl3COCl, Zn-Cu couple, Et2O (decomp). 
In a final attempt to effect successful cycloaddition to the enone 240 with dichloroketene, 
the alcohol 392 was protected with a more robust methyl group (Scheme 2.64). This 
sequence was performed using standard methylation conditions, and provided 400 in 93% 
yield. Subsequent cycloaddition provided an extremely sensitive compound which could not 
be fully identified. However, analysis of the IR spectrum showed a peak at 1806 cm―1, 
which is characteristic to a bis-chlorinated cyclobutanone.140 This compound was treated 
with O-mesitylenesulfonylhydroxylamine (MSH),140 in the aim of forming the corresponding 
amide 402 by Beckmann rearrangement pathway. The resulting compound was also very 
sensitive and again could not be fully identified. In the same manner, analysis of the IR 
spectrum showed a peak at 1735 cm-1, characteristic to a bis-chlorinated 5 membered 
lactam. However, attempt to the dechlorination of 402 failed to produce the desired 
tricyclic compound 403. 
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Scheme 2.64: Conditions: a) MeI, NaH, THF, 93%; b) Cl3COCl, Zn-Cu couple, Et2O, used 
crude; c) MSH, CH2Cl2, used crude; d) Zn-Cu couple, NH4Cl, MeOH, rt, 3 h (decomp). 
Following these somewhat promising results, we turned to the dechlorination of 401 
(Scheme 2.65, Table 2.7). Unfortunately, attempts to perform this reaction proved 
unsuccessful, both when using Zn-Cu couple (Entry 1),140 or zinc dust (Entry 2).141 
Treatment of 401 with Bu3SnH in toluene also proved unsuccessful (Entry 3) and only led to 
the decomposition of the starting material.142 As a consequence of these negative results, 
the cycloaddition strategy with dichloroketenes was terminated. The major drawback of 
this technique was the poor stability of the chlorinated products, thus it was necessary to 
use the crude product directly in the following steps. Not being able to determine which 
reaction failed within a 3-step sequence was obviously undesirable. 
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Scheme 2.65: Conditions: see Table 2.7.  
 
Entry Conditions (eq.) Solvent T Time Results 
1 Zn-Cu (2.1), NH4Cl (sat) MeOH rt 5 h Decomp. 
2 Zn dust (4) AcOH rt 3 h Decomp. 
3 Bu3SnH (2.2), AIBN (0.1) Toluene rt 24 h Decomp. 
Table 2.7: Dechlorination. 
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2.2.12 Formation of the desired α-amidoketone 
At this stage, our attention returned to a by-product discussed earlier in this chapter. We 
first observed the formation of by-product 323, when treating ester 321 with base 
(Scheme 2.66 and refer to Scheme 2.33). Upon reviewing the literature, this type of 
transformation was also observed by Magnus and co-workers.143 The authors suggested that 
an oxidation mechanism - involving the oxygen of the air - via an intermediate such as 148 
is possible. To confirm the structure of 323 an X-ray crystal analysis was obtained (Figure 
2.4 and Appendix 2).  
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Scheme 2.66: Formation of 323. Conditions: NaOHaq, MeCN, rt, 16 h, 45% 
 
Figure 2.4: X-ray of 323 (see Appendix 2) 
Whilst we were surprised the compound 323 was obtained, we decided to explore the 
possibility of making use of this intermediate in our synthesis. Consequently, our attention 
turned to the strategy depicted in Scheme 2.67. Starting from 323, protection of the 
hydroxyl group would be followed by the transformation of the ketone functionality into an 
oxime, delivering compound 407. Subsequent reduction of the oxime would afford the 
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amine 408 and we were aware of the possibility of a facial bias, leading to either the cis or 
trans product. A further reaction with a corresponding acid chloride would form the desired 
amide 344.  
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Scheme 2.67: Final strategy to form the α-amidoketone 344. 
Our first goal was to prepare 323 in a higher yield (Scheme 2.68). This task was achieved 
by the use of DMP to oxidise hydroxyl ketone 316 and provided the enol form of the 
diketone (323) in excellent 99% yield.42,144 Subsequent protection of the hydroxyl group was 
followed by the preparation of oxime 410.145 The reaction time of this transformation was 
long (7 days at 40 ºC), and attempts to increase the reaction rate via a temperature 
increase resulted in a lower yield being obtained. Optimal yields were obtained when 2 
equivalents of hydroxylamine hydrochloride were added every 24 h for a period of seven 
days.  
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Scheme 2.68: Successful preparation of oxime 410. Conditions: a) DMP, CH2Cl2, rt, 2 h, 
99%; b) TBSOTf, 2,6-lutidine, CH2Cl2, 0 ºC to rt, 17 h, 78%; c) NH2OH.HCl, pyr, 40 ºC, 7 
days, 72%. 
Following the synthesis of the oxime 410 in good yield, attention was then focused on the 
reduction of 410 to give the amine 294 (Scheme 2.69). This step proved to be difficult, 
and deployment of standard conditions failed (Table 2.8). Indeed, attempts to reduce the 
oxime functionality with LAH in diethyl ether (Entry 1) resulted in decomposition of the 
starting material,146 and the same result was obtained when treating 410 with ammonium 
acetate or ammonium formate and zinc (Entries 2 and 3).147-148 Optimal conditions were 
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finally realised when using hydrogen gas and Pd/C, with hydrochloric acid, to trap the free 
amine 294 as its salt (Entry 4).149 Salt 411 was used in further steps as the crude product. 
Although a single isomer was formed, it is important to note that the configuration at this 
newly formed stereocentre was not determined at this point. 
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Scheme 2.69: Conditions: a) Pd/C, HCl, H2 (1 atm), rt, 3 h, used crude (and see Table 
2.8). 
 
Entry Conditions (eq) Solvent T  Time Results 
1 LAH (2) Et2O reflux 5 h  Decomp. 
2 CH3CO2NH4 (1.7), Zn (4.5) EtOH/H2O/ 
NH3(aq) 
80 ºC 20 h  Decomp. 
3  HCO2NH4 (3),  Zn dust (2) MeOH reflux 5 h 
No 
reaction 
4b  Pd/C, H2, HCl(aq)  EtOH 0 ºC 2 h 411  
b  The corresponding hydrochloride salt was obtained. 
Table 2.8: Reduction of 410.  
With 411 in hand, subsequent treatment of this compound with propionyl chloride and NMM 
provided the corresponding crystalline amide 157 as a single isomer as depicted Scheme 
2.70. The simple commercially available acyl chloride was used as a proof of concept for 
the preparation of the amide functionality. Regarding the configuration of 157, submission 
of the crystalline compound to X-ray studies showed that it had the undesired trans 
configuration (Figure 2.5 and Appendix 3).  
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Scheme 2.70: Conditions: a) NMM, propionyl chloride, THF, 0 ºC to rt, 24 h, 50% over 2 
steps. 
 
Figure 2.5: X-Ray of ketoamide 412 (see Appendix 3). 
Considering all of our synthetic efforts it was very encouraging to have finally installed the 
desired amide functionality present in compound 157. Although the configuration was the 
undesired (trans), we envisaged that an epimerisation reaction would address this issue 
(Scheme 2.71). Unfortunately, initial attempts to effect epimerisation were unsuccessful 
and we were unable to optimise the conditions due to time considerations.  
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Scheme 2.71: Epimerisation. Conditions: DBU, toluene, 0 ºC to rt, 16 h (no reaction). 
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2.2.13 Ongoing work 
Following the realisation of a strategy for the introduction of the amide functionality, the 
next step in our sequence required introduction of the correct side chain between the A 
and B ring (Scheme 2.72). Unfortunately, our strategy of reducing the oxime 410 to form 
the amide 411 involved hydrogenation with Pd/C. Of course, it is unlikely that such 
conditions would be compatible with a substrate, containing an alkyne or alkene.84 
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Scheme 2.72: Compatibility. 
In this regard, it would be necessary to find a milder method to reduce the oxime 
functionality. In a preliminary experiment, commercially available allyl magnesium 
bromide was used for the 1,4-addition onto the enone 240 (Scheme 2.73). From there, a 
similar pathway would lead us to the preparation of hydroxyketone 419. 
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Scheme 2.73: Rubottom oxidation 
Unfortunately this sequence was not successful, and two by-products were obtained instead 
of the required hydroxyketone 419. After reactions with allyl magnesium bromide and 
DMDO, ketone 243 and epoxide 420 were isolated, respectively in 52% and 23% as depicted 
Scheme 2.74. 
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Scheme 2.74: By-products of the Rubottom oxidation. Conditions: a) allylMgBr, CuI, TMSCl, 
THF, used crude; b) DMDO, CH2Cl2, (2 by-products 243 (52%) and 420 (23%)). 
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While the formation of 243 was clearly the product of the conjugated addition followed by 
hydrolysis of the TMS enol ether, we believed 420 was obtained by a 1,2-addition of the 
allyl magnesium bromide to the enone 6, followed by the epoxidation of the endo cyclic 
alkene with DMDO, as shown in Scheme 2.75. At this point, no further practical 
experiments were carried out on this part of the molecule.  
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Scheme 2.75: Formation of 420. Conditions: a) allylMgBr, CuI, TMSCl, THF, used crude; b) 
DMDO, CH2Cl2, 23%. 
 
2.3 Construction of the furan ring 
2.3.1 Initial strategy and model system 
In order to explore the formation of additional ring system within nakadomarin A, our 
attention focused on the construction of the furan ring (ring C). This work was performed in 
parallel with the research on the AB system as previously discussed. According to our 
proposed synthesis, the furan could be installed via an aldol condensation between 
aldehyde 422 and α-amino ketone 421 to form the resulting hydroxyketone 423 (Scheme 
2.76).150 Subsequent removal of the protecting group (PG) would allow the formation of the 
furan ring, and provide tricyclic system 424.151 
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Scheme 2.76: Strategy to install the furan ring.  
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The aldehyde 422, required for the aldol reaction could be obtained by a Grignard reaction 
between aldehyde 425 and alkyne 426 to form 427 (Scheme 2.77). Protecting group 
manipulation would be followed by oxidation to form the desired aldehyde 422. 
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Scheme 2.77: Strategy to form aldehyde 422.  
We initially focused on a model system to validate this approach strategy. Thus, aldehyde 
431 was prepared in two steps from commercially available L-isopropyl lactate 429 
following literature procedures (Scheme 2.78).152 First, L-isopropyl lactate 429 was 
protected with a THP group, in near quantitative yield. Subsequent reduction with DIBAL-H 
provided the desired aldehyde 431 in 63% yield. The main advantages of working with this 
model system were the low cost of the starting material and the easy scale-up. 
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Scheme 2.78: Aldehyde 431. Conditions: 3,4-dihydro-2H-pyran, PPTS, CH2Cl2, 98%; b) 
DIBAL-H, CH2Cl2, 63%. 
It was possible to attempt the aldol condensation of aldehyde 431 and the subsequent 
cyclisation reaction. Because the α-amino ketone 421 had not been prepared at this point, 
it was thought that the enone 240 could be used as a starting substrate (Scheme 2.79). 
The aldol reaction to introduce the oxygenated side chain would be followed by the 
protection of the free hydroxyl group in hydroxyketone 432 to provide the enone 433. 
Subsequent 1,4 addition and treatment with TMSCl should lead to compound 434. After the 
Rubottom oxidation and the formation of the corresponding α-hydroxy ketone 435, 
subsequent deprotection and cyclisation would provide tricyclic compound 436. We were 
hoping that at this stage the formation of the corresponding azide 437 would be more 
facile because there would be activation of the leaving group from the adjacent furan ring.  
90 
 
N
Ts
O
N
Ts
O
HO
OTHP
N
Ts
O
N
Ts
O
PGO
OTHP
N
Ts
OTMS
PGO
OTHP
R
N
Ts
O
PGO
OTHP
OH OH
N
Ts
O
N3
240 432 433 434
435 436 437
H
HHH
 
Scheme 2.79: Strategy to install the furan ring. 
The enone 6 proved to be unreactive towards an aldol reaction, and products of type 184 
were never obtained (Scheme 2.80). Numerous conditions were explored using various 
electrophiles (Table 2.9) such as 174 (Entries 1-3), acetone (Entry 4),153 or 3-
methylbutanal (Entry 5). Bases were also screened, with the use of LDA (Entries 1, 4 and 
5),154 NaHMDS (Entry 2) or LiHMDS (Entry 3),155 all proving to be unsuccessful in providing 
184.  
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Scheme 2.80: Attempts on the aldol reaction. Conditions: see Table 2.9. 
Entry Carbonyl 
(eq.) 
Eq. 
ZnCl2 
Base (eq.) T Results 
1 431 (2) 2.3 LDA (1.6) —78 ºC to 0 ºC 
to rt 
No reaction + 
decomp. 
2 431 (4) 6 NaHMDS (4) —65 ºC to 0 ºC 
to rt 
No reaction 
3 431 (4) 6 LiHMDS (4) —65 ºC to 0 ºC No reaction 
4 Acetone (1.4) 1.5 LDA (1.2) —50 ºC to 0 ºC 
to rt 
No reaction 
5 O
    
(1.4) 
1.5 LDA (1.2) —50 ºC to 0 ºC 
to rt 
No reaction 
Table 2.9: Aldol reaction. 
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2.3.2 Aldol reaction of the hydroxyketone 
Undaunted by these results, our attention focused on the use an alternative substrate in 
the aldol reaction. After synthesis of the hydroxyketone 316, a new strategy was 
considered (Scheme 2.81). Starting from 316, protection of the hydroxyl group could be 
followed by the aldol reaction to form 439, which would subsequently provide azide 437 in 
a few steps. 
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Scheme 2.81: Tactic starting from the hydroxyketone 316. 
The sequence started with TBS protection of the α-hydroxy ketone 316, to give the ketone 
440 in 87% yield (Scheme 2.82). Following this, we were pleased to discover that the 
subsequent aldol reaction provided compound 441. However, several diastereoisomers of 
441 were formed, making NMR interpretation difficult. Moreover, deprotection and 
cyclisation with the aim of preparing 442, did not work as expected (Table 2.10). In fact, 
treatment of 441 with pTSA, in THF/H2O at 70 ºC resulted in no reaction (Entry 1),
150 and 
the use of a combination of acetic acid and pTSA at rt for 16 h did not change the outcome 
(Entry 2). The same result was obtained when reacting 441 with acetic acid for 5 h at 70 ºC 
(Entry 3), but increasing the reaction time to 36 h decomposed the product (Entry 4). Using 
methanol as the solvent, with pTSA also resulted in decomposition of the starting material 
(Entry 5). 
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Scheme 2.82: Attempts to form 442. Conditions: a) TBSCl, imid., DMF, 87%; b) aldehyde 
431, LDA, ZnCl2, THF, —78 ºC, 67%; c) acid, solvent (see Table 2.10). 
 
Entry Acid (eq.) Solvent T Time Results 
1 pTSA (0.1)  THF/H2O 70 ºC 2 h No reaction 
2 pTSA (0.1) AcOH/THF/H2O rt 16 h No reaction 
3 AcOH (solv) THF/H2O 70 ºC 5 h No reaction 
4 AcOH (solv) THF/H2O 70 ºC 36 h Decomp.  
5 pTSA (0.1) MeOH rt 1 h Decomp. 
Table 2.10: Closure of the furan ring. 
To overcome this deprotection issue, we decided to switch protecting groups and use the 
PMB-protected analogue of 431. This new protecting group was expected to have two 
major advantages: firstly NMR interpretation would be easier (fewer isomers), and secondly 
deprotection and cyclisation would occur in a stepwise fashion under acidic conditions. 
Thus, the aldehyde precursor 444 was prepared from commercially available L-isopropyl 
lactate, in two steps (Scheme 2.83). Protection of the hydroxyl group in 429 was followed 
by reduction with DIBAL-H and affored the desired aldehyde 444. 
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Scheme 2.83. Preparation of aldehyde 446. Conditions: a) PMBCl, NaH, Bu4NI, DMF, 0 ºC to 
rt, 48%; b) DIBAL-H, DCM, —78 ºC, 77%. 
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With the aldehyde 444 in hand, the aldol condensation with 440 was performed providing 
the product 445 in a 65% yield (Scheme 2.84). Subsequent deprotection using ceric 
ammonium nitrate (CAN), in aqueous acetonitrile, provided the desired enone 447 in 75% 
yield.156 This compound, obtained as a mixture of isomers, was the result of PMB 
deprotection and dehydration of the adjacent alcohol of compound 446. This dehydratation 
reaction was not regarded as a problem, as the dehydration product is an intermediate 
expected on the pathway towards formation of the furan. 
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Scheme 2.84: Aldol condensation. Conditions: a) 444, LDA, ZnCl2, THF, —78 ºC, 65%; b) CAN, 
H2O, MeCN, rt, 75%. 
Following successful implementation of the aldol reaction, the next step was cyclisation to 
form the furan (Scheme 2.85). From enone 447, several sets of acidic conditions were 
investigated (Table 2.11). The use of pTSA in THF proved to be unsuccessful, resulting in the 
recovery of the starting material only (Entry 1). When acetic acid was employed (Entry 2), 
the same outcome was observed and cyclisation did not occur. Upon switching solvent to 
dichloromethane, pTSA did not react (Entry 3).157 However, by increasing the acidity and 
using sulfuric acid in dichloromethane (Entry 4), the unexpected by-product 448 was 
obtained (Figure 2.6). Treatment of 447 with acetic acid and hydrochloric acid in methanol 
at rt resulted in no reaction (Entry 5), and increasing the reaction temperature to 50 ºC 
resulted in the formation of the by-product 449 (Entry 6) (Figure 2.6). 
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Scheme 2.85: Efforts to close the furan ring. 
 
Entry Acid (eq.) Solvent T Time Results 
1 pTSA (0.1) H2O/THF rt 24 h No reaction 
2 pTSA (0.1) H2O/THF/AcOH 70 ºC 24 h No reaction 
3 pTSA (0.1) CH2Cl2 rt 16 h No reaction 
4 HCl (0.5) + H2SO4 (0.5) CH2Cl2 70 ºC 3 h 
By-product 448 (58%) 
5  HCl (0.5) MeOH/AcOH rt,  3 h No reaction 
6 HCl (0.5) MeOH/AcOH 50 ºC 2 h 
By-product 448 (68%) 
Table 2.11: Conditions tried to form the furan ring. 
The two by-products ― 448 and 449 ― were obtained in good yield and their structures 
were deduced by extensive analysis. The by-products were unexpected but mechanisms 
could be proposed for their formation (Scheme 2.86). Removal of the TBS group in 447 
could lead to 450. Subsequent keto-enolic equilibrium in 450 could lead to the formation 
of 451. From there, protonation of the hydroxyl group and dehydration would form enol 
453, which would rearrange to compound enone 454. The ketone 448 or 449 would then 
be obtained by alkene migration. To the best of our knowledge this kind of reaction is 
without literature precedent. 
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Figure 2.6: By-products. 
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Scheme 2.86: Proposed Mechanism.  
In the mechanism above, the starting point is the loss of the TBS group. Thus, our attention 
focused on the use of a protecting group which would be less sensitive to acidic conditions. 
First, the use of TBDPS group was examined, but reaction between 316 and TBDPSCl in DMF 
at rt for 70 h failed to provide the desired product 455; only starting material was 
recovered from this reaction (Scheme 2.87). Different conditions ― adding DMAP to 
promote the reaction, or heating to 60 ºC ― did not change the outcome. 
316 455
N
O
OH
Ts
N
Ts
OTBDPS
O
H H
//
 
Scheme 2.87: Use of TBDPS as a protecting group. Conditions: TBDPSCl, imid, DMF, rt for 
70 h or 60 ºC for 6h. No reaction. 
Despite the above, we decided to investigate the use of an alternative protecting group. 
The pivaloyl group seemed to be the group of choice as it is known to be fairly resistant to 
acid.158 Protection of the hydroxyketone 316 with PivCl was achieved in a near quantitative 
yield (Scheme 2.88). Subsequent aldol reaction between 456 and aldehyde 444 provided 
the desired compound 457, in 74% yield. Subsequent removal of the PMB group was 
achieved in a 71% yield, using ceric ammonium nitrate, forming the allylic alcohol 458. 
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Scheme 2.88: Formation of 458. Conditions: PivCl, pyr., rt to 40 ºC, 99%; b) aldehyde 444, 
LDA, ZnCl2, THF, —78 ºC, 74%; c) CAN, H2O, MeCN, 71%. 
Satisfactory removal of the PMB group meant a range of acidic conditions could be used to 
promote the formation of the furan ring (Scheme 2.89, Table 2.12). Following Mukai’s 
conditions, 31 treatment of 458 with CSA in toluene at reflux failed to deliver the desired 
product and only provided the same by-product 448 obtained previously (Entry 1). 
Decreasing the temperature to 70 ºC led to the recovery of the starting material without 
product formation (Entry 2), and the same outcome was obtained when employing acetic 
acid (Entry 3). Finally, treatment of 458 with hydrochloric acid also provided by-product 
449 (Entry 4).  
459458
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Scheme 2.89: Towards 459. 
 
Entry Acid (eq.) Solvent T time results 
1 CSA (2) toluene 110 ºC 4 h 448 (51%) 
2 CSA (2) toluene 70 ºC 16 h No reaction 
3 AcOH (0.1) H2O/THF 85 ºC 3 h No reaction 
4 HCl(aq) (0.1) H2O/THF 85 ºC 1h 449 (54%) 
 
Table 2.12: Towards 459. 
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2.3.3 An alkyne as the precursor for the furan ring 
It was at this juncture that Mukai and co-workers published their work on nakadomarin A 
(see section 1.2.5, Chapter 1). Their strategy was similar to ours with regards to the 
formation of the furan ring. Consequently, in order to deviate from their pathway, another 
route was proposed (Scheme 2.90). Starting from α-hydroxy ketone 439 our goal was to 
prepare alkyne 460. Subsequent furan closure would be performed using a gold catalysed 
reaction to provide the tricyclic system 461.159  
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Scheme 2.90: New route. 
Thus, our first aim was to install the alkyne functionality. The initial strategy we 
investigated involved the formation of keto ester 466, as a precursor of alkyne 468 
(Scheme 2.91).  
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465 X = OMe  
Scheme 2.91: Proposed route to form the alkyne 468. 
99 
 
Various sets of reagents and conditions were investigated in order to prepare keto-ester 
466 from hydroxyketone 440 (Scheme 2.92). Regrettably, despite the use of reagents, 
such as methylchloroformate 463 (Entry 1), methylcyanoformate 464 (Entries 2-4),136 or 
dimethyl carbonate 465 (Entry 5), no reaction occurred and the desired β-keto ester 466 
was not obtained (Table 2.13).160 
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464 X = CN
465 X = OMe  
Scheme 2.92: Attempts to prepare the β-keto ester 466. Conditions: ester, base, solvent 
(see Table 2.13) 
Entry Ester Base Solvent T Time Results 
1 463 LDA THF —78 ºC to —30 ºC 3 h No reaction 
2 464 LDA THF —78 ºC to —30ºC 3 h No reaction 
3 464  LDA/HMPA  THF —78 ºC to rt 3 h No reaction 
4 464  LDA/ZnCl2 THF —78 ºC to rt 3 h No reaction 
5 465 NaH MeOH reflux 4 h No reaction 
Table 2.13: Attempts to prepare β-keto ester 466. 
Despite the failure above, attention turned to the discovery of an alternative pathway to 
prepare alkyne 462. In this second approach, the aim was to prepare alkyne 462 from 
aldehyde 470 by a Corey Fuchs or Ohira Bestmann reaction (Scheme 2.93). Ultimately, 
alcohol 469 would be our required starting material. 
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Scheme 2.93: Corey Fuchs/Ohira Bestmann approach. 
In order to prepare 471 the first route we envisaged was the direct introduction of the 
hydroxy group (Scheme 2.94, Table 2.14). To install this functionality, our attention 
focused on the use of paraformaldehyde and proline. Several solvents and temperatures 
were screened, such as water at rt or 70 ºC (Entries 1 and 4), water/methanol at 50 ºC 
(Entry 2), or DMSO at 70 ºC (Entry 3). However, all these protocols led only to the recovery 
of the starting material.161-162 
471
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440  
Scheme 2.94: Towards 471. Conditions: OH(CH2O)nH, L-proline , solvent (see Table 2.14). 
 
Entry Solvent T Time Results 
1 H2O rt 1 h, No reaction  
2 H2O/MeOH 50 ºC 5 h No reaction 
3 H2O 100 ºC 5 h No reaction 
4 DMSO 70ºC 20 h No reaction 
Table 2.14: Conditions tested to form 471. 
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In addition to the above reactions, another set of conditions were tried to form the 
hydroxyketone 471, using hydroxymethylphtalimide (Scheme 2.95), but still no reaction 
occurred.161 
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Scheme 2.95: Condition: a) hydroxymethylphtalimide, LDA, THF, —78 ºC to rt, 3 h (no 
reaction); b) hydroxymethylphtalimide, 2,2,6,6-tetramethylpiperidine, THF, —78 ºC to rt, 3 
h (no reaction). 
Dismayed by the outcome of the reactions described above, introduction of the required 
substituent in the original Pauson-Khand reaction (as used previously) was considered. The 
bicyclic ketone 473 would be prepared from enyne 472, which itself would come from 
propargylamine 241 (Scheme 2.96).  
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Scheme 2.96: Pathway to form 473. 
The new Pauson-Khand sequence commenced with propargylamine 241 being treated with 
tosyl chloride to afford tosylated derivative 242 (Scheme 2.97). Subsequent Mitsunobu 
reaction with the appropriate protected diol 476 to form 474 was followed by a removal of 
the TBS group to provide 475.163  
HN NTs
OTBS
H2N
a bTs NTs
OH
c
474 475241 242  
Scheme 2.97: Conditions: a) TsCl, pyr, 0 ºC to rt, 16 h, 88%; b) DIAD, HO(CH2)3OTBS 476, 
PPh3, THF, rt, 17 h, 96%; c) TBAF, THF, 0 ºC to rt, 96%. 
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With the alcohol 475 in hand, the sequence continued with a Swern oxidation which 
provided aldehyde 476 in 88% yield. Subsequent Wittig reaction with the corresponding 
ylide [methyl (triphenylphosphoranylidene)acetate], provided the ester 477 in 89% yield 
(Scheme 2.98).164 Finally, DIBAL-H reduction of the ester 477 delivered the desired alcohol 
478 in 90% yield. 
NTs
OH
NTs
O
NTs
O
MeO
NTs
OH
a b c
475 476 477 478  
Scheme 2.98: Conditions: a) (COCl)2, DMS, Et3N, CH2Cl2, 88%; b) methyl 
(triphenylphosphoranylidene)acetate, CH2Cl2, rt, 17 h, 89%; c) DIBAL-H, CH2Cl2, —78 ºC, 1 h, 
90%. 
With this material in hand, the protection of the hydroxyl group in 478 allowed the 
formation of the enyne 479, precursor for the Pauson-Khand reaction (Scheme 2.99). 
When compound 479 was submitted to the set of Pauson-Khand reaction conditions used 
previously (catalytic amount of dicobalt octacarbonyl, 1 atm of CO, toluene), the product 
480 was obtained in low yield (20%). However, treatment of 479 with a stoichiometric 
amount of the cobalt complex provided a much improved 78% yield.165 It is worth noting 
that this reaction was difficult to scale up, as cobalt residues were not removed easily from 
the mixture. Unfortunately, subsequent removal of the TBS group in 480 failed to provide 
the hydroxyl ketone 481, and instead resulted in decomposition of the starting material. It 
is most likely that the newly revealed hydroxyl group underwent elimination, allowing 
polymerisation of the molecule.  
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478 479 481 
Scheme 2.99: Conditions: a) TBSCl, imid, CH2Cl2, rt, 17 h, 85%; b) Co2(CO)8, NMO, CH2Cl2, 
78%; c) TBAF, THF, 0 ºC, decomp. 
Thus, with the aim of avoiding the elimination of the hydroxyl group in 481, we considered 
tuning the reactivity of the bicyclic core by masking the enone functionality, with the 
expectation that elimination would be less likely to occur (Scheme 2.100). Accordingly, 
enone 480 was submitted to 1,4-cuprate addition to form the ketone 482 in 53% yield. 
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Unfortunately, subsequent treatment of 482 with ethylene glycol and pTSA, in toluene, at 
reflux resulted in the formation of the by-product 484 through elimination and alkene 
isomerisation.  
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Scheme 2.100: Toward 483. Conditions: a) MeMgBr, CuI, THF, rt, 1 h, 53%; b) ethylene 
glycol, pTSA, toluene, reflux, 6 h, Dean-Stark apparatus, 100% of 484. 
Alternatively, the same sequence could be performed replacing the TBS with a TES group 
(Scheme 2.101). Treatment of 478 with TESCl to provide 485 and this was followed by a 
Pauson-Khand reaction, forming 486 in a good overall yield. Compound 487 was the result 
of the subsequent 1,4-cuprate addition reaction using methyl magnesium bromide.  
478
N
Ts
O
486
N
OH
NTs
OTES OTES
N
Ts
O
OTES
H
a b c
Ts
485
487
 
Scheme 2.101: Alternative protecting groups. Conditions: a) TESCl, imid., CH2Cl2, rt, 17 h, 
100%; b) Co2(CO)8, NMO, CH2Cl2, 0 ºC, 64%; c) MeMgBr, CuI, THF, rt, 1 h, 64%. 
With bicyclic ketone 487 in hand, reduction of the ketone and TBS protection of the 
resulting alcohol provided compound 488 (Scheme 2.102). Unfortunately, the subsequent 
oxidation of the hydroxyl group under standard conditions (Swern or Dess Martin conditions) 
failed to deliver the desired aldehyde 489 and did not allow the formation of desired 
alkyne 490. As a consequence this strategy was aborted in order to focus on another 
pathway.  
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Scheme 2.102: Attempts towards the formation of 490. Conditions: a) NaBH4, MeOH, 0 ºC, 
1 h, 86%; b) TBSOTf, 2,6-lutidine, CH2Cl2, 0 ºC to rt, 17 h, 100%; c) (COCl)2, DMS, Et3N, 
CH2Cl2, —78 ºC to rt, 4 h (decomp.); d) DMP, CH2Cl2, 0 ºC, 1 h (decomp.). 
2.3.4 Photochemical Cycloaddition  
Finally, our attention returned to the feasibility of our first aldol strategy using the mixture 
of compounds obtained from the cycloaddition reaction (Scheme 2.103). As previously 
described, regioisomers 374, 380 and 381 were not separable. Aldol reaction of 374, 380 
and 381 provided 491 and was followed by removal of the PMB group. Finally, treatment of 
491 with CSA in toluene at reflux provided a new compound again as a mixture of 
regioisomers. The products were not separable, however analysis of the 1H NMR spectrum 
showed a peak at 5.76 ppm, characteristic of the C-H proton on the furan. Moreover, the IR 
spectrum showed the absence of the ketone and the mass spectrometry analysis was 
consistent with the formation of tetracyclic system 492.  
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Scheme 2.103: Suspected formation of 492. Conditions: a) 446, LDA, ZnCl2, THF, —78 ºC 
to rt, 18 h, 47%; b) CAN, MeCN/H2O, rt, 3 h; c) CSA, toluene, reflux, 3 h. 
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2.4 Conclusions and outlook 
2.4.1 Formation of aminoketone 316. 
The AB core of nakadomarin A was formed through a Pauson-Khand reaction. Subsequent 
cuprate addition and Rubottom oxidation allowed us to functionalise the α-position of the 
ketone, with the formation of hydroxyketone 316 (Scheme 2.104).  
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Scheme 2.104: Formation of hydroxyl ketone 316.  
We then demonstrated that it was possible to convert the hydroxyketone 316 into the 
oxidized product 323. This compound was the starting point of a new synthetic pathway 
that was used to prepare 412 (Scheme 2.105). Following this method, we successfully 
installed the required nitrogen atom. In total, from the starting commercially available 
propargylamine 241, 11 steps are required to prepare the amine.  
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Scheme 2.105: Formation of 412.  
By applying this strategy to the fully functionalised precursor, we could expect to prepare 
amide 494, (Scheme 2.106). Subsequent epimerisation and functionalisation would 
provide the diyne 496, precursor for alkyne RCM. At this stage, the southern part of 
nakadomarin A (1) will be in place. 
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Scheme 2.106: Future work. 
2.4.2 Formation of the furan ring 
Regarding the northern part of the molecule, our strategy for the introduction of the furan 
used an aldol reaction as the key step. Even though furan 492 could not be isolated and 
fully characterised, the data collected were consistent with its formation.  
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Scheme 2.107: Furan formation. 
By application of this strategy, amide 237 could be a potential starting point for furan 
formation (Scheme 2.109). Aldol reaction between 237 and a corresponding aldehyde 
would form 240 and subsequent removal of the THP group, followed by formation of the 
furan would deliver the desired amide 241.  
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Scheme 2.108: Future work. 
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Experimental Section 
 
General Reaction Conditions 
Reactions involving air-sensitive reagents and dry solvents were performed in glassware 
dried (120 °C) or flame dried prior to use. These reactions were carried out with the 
exclusion of air using a nitrogen or an argon atmosphere. 
 
Solvents and Reagents 
Organic solvents were dried using a Pure Solv™ solvent purification system. Liquid reagents 
were distilled prior to use if needed.166 All reagents were purchased from commercial 
suppliers and used without further purification except where it is stated. 
 
Chromatography 
Column chromatography was performed under pressure using silica gel (Fluorochem LC60A, 
35-70 micron, 60A) as solid support and HPLC-graded solvents as eluent. Petroleum ether 
used for column chromatography was 40―60 °C fraction. The reactions were monitored by 
thin-layer chromatography (TLC) on Fisher and Merck silica gel 60 covered alumina plates. 
The TLC plates were developed under UV-light and/or with a KMnO4-solution (3 g KMnO4, 20 
g K2CO3, 5 mL 5% NaOH (aq)  and 300 mL H2O) or in an anisaldehyde solution (anisaldehyde 
(15 g), EtOH (250 mL), concentrated H2SO4 (2.5 mL)). 
 
Apparatus 
IR spectra were recorded using a type IIa diamond single reflection element on a Shimadzu 
FTIR-8400 instrument. The IR spectrum of the compound (solid or liquid) was directly 
detected as a thin layer at ambient temperature.  
1H NMR spectra were recorded on a Bruker 400 MHz or 500 MHz spectrometer at ambient 
temperature. Data are reported as follows: chemical shift in ppm relative to CDCl3 (7.27) 
on the δ scale, integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m 
= multiplet, br = broad, or a combination of these), coupling constant(s) J (Hz) and 
assignment. 13C NMR spectra were recorded on a Bruker 400 MHz or 500 MHz Spectrospin 
spectrometer at 100 MHz or 126 MHz at ambient temperature and multiplicities were 
obtained using a DEPT sequence. Data are reported as follows: chemical shift in ppm 
relative to CHCl3 (77.16) on the δ scale and assignment. 
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High resolution mass spectra (HRMS) were obtained under EI, FAB, CI and ES conditions by 
the analytical services of the University of Glasgow on a Jeol MStation JMS-700 instrument. 
Low resolution mass spectra (LRMS) were carried out on the same instrument; the intensity 
of each peak is quoted as a percentage of the largest, where this information was 
available.  
Elemental analyses were carried out on an Exeter Analytical Elemental Analyser EA 440 by 
the analytical services of the University of Glasgow. Melting points were recorded with an 
Electrothermal IA 9100 apparatus.  
Nomenclature 
Compounds were named according to the IUPAC rules, whereas numbering of the carbons 
has been done independently to these rules to help with their identification. 
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4-Methyl-N-(prop-2-ynyl) benzenesulfonamide 272: 
                          
S
O
O
4
98
7
6
5
10
NH
32
1
272  
Pyridine (5.7 mL, 73 mmol) was added to a solution of p-toluenesulfonyl chloride (13.9 g, 
73.0 mmol) in tetrahydrofuran (150 mL). The solution was cooled to 0 ºC and 
propargylamine (5.0 mL, 73 mmol) was added dropwise. The mixture was stirred for 16 h, 
before an aqueous solution of sodium hydroxide (0.25 L, 2.0 M) was added. The resulting 
solution was stirred for 2 h at rt and the phases were separated. The aqueous phase was 
then extracted with ethyl acetate (3 × 200 mL), and the combined organic phases were 
washed with brine (400 mL), then dried over magnesium sulfate and concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel (petroleum 
ether:ethyl acetate, 7:3) gave the title compound 272 (13.5 g, 64.5 mmol, 88%) as a 
colourless solid.  
Rf: 0.48 (petroleum ether:ethyl acetate, 8:2); m.p.: 73―75 ºC (lit: 71―73 ºC); IR: νmax 3263, 
3032, 2862, 2121, 1597, 1435, 1319, 1149 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.77 (2H, d, J 
= 8.2 Hz, CH-C5, CH-C9), 7.31 (2H, d, J = 8.2 Hz, CH-C6, CH-C8), 4.72 (1H, br s, NH), 3.84 
(2H, dd, J = 6.0, 2.4 Hz, CH2-C1), 2.43 (3H, s, CH3-C10), 2.10 (1H, t, J = 2.4 Hz, CH-C3); 
13C 
NMR (101 MHz, CDCl3) δ 143.9 (C-C7), 136.5 (C-C4), 129.8 (CH-C6, CH-C8), 127.4 (CH-C5, 
CH-C9), 77.9 (C-C2), 73.0 (CH-C3), 32.9 (CH2-C1), 21.6 (CH3-C10); HRMS (CI, isobutane) for 
C10H12NO2S ([M+H]
+) calculated: 210.0589, found 210.0587; LRMS (CI, isobutane) m/z 
(intensity): 210 (100), 113 (30), 97 (38), 71 (57); Elemental analysis: C10H11NO2S requires 
C: 57.41%, N: 6.70%, H: 5.26%, found C: 57.35%, N: 6.65%, H 5.27%. The data observed are 
in accordance with literature values.167 
 
 
N-But-3-enyl-4-methyl-N-prop-2-ynyl-benzensulfonamide 242: 
                                  242
N
S
O
O
1
2
3
4
5
6
7
8
9
10
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12
13
14
  
C14H17NO2S 
  Molecular weight: 263.36 g.mol―1  
C10H11NO2S 
Molecular weight: 209.26 g.mol―1 
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Potassium carbonate (11.1 g, 80.3 mmol) and 4-bromo-1-butene (8.1 mL, 80 mmol) were 
added to a solution of 272 (14.0 g, 66.9 mmol) in acetone (300 ml) and the mixture was 
heated to reflux for 17 h. The reaction mixture was then cooled to rt and concentrated in 
vacuo. Ethyl acetate (300 mL) and water (200 mL) were added and the phases were 
separated. The aqueous phase was extracted with ethyl acetate (2 × 300 ml), and the 
combined organic phases were washed with brine (300 mL), then dried over magnesium 
sulfate and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether:ethyl acetate, 8:1) provided the title 
compound 242 (16.1 g, 61.1 mmol, 91%) as a colourless oil.  
Rf: 0.51 (petroleum ether:ethyl acetate, 6:1); IR: νmax 3279, 3070, 2924, 2121, 1597, 1442, 
1342, 1157 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.72 (2H, d, J = 8.2 Hz, CH-C9, CH-C13), 7.28 
(2H, d, J = 8.2 Hz, CH-C10, CH-C12), 5.75 (1H, ddt, J = 17.3, 10.3, 7.0 Hz, CH-C3), 5.08 
(1H, dd, J = 17.3, 1.2 Hz, CH2-C4), 5.06 (1H, d, J = 10.3 Hz, CH2-C4), 4.14 (2H, d, J = 2.2 
Hz, CH2-C5), 3.26 (2H, t, J = 7.2 Hz, CH2-C1), 2.41 (3H, s, CH3-C14), 2.33 (2H, dt, J = 7.2, 
7.0 Hz, CH2-C2), 2.02 (1H, t, J = 2.2 Hz, CH-C7); 
13C NMR (101 MHz, CDCl3): δ 143.5 (C-
C11), 135.9 (C-C8), 134.5 (CH-C3), 129.5 (CH-C10, CH-C12), 127.7 (CH-C9, CH-C13), 117.3 
(CH2-C4), 76.5 (C-C6), 73.8 (CH-C7), 45.7 (CH2-C1), 36.4 (CH2-C5), 32.2 (CH2-C2), 21.6 (CH3-
C14); HRMS (CI, isobutane) for C14H18NO2S ([M+H]
+) calculated 264.1058, found 264.1054; 
LRMS (CI, isobutane) m/z (intensity): 264 (100), 222 (55), 157 (9), 110 (18); Elemental 
analysis: C14H17NO2S requires C: 63.85%, N:  5.32%, H  6.51%, found C: 63.64%, N: 5.27%, H: 
6.65%. The data observed are in accordance with literature values.89  
 
2-(Toluene-4-sulfonyl)-1,2,3,4a,5-hexahydro-[2]pyrindin-6-one 240: 
                            
240
9 N
8 7
6
5
4
3
14
1
O
10 S
11
O
12
O
13
7a
4a
 
Tetramethylthiourea (2.1 g, 16 mmol) and dicobalt octacarbonyl (0.91 g, 2.7 mmol) were 
added to a flask, under argon atmosphere. This apparatus was evacuated and refilled with 
carbon monoxide (× 3), and toluene (400 ml) was added. A solution of 242 (7.0 g, 27 mmol) 
in toluene (100 mL) was added dropwise to the solution. The reaction mixture was stirred 
at 70 C for 6 h, and then then solvent was removed in vacuo. Purification of the residue by 
flash column chromatography on silica gel (petroleum ether:ethyl acetate, 6:4) provided 
the product 240 (5.5 g, 19 mmol, 71%) as a pale yellow solid.  
C15H17NO3S 
Molecular weight: 291.37 g.mol―1 
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Rf: 0.18 (petroleum ether-ethyl acetate, 5:5); m.p. 124―126 C (lit: 124―126 C); IR: νmax 
1708, 1342, 1155 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.65 (2H, d, J = 8.0 Hz, CH-C9, CH-
C13), 7.34 (2H, d, J = 8.0 Hz, CH-C10, CH-C12), 6.00 (1H, s, CH-C7), 4.72 (1H, d, J = 13.3 
Hz, CH2-C1), 3.94―3.97 (1H, m, CH2-C3), 3.20 (1H, d, J = 13.3 Hz, CH2-C1), 2.60―2.50 (3H, 
m, CH2-C3, CH2-C5, CH-C4a), 2.44 (3H, s, CH3-C14), 2.13―2.10 (1H, m, CH2-C4), 2.01 (1H, 
d, J = 16.2 Hz, CH2-C5), 1.46 (1H, ddd, J = 12.4, 11.7, 3.6 Hz, CH2-C4); 
13C NMR (101 MHz, 
CDCl3): δ 207.2 (C-C6), 172.2 (C-C7a), 144.2 (C-C11), 133.0 (C-C8), 129.9 (CH-C10, CH-
C12), 129.2 (CH-C9, CH-C13), 127.8 (CH-C7), 47.5 (CH2-C1), 45.7 (CH2-C3), 41.4 (CH2-C5), 
39.2 (CH-C4a), 32.1 (CH2-C4), 21.6 (CH3-C14); HRMS (EI) for C15H17NO3S ([M]
+) calculated 
291.0929, found 291.0932; LRMS (EI) m/z (intensity): 291 (62), 263 (24), 249 (13), 136 (91), 
108 (99), 91 (81); Elemental analysis: C15H17NO3S requires C: 61.83%, N: 4.81%, H: 5.88%, 
found C: 61.79%, N: 4.86%, H: 5.92%. The data observed are in accordance with literature 
values.83-84  
 
But-3-ynyloxy-trimethylsilane 273: 
          273
O Si
1
2
34
5
6
7
 
Trimethylsilylchloride (26.3 mL, 207 mmol) was added dropwise to a solution of 3-butyn-1-
ol (15.0 mL, 198 mmol) and triethylamine (30.1 mL, 217 mmol) in dichloromethane (150 
mL) at 0 C. The mixture was stirred at rt for 15 h and then a saturated aqueous solution of 
sodium hydrogenocarbonate (150 mL) was added. The phases were separated and the 
aqueous phase was extracted with dichloromethane (3 × 150 mL). The combined organic 
phases were washed with water (150 mL) and brine (150 mL), then dried over magnesium 
sulfate. After filtration, the solution was reduced in vacuo to 35 mL, and the crude 
compound was distilled at 124―128 C (1 atm) to provide the product 273 (20.5 g, 144 
mmol, 73%) as yellow oil.  
Rf: 0.71 (petroleum ether:ethyl acetate, 9:1); b.p.: 124―128 C (lit: 125―128 C); IR: νmax  
3313, 2956, 1251 cm―1; 1H NMR (400 MHz, CDCl3): δ 3.71 (2H, t, J = 7.1 Hz, CH2-C1), 2.40 
(2H, td, J = 7.1, 2.6 Hz, CH2-C2), 1.96 (1H, t, J = 2.6 Hz, CH-C4), 0.12 (9H, s, CH3-C5, CH3-
C6, CH3-C7); 
13C NMR (101 MHz, CDCl3): δ 81.5 (C-C3), 69.5 (CH-C4), 61.2 (CH2-C1), 22.8 
(CH2-C2), ―0.4 (CH3-C5, CH3-C6, CH3-C7); HRMS (CI, isobutane) for C7H15OSi ([M+H]
+) 
calculated 143.0892, found 143.0893; LRMS (CI, isobutane) m/z (intensity): 143 (100), 103 
C7H14OSi 
Molecular weight: 142.27 g.mol―1 
112 
 
(34), 85 (49), 69 (80); Elemental analysis: C7H14OSi requires C: 59.09%, H: 9.92%, found C: 
58.82%, H: 9.97%. The data observed are in accordance with literature values.86 
 
4-Triisopropylsilanyl but-3-yn-1-ol 275: 
    
5
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A solution of n-butyllithium (0.88 mL of a 2.5 M solution in hexane, 2.2 mmol), was added 
to a solution of 273 (300 mg, 2.11 mmol) in diethyl ether (10 ml), at ―40 C and the 
mixture was stirred at this temperature for 30 min. Triisopropylsilyl 
trifluoromethanesulfonate (0.62 mL, 2.3 mmol) was added and the mixture was allowed to 
warm to rt, and stirred for 16 h. The reaction mixture was then washed with an aqueous 
solution of sodium hydrogenocarbonate (5%, 20 ml), and brine (20 mL), then dried over 
magnesium sulfate and concentrated in vacuo. The residue was dissolved in a mixture of 
tetrahydrofuran (5 mL), water (2 mL) and glacial acetic acid (2 mL). The mixture was 
stirred for 24 h and then neutralised by the addition of a saturated aqueous solution of 
ammonium hydroxide (20 mL). Ethyl acetate (30 mL) was added and the phases were 
separated. The aqueous phase was extracted with ethyl acetate (3 × 30 mL), and the 
combined organic phases were washed with brine (30 mL), then dried over sodium sulfate 
and concentrated in vacuo. Purification of the residue by flash column chromatography on 
silica gel (petroleum ether:ethyl acetate, 7:1) provided the product 275 (408 mg, 1.8 
mmol, 85%) as a colourless oil.  
Rf: 0.63 (petroleum ether:ethyl acetate, 7:3); IR: νmax 3335, 2943, 2866, 2173, 1464 cm
―1; 
1H NMR (400 MHz, CDCl3): δ 3.72 (2H, t, J = 6.3 Hz, CH2-C1), 2.52 (2H, t, J = 6.3 Hz, CH2-
C2), 1.94 (1H, br s, OH), 1.05―1.03 (21H, m, CH-C5, CH3-C6, CH3-C7, CH-C8, CH3-C9, CH3-
C10, CH-C11, CH3-C12, CH3-C13). 
13C NMR (101 MHz, CDCl3) δ 105.2 (C-C4), 83.1 (C-C3), 
61.3 (CH2-C1), 24.4 (CH2-C2), 18.7 (CH3-C6, CH3-C7, CH3-C9, CH3-C10, CH3-C12 CH3-C13), 
11.3 (CH-C5, CH-C11, CH-C8); HRMS (CI, isobutane) for C13H27SiO ([M+H]
+) calculated 
227.1831, found 227.1826; LRMS (CI, isobutane) m/z (intensity): 227 (42), 185 (100), 113 
(14), 81 (31); Elemental analysis: C13H26SiO requires C: 68.96%, H: 11.57%, found C: 
68.84%, H: 11.63%. The data observed are in accordance with literature values.86 
 
C13H26OSi 
Molecular weight: 226.43 g.mol―1 
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Methanesulfonic acid 4-triisopropylsilanyl-but-3-ynyl ester 276: 
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Methanesulfonyl chloride (0.13 ml, 1.7 mmol) was added to a solution of 275 (340 mg, 1.50 
mmol) and triethylamine (0.23 mL, 1.7 mmol) in dichloromethane (30 mL) at 0 C. The 
solution was warmed to rt and stirred for 17 h. The mixture was then washed with a 
saturated aqueous solution of ammonium chloride (30 mL) and brine (30 mL), then dried 
over magnesium sulfate and concentrated in vacuo to provide 276 (0.45 g, 1.4 mmol, 98%) 
as a yellow oil. This product was used without further purification.  
1H NMR (400 MHz, CDCl3): δ 4.30 (2H, t, J = 6.3 Hz, CH2-C1), 3.03 (3H, s, CH3-C14), 2.71 
(2H, t, J = 6.3 Hz, CH2-C2), 1.05―1.03 (21H, m, CH-C5, CH3-C6, CH3-C7, CH-C8, CH3-C9, 
CH3-C10, CH-C11, CH3-C12, CH3-C13). The data observed are in accordance with literature 
values.86 
 
 (4-Iodo but-1-ynyl)-triisopropyl-silane 247: 
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Sodium iodide (2.2 g, 1.5 mmol) was added to a solution of 276 (0.45 g, 1.5 mmol) in 
acetone (10 mL). The solution was heated to reflux for 24 h and was then cooled to rt and 
partitioned between petroleum ether (20 mL) and water (20 mL). The phases were 
separated and the aqueous phase was extracted with petroleum ether (2 × 50 mL) and the 
combined organic layers were washed with a saturated aqueous solution of sodium 
thiosulfate (100 mL) and brine (100 mL), then dried over magnesium sulfate and 
concentrated in vacuo to provide 247 (0.46 g, 1.4 mmol, 93%) as a yellow oil. This product 
was used without further purification.  
1H NMR (400 MHz, CDCl3) δ 3.24 (2H, t, J = 7.3 Hz, CH2-C1), 2.82 (2H, t, J = 7.3 Hz, CH2-
C2), 1.04―1.07 (21H, m, CH-C5, CH3-C6, CH3-C7, CH-C8, CH3-C9, CH3-C10, CH-C11, CH3-
C12, CH3-C13). The data observed are in accordance with literature values.
86 
  
C14H28O3SSi 
Molecular weight: 304.52 g.mol―1 
C13H25ISi 
Molecular weight: 336.33 g.mol―1 
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2-(Toluene-4-sulfonyl)-7a-(4-triisopropylsilanyl-but-3-ynyl)-6-trimethylsilanyloxy-
2,3,4,4a,5,7a-hexahydro-1H-[2]pyrindine 249: 
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A solution of t-butyllithium (1.9 mL of a 1.6 M solution in heptane, 1.9 mL, 3.0 mmol,) was 
added dropwise to a solution of iodide 247 (0.51 g, 1.5 mmol), in diethyl ether (4 mL), at 
―78 ºC. The reaction was stirred at this temperature for 15 min, then allowed to warm at 
rt for 30 min. Meanwhile, dimethyl sulfide (0.8 mL, 0.01 mol) was added to a solution of 
copper (I) iodide (0.14 g, 0.75 mmol) in tetrahydofuran (4 mL), and the mixture was cooled 
at ―42 ºC. Immediately after the cooling, the lithium reagent was added dropwise, by 
canula, to this mixture. Chlorotrimethylsilane (0.14 mL, 1.1 mmol) was added to a solution 
of enone 240 (125 mg, 0.429 mmol) in tetrahydrofuran (4 mL), cooled to 0 ºC and the 
resulting mixture was then added dropwise, by canula, to the previously formed cuprate 
compound. After 2 h, the mixture was quenched with a mixture of a saturated aqueous 
solution of ammonium chloride (10 mL), saturated aqueous solution of ammonium 
hydroxide (10 mL) and water (20 mL). Diethyl ether (20 mL) was added and the phases 
were separated. The aqueous phase was extracted with diethyl ether (3 × 20 ml), and the 
combined organic phases were washed with water (40 mL) and brine (40 mL), then dried 
over sodium sulfate and concentrated in vacuo to provide 249 as a colourless foam. 
Product 249 was used directly in the next step without further purification. 1H NMR 
analysis showed a characteristic singlet at 4.5 ppm, corresponding to the enol CH-C7. The 
compound isolated after flash column chromatography on silica gel (petroleum ether:ethyl 
acetate, 7:3) was the corresponding ketone 250 (236  mg,  0.412 mmol, 96%) as a 
colourless oil. 
 
 
 
 
C31H51NO3SSi2 
Molecular weight: 573.31 g.mol―1 
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Isolation and characterisation of the corresponding ketone 2-(toluene-4-sulfonyl)-7a-(4-
triisopropylsilanyl-but-3-ynyl)-octahydro-[2]pyrindin-6-one 250: 
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Rf: 0.60 (petroleum ether:ethyl acetate, 5:5); IR: νmax  2941, 2864, 2360, 2169, 1745,1464, 
1163 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.61 (2H, d, J = 7.7 Hz, CH-C22, CH-C26), 7.33 (2H, 
d, J = 7.7 Hz, CH-C23, CH-C25), 3.24―3.27 (1H, m, CH2-C3), 3.09 (1H, d, J = 12.1 Hz, CH2-
C1), 2.73 (1H, dd, J = 9.8, 9.8 Hz, CH2-C3), 2.44 (3H, s, CH3-C27), 2.40―2.22 (6H, m, CH2-
C9, CH-C4a, CH2-C5, CH2-C7), 2.28 (1H, d, J = 12.1, CH2-C1), 2.10―1.98 (2H, m, CH2-C4, 
CH2-C8), 2.02 (1H, dd, J = 18.7, 7.5 Hz, CH2-C5), 1.71 (1H, ddd, 14.9, 7.4, 7.4 Hz, CH2-C8), 
1.56―1.61 (1H, m, CH2-C4), 1.03―1.06 (21H, m, CH-C12, CH3-C13, CH3-C14, CH-C15, CH3-
C16, CH3-C17, CH-C18, CH3-C19, CH3-C20); 
13C NMR (101 MHz, CDCl3): δ 216.2 (C-C6), 143.9 
(C-C24), 132.8 (C-C21), 129.9 (CH-C23, CH-C25), 127.5 (CH-C22, CH-C26), 107.7 (C-C10), 
81.4 (C-C11), 48.8 (CH2-C1), 47.6 (CH2-C3), 42.2 (CH2-C7), 41.4 (C-C7a), 40.4 (CH2-C5), 37.2 
(CH-C4a), 34.9 (CH2-C8), 24.8 (CH2-C4), 21.5 (CH3-C27), 18.6 (CH3-C13, CH3-14, CH3-C16, 
CH3-C17, CH3-C19, CH3-C20), 15.2 (CH2-C9), 11.2(CH-C12, CH-C15, CH-C18); HRMS (CI, 
isobutane) for C28H44NO3SSi ([M+H]
+) calculated 502.2811, found 502.2807; LRMS (CI, 
isobutane) m/z (intensity): 502 (100), 348 (35), 157 (31). The data observed are in 
accordance with literature values.84 
 
7a-But-3-ynyl-2-(toluene-4-sulfonyl)-octahydro-[2]pyrindin-6-one 277: 
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Tetrabutylammonium fluoride (1.4 mL of a 1.0 M solution in tetrahydrofuran, 1.4 mmol) 
was added dropwise to a solution of crude 249 (404 mg, 1.17 mmol) in tetrahydrofuran (15 
mL), at ―78 ºC. The reaction was allowed to warm at rt and stirred for 17 h. Diethyl ether 
C28H43NO3SSi 
Molecular weight: 501.8 g.mol―1 
C19H23NO3S 
Molecular weight: 345.46 g.mol―1 
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(15 mL) and a saturated aqueous solution of ammonium chloride (10 mL) were added and 
the phases were separated. The aqueous phase was extracted with diethyl ether (2 × 15 
mL), and the combined organic phases were washed washed with brine (20 mL), then dried 
over magnesium sulfate and concentrated in vacuo. Purification of the residue by flash 
column chromatography on silica gel (petroleum ether:ethyl acetate, 8:2) provided the 
product 277 (0.34 g, 0.98 mmol, 84%) as a colourless solid. 
Rf: 0.57 (petroleum ether:ethyl acetate, 5:5); m.p.: 129―131 ºC; IR: νmax 3281, 2926, 1737 
cm―1; 1H NMR (400 MHz, CDCl3): δ 7.59 (2H, d, J = 8.4 Hz, CH-C13, CH-C17), 7.32 (2H, d, J 
= 8.4 Hz, CH-C14, CH-C16), 3.27―2.23 (1H, m, CH2-C3), 3.11 (1H, d, J = 12.4 Hz, CH2-C1), 
2.71 (1H, dd, J = 9.6, 9.6 Hz,  CH2-C3), 2.42 (3H, s, CH3-C18), 2.39 (1H, d, J = 12.4 Hz, CH2-
C1), 2.30―1.97 (10H, m, CH2-C4, CH-C4a, CH2-C5, CH2-C7, CH-C11, CH2-C8, CH2-C9), 1.67 
(1H, ddd, J = 14.3, 7.6, 6.6 Hz, CH2-C8), 1.59―1.56 (1H, m, CH2-C4); 
13C NMR (101 MHz, 
CDCl3): 216.1 (C-C6), 143.9 (C-C15), 132.8 (C-C12), 129.8 (CH-C14, CH-C16), 127.5 (CH-C13, 
CH-C17), 83.7 (C-C10), 69.3 (CH-C11), 48.6 (CH2-C1), 47.5 (CH2-C7), 42.2 (CH2-C3), 41.5 (C-
C7a), 40.3 (CH2-C5), 37.6 (CH-C4a), 34.7 (CH2-C8), 24.7 (CH2-C4), 21.6 (CH3-C18), 13.8 
(CH2-C9); HRMS (CI, isobutane) for C19H24NO3S ([M+H]
+) calculated 346.1477, found 
346.1476; LRMS (CI, isobutane) m/z (intensity): 346 (16), 278 (7), 107 (27), 81 (70); 
Elemental analysis: C19H23NO3S requires C: 66.06%, N: 4.05 %, H: 6.71%, found C: 66.15%, 
N: 4.05%, H: 6.80%. The data observed are in accordance with literature values.84 
 
7a-Methyl-2-(toluene-4-sulfonyl)-6-trimethylsilanyloxy-2,3,4,4a,5,7a-hexahydro-1H-
[2]pyrindine 287: 
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Methyl magnesium bromide (1.0 mL of a 1.4 M solution in tetrahydrofuran/toluene, 1.4 
mmol) was added dropwise to a solution of copper(I) iodide (0.13 g, 0.69 mmol), in 
tetrahydrofuran (10 mL) at rt. This was followed by the dropwise addition of a solution of 
enone 240 (0.10 g, 0.34 mmol) and chlorotrimethylsilane (0.11 mL, 0.86 mmol), in 
tetrahydrofuran (5 mL). After 1h, the mixture was quenched by the addition of a mixture of 
saturated aqueous ammonium chloride solution (5 mL), saturated aqueous ammonium 
hydroxide solution (5 mL) and water (10 mL). Diethyl ether (20 mL) was added and the 
C19H29NO3SSi 
Molecular weight: 379.59 g.mol―1 
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phases were separated. The aqueous phase was extracted with diethyl ether (3 × 20 ml), 
and the combined organic phases were washed with water (30 mL), and brine (30 mL), then 
dried over sodium sulfate and concentrated in vacuo to provide 287. This compound 287 
was used directly in the next step without further purification. 1H NMR analysis showed a 
characteristic singlet at 4.28 ppm, corresponding to the enol CH-C7. The compound 
isolated after flash column chromatography on silica gel (petroleum ether:ethyl acetate, 
7:3) was the corresponding ketone 288 ( 0.10 g,  0.33 mmol, 96%) as a coulorless oil. 
 
Isolation and characterisation of the corresponding ketone 7a-Methyl-2-(toluene-4-
sulfonyl)-octahydro-[2]pyrindin-6-one 288: 
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Rf: 0.24 (petroleum ether:ethyl acetate, 5:5); IR: νmax  2924, 1735, 1458, 1334, 1157 cm
―1; 
1H NMR (400 MHz, CDCl3): δ 7.63 (2H, d, J = 8.0 Hz, CH-C10, CH-C14), 7.33 (2H, d, J = 8.0 
Hz, CH-C11, CH-C13), 3.24―2.19 (1H, m, CH2-C3), 3.30 (1H, d, J = 12.0, CH2-C1), 2.77 (1H, 
ddd, J = 10.2, 8.6, 0.6, CH2-C3), 2.59 (1H, d, J = 12.0, CH2-C1), 2.46 (1H, d, J = 18.7 Hz, 
CH2-C7), 2.44 (3H, s, CH3-C15), 2.39―2.44 (1H, m, CH2-C5), 2.01―1.94 (2H, m, CH-C4a, 
CH2-C5), 1.97 (1H, d, J = 18.7 Hz, CH2-C7), 1.94―1.91 (1H, m, CH2-C4), 1.52―1.48 (1H, m, 
CH2-C4), 1.14 (3H, s, CH3-C8); 
13C NMR (101 MHz, CDCl3): δ 217.1 (C-C6), 143.7 (C-C12), 
133.0 (C-C9), 129.8 (CH-C11, CH-C13), 127.6 (CH-C10, CH-C14), 52.3 (CH2-C1), 47.6 (CH2-
C7), 43.9 (CH2-C3), 42.4 (CH2-C5), 38.9 (C-7a), 38.4 (CH-C4a), 26.8 (CH2-C4), 24.8 (CH3-
C15), 21.5 (CH3-C8); HRMS (EI) for C16H21NO3S ([M]
+) calculated 307.1242, found 307.1244; 
LRMS (EI) m/z (intensity): 307 (45), 198 (62), 152 (100), 91 (74); Elemental analysis: 
C16H21NO3S requires C: 62.51%, N: 4.56 %, H: 6.89%, found, C: 62.32%, N: 4.52%, H: 6.98%. 
The data observed are in accordance with literature values.84 
 
 
 
C16H21NO3S 
Molecular weight: 307.41 g.mol―1 
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6-(2-[1,3]Dioxolan-2-yl-ethyl)-2-(toluene-4-sulfonyl)-2,3,4,4a,5,6-hexahydro-1H-
[2]pyrindin-6-ol 313: 
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Copper(I) iodide (65 mg, 0.34 mmol) was introduced in a solid addition funnel, fitted on a 
flask containing magnesium (0.16 g, 6.8 mmol) and iodine (1 crystal), and tetrahydrofuran 
(14 mL) was then added. A solution of 2-(2-bromoethyl)-1,3-dioxolane (0.40 mL, 3.4 mmol) 
in tetrahydrofuran (4 mL) was added dropwise, while the reaction mixture was heated at 
60 C. This mixture was then cooled to rt and stirred for 30 min before further cooling to 
―15 C, prior to the addition of the copper (I) iodide. After 15 min at this temperature, a 
solution of 240 (500 mg, 1.72 mmol) in tetrahydrofuran (4 mL) was added and the solution 
was stirred for a further 2 h. The mixture was quenched by addition of saturated aqueous 
ammonium chloride solution (5 mL), saturated aqueous ammonium hydroxide solution (5 
mL) and water (10 mL). Diethyl ether (20 mL) was added and the phases were separated. 
The aqueous phase was extracted with diethyl ether (3 × 20 ml), and the combined organic 
phases were washed with water (30 mL) and brine (30 mL), then dried over sodium sulfate 
and concentrated in vacuo. Purification of the residue by flash column chromatography on 
silica gel (petroleum ether:ethyl acetate, 2:8) provided the product 313 (421 mg, 1.07 
mmol, 62%) as a foam. 
Rf: 0.38 (ethyl acetate); IR: νmax 3464, 2928, 2854, 1597, 1446, 1334, 1161 cm
―1; 1H NMR 
(400 MHz, CDCl3): δ 7.64 (2H, d, J = 8.1 Hz, CH-C16, CH-C20), 7.31 (2H, d, J = 8.1 Hz, CH-
C17, CH-C19), 5.48 (1H, s, CH-C7), 4.84―4.82 (1H, m, CH-C10), 4.36 (1H, d, J = 12.5 Hz, 
CH2-C1), 3.95―3.80 (5H, m, CH2-C3, CH2-C12, CH2-C13), 2.88 (1H, d, J = 12.5 Hz, CH2-C1), 
2.41 (3H, s, CH3-C21), 2.34―2.28 (3H, m, CH2-C3, CH-C4a, CH2-C5), 1.92―1.88 (1H, m, CH2-
C4), 1.71―1.61 (4H, m, CH2-C8, CH2-C9), 1.44 (1H, dd, J = 12.7, 5.8 Hz, CH2-C5), 1.42―1.32 
(1H, m, CH2-C4,); 
13C NMR (101 MHz, CDCl3): δ 143.6 (C-C18), 139.3 (C-C15), 132.8 (C-C7a), 
130.9 (CH-C7), 129.6 (CH-C17, CH-C19), 128.2 (CH-C16, CH-C20), 104.3 (CH-C10), 84.2 (C-
C6), 64.8 (CH2-C12, CH2-C13), 46.9 (CH2-C1), 46.0 (CH2-C3), 45.5 (CH2-C5), 41.3 (CH-C4a), 
34.5 (CH2-C9), 33.0 (CH2-C4), 28.6 (CH2-C8), 21.5 (CH3-C21); HRMS (CI, isobutane) for 
C20H28NO5S ([M+H]
+) calculated 394.1688, found 394.1683; LRMS (CI, isobutane) m/z 
(intensity): 394 (14), 376 (100), 85 (49); Elemental analysis: C20H27NO5S requires C: 
61.05%, N: 3.56%, H: 6.92%, found C: 60.87%, N: 3.62%, H: 6.91%. 
 
C20H27NO5S 
Molecular weight: 393.50 g.mol―1 
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7a-(2-[1,3]Dioxolan-2-yl-ethyl)-2-(toluene-4-sulfonyl)-octahydro-[2]pyrindin-6-one 312: 
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Copper(I) iodide (0.39 g, 2.1 mmol) was introduced in a solid addition funnel, fitted on a 
flask containing magnesium (0.16 g, 6.8 mmol) and iodine (1 crystal), and tetrahydrofuran 
(14 mL) was added. A solution of 2-(2-bromoethyl)-1,3-dioxolane (0.40 mL, 3.4 mmol), in 
tetrahydrofuran (4 mL) was added dropwise, while the reaction mixture was heated at 60 
C. This mixture was then cooled to rt and stirred for 30 min before further cooling to ―30 
C, prior to the addition of the copper (I) iodide. The resulting mixture was cooled to ―78 
C for 15 min prior to the addition of a solution of 240 (500 mg, 1.72 mmol) in 
tetrahydrofuran (4 mL). The solution was then stirred for a further 2 h at ―78 C and the 
reaction was quenched by the addition of a saturated aqueous of ammonium chloride 
solution (5 mL), saturated aqueous ammonium hydroxide solution (5 mL) and water (10 
mL). Diethyl ether (20 mL) was added and the phases were separated. The aqueous phase 
was extracted with diethyl ether (3 × 20 ml) and the combined organic phases were washed 
with water (30 mL) and brine (30 mL), then dried over sodium sulfate and concentrated in 
vacuo. Purification of the residue by flash column chromatography on silica gel (petroleum 
ether:ethyl acetate, 8:2 to 7:3) provided the product 312 (380 mg, 0.966 mmol, 55%) as a 
colourless foam. 
Rf: 0.45 (ethyl acetate); IR: νmax 2924, 2885, 1743, 1303, 1141 cm
―1; 1H NMR (400 MHz, 
CDCl3): δ 7.58 (2H, d, J = 8.1 Hz, CH-C16, CH-C20), 7.29 (2H, d, J = 8.1 Hz, CH-C17, CH-
C19), 4.81 (1H, dd, J = 4.5, 4.5 Hz, CH-C10), 3.95―3.91 (2H, m, CH2-C12), 3.83―3.79 (2H, 
m, CH2-C13), 3.73―3.70 (1H, m, CH2-C3), 2.90 (1H, d, J = 12.2 Hz, CH2-C1), 2.90―2.86 (1H, 
m, CH2-C3), 2.56 (1H, d, J = 12.2 Hz, CH2-C1), 2.40 (3H, s, CH3-C21), 2.31 (1H, dd, J = 18.2, 
7.4 Hz, CH2-C5), 2.22 (1H, d, J = 18.5 Hz, CH2-C7), 2.08 (1H, d, J = 18.5 Hz, CH2-C7), 
2.07―1.95 (3H, m, CH2-C5, CH-C4a, CH2-C4), 1.83 (1H, dd, J = 13.6, 3.8 Hz, CH2-C8), 1.69 
(1H, ddd, J = 12.3, 4.5, 3.8 Hz, CH2-C9), 1.45―1.43 (3H, m, CH2-C4, CH2-C8, CH2-C9); 
13C 
NMR (101 MHz, CDCl3): δ 216.4 (C-C6), 143.7 (C-C18), 133.0 (C-C15), 129.8 (CH-C17, CH-
C19), 127.5 (CH-C16, CH-C20), 104.1 (CH-C10), 64.9 (CH2-C12, CH2-C13), 49.1 (CH2-C1), 
46.6 (CH2-C7), 42.7 (CH2-C3), 41.1 (CH2-C5), 41.0 (C-C7a),37.7 (CH-C4a), 30.2 (CH2-C8), 
28.5 (CH2-C9), 25.4 (CH2-C4), 21.5 (CH3-C21); HRMS (CI, isobutane) for C20H28NO5S 
C20H27NO5S 
Molecular weight: 393.50 g.mol―1 
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7-Hydroxy-7a-methyl-2-(toluene-4-sulfonyl)-octahydro-[2]pyrindin-6-one 316: 
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Dimethyldioxirane (4 mL of a 0.085 M solution in acetone, 0.47 mmol) was added to a 
solution of enol ether 287 (0.11 g, 0.34 mmol), in dichloromethane (1.5 mL), at 0 ºC. After 
5 min, the solution was concentrated in vacuo and the resulting epoxide 315 was diluted in 
a mixture of tetrahydrofuran (5 mL), water (2 mL) and acetic acid (2 mL). The mixture was 
stirred at rt for 3 h. Solid sodium hydrogenocarbonate was added until the gas formation 
ceased. Ethyl acetate (10 mL) and water (10 mL) were added and the phases were 
separated. The aqueous phase was extracted with ethyl acetate (3 × 20 ml) and the 
combined organic phases were washed with a saturated aqueous solution of sodium 
hydrogenocarbonate (10 mL), water (10 mL), and brine (10 mL), then dried over magnesium 
sulfate, and concentrated in vacuo. Purification of the residue by flash column 
chromatography (petroleum ether:ethyl acetate, 6:4 to 5:5) provided the product 316 (408 
mg, 1.2 mmol, 73% over 3 steps) as a colourless crystalline solid allowing a crystal structure 
to be obtained (see Appendix 1).  
Rf: 0.28 (petroleum ether:ethyl acetate, 5:5); m.p.: 163―164 ºC; IR: νmax 3481, 2926, 1747, 
1338 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.66 (2H, d, J = 8.0 Hz, CH-C10, CH-C14), 7.34 (2H, 
d, J = 8.0, CH-C11, CH-C13), 4.52 (1H, s, CH-C7), 3.86―3.84 (1H, m, CH2-C3), 3.82 (1H, d, J 
= 12.1, CH2-C1), 2.83 (1H, d, J = 3.2 Hz, OH), 2.53 (1H, dd, J = 19.7 Hz, J = 8.0 Hz, CH2-
C5), 2.43 (3H, s, CH3-C15), 2.29 (1H, dd, J = 12.4, 11.5 Hz, CH2-C3), 2.12 (1H, d, J = 12.1 
Hz, CH2-C1), 2.04 (1H, d, J = 19.7 Hz, CH2-C5), 1.92―1.77 (2H, m, CH2-C4, CH-C4a), 
1.53―1.49 (1H, m, CH2-C4), 0.80 (3H, s, CH3-C8); 
13C NMR (101 MHz, CDCl3): δ 216.0 (C-C6), 
143.7 (C-C12), 133.4 (C-C9), 129.8 (CH-C11, CH-C13), 127.6 (CH-C10, CH-C14), 75.9 (CH-
C7), 51.2 (CH2-C1), 45.9 (CH2-C3), 41.1 (C-C7a), 39.5 (CH2-C5), 35.1 (CH-C4a), 29.9 (CH2-
C4), 21.6 (CH3-C8), 18.8 (CH3-C15); HRMS (EI) for C16H21NO4S, ([M]
+) calculated 323.1191, 
found 323.1195; LRMS (EI) m/z (intensity): 323 (29), 295 (10), 185 (28), 168 (100), 155 
(40), 82 (73); Elemental analysis: C16H21NO4S: requires C: 59.42%, N: 4.33%, H: 6.54%, 
found C: 59.46%, N: 4.34%, H: 6.64%. 
 
 
C16H21NO4S 
Molecular weight: 323.41 g.mol―1 
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4-Nitro-benzoic acid 7a-methyl-6-oxo-2-(toluene-4-sulfonyl)-octahydro-[2]pyrindin-7-yl 
ester 321:  
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A solution of 316 (100 mg, 0.31 mmol), 4-nitrobenzoyl chloride (69 mg, 0.37 mmol), 
triethylamine (0.13 mL, 0.93 mmol), and dimethylaminopyridine (6 mg, 0.05 mmol) in 
dichloromethane (15 mL) was stirred at rt for 3h. This mixture was then washed with a 
aqueous 10% hydrochloric acid solution (3 × 10 mL) and brine, then dried with magnesium 
sulfate and concentrated in vacuo. Purification of the residue by flash column 
chromatography (petroleum ether:ethyl acetate, 7:3) provided the product 321 (260 mg, 
0.55 mmol, 95%) as a colourless solid, in a 95% yield. 
Rf: 0.32 (petroleum ether:ethyl acetate, 5:5); m.p.: 179―182 ºC IR: νmax 3063, 2924, 1759, 
1735, 1527, 1342 cm―1; 1H NMR (400 MHz, CDCl3): δ 8.28 (2H, d, J = 8.4 Hz, CH-C19, CH-
C21), 8.12 (2H, d, J = 8.4 Hz, CH-C18, CH-C22), 7.63 (2H, d, J = 7.7 Hz, CH-C10), CH-C14), 
7.29 (2H, d, J = 7.7 Hz, CH-C11, CH-C13), 5.96 (1H, s, CH-C7), 3.85 (1H, d, J = 11.4 Hz, 
CH2-C3), 3.66 (1H, d, J = 12.4 Hz, CH2-C1), 2.62 (1H, dd, J = 19.6, 7.6 Hz, CH2-C5), 2.38 
(3H, s, CH3-C15), 2.28―2.26 (1H, m, CH2-C3), 2.27 (1H, d, J = 12.4 Hz, CH2-C1), 2.12 (1H, 
d, J = 19.6 Hz, CH2-C5), 1.96―1.95 (2H, m, CH2-C4, CH-C4a), 1.73―1.75 (1H, m, CH2-C4), 
1.06 (3H, s, CH3-C8); 
13C NMR (101 MHz, CDCl3): δ  209.2 (C-C6), 163.4 (C-C16), 150.7 (C-
C20), 143.9 (C-C12), 134.9 (C-C9/C17), 133.3 (C-C9/C17), 131.5 (CH-Car, CH-Car), 129.9 
(CH-Car, CH-Car), 127.8 (CH-Car, CH-Car), 123.6 (CH-Car, CH-Car), 77.7 (CH-C7), 50.7 
(CH2-C1), 45.6 (CH2-C3), 40.6 (CH2-C5), 39.9 (C-C7a), 35.8 (CH-C4a), 29.6 (CH2-C4), 21.6 
(CH3-C15), 19.8 (CH3-C8); HRMS (FAB) for C23H25N2O7S ([M+H]
+) calculated 473.1382, found 
473.1376; LRMS (FAB) m/z (intensity): 473 (54), 307 (94), 154 (100), 137 (95); Elemental: 
analysis calculated for C23H24N2O7S: requires C: 58.46%, N: 5.93%, H: 5.12% found C: 58.51%, 
N: 5.78%, H: 5.22%. 
 
                               
 
C23H24N2O7S 
Molecular weight: 472.51 g.mol―1 
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7-Azido-2-(toluene-4-sulfonyl)-1,2,3,4,4a,5-hexahydro-[2]pyrindin-6-one 335: 
     
9 N
8 7
6
54
3
14
1
O
10 S
11
O
12
O
13
7a
4a
N3
335  
Water (40 mL) was added to a solution of enone 240 (0.30 g, 1.0 mmol) in tetrahydrofuran 
(40 mL). The solution was cooled to 0 ºC and sodium hydrogenocarbonate (1.5 g, 17 mmol) 
was added, followed by hydrogen peroxide (1.6 mL of a 27% solution in water, 26 mmol). 
The solution was stirred at 0 ºC for 6 h. Diethyl ether was added, the phases were 
separated and the aqueous phase was extracted with diethyl ether (2 × 80 mL). The 
combined organic phases were washed with and brine (100 mL), then dried over magnesium 
sulfate and concentrated in vacuo. Due to poor stability, epoxide 334 was used directly in 
the next step without further purification. 
Lithium perchlorate (11 mg, 0.10 mmol), 4-(dimethyamino)pyridine (0.15 g, 1.2 mmol), and 
diphenyl phosphoryl azide (0.27 mL, 1.2 mmol) were added to a solution of crude 334 in 
dimethylformamide (9 mL). The mixture was stirred at 50 ºC for 17 h, cooled to rt and 
diethyl ether (20 mL) and water (20 mL) were added. The phases were separated and the 
organic phase was washed with water (3 × 20 mL) and brine (10 mL), then dried over 
magnesium sulfate and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether:ethyl acetate, 8:2) provided the product 
335 (40 mg, 0.12 mmol, 12% over 2 steps) as a colourless foam. 
Rf: 2.0 (petroleum ether:ethyl acetate, 8:2); IR: νmax 2924, 2126, 1709, 1654 cm
―1; 1H NMR 
(400 MHz, CDCl3): δ 7.69 (2H, d, J = 8.4 Hz, CH-C9, CH-C13), 7.34 (2H, d, J = 8.4 Hz, CH-
C10, CH-C12), 4.72 (1H, d, J = 14.0 Hz, CH2-C1), 3.97―3.95 (1H, m, CH2-C3), 3.05 (1H, d, J 
= 14.0 Hz, CH2-C1), 2.65 (1H, dd, J = 19.0, 6.3 Hz, CH2-C5), 2.60 (1H, ddd, J = 12.5, 12.5, 
2.3 Hz, CH2-C3), 2.56―2.53 (1H, m, CH-4a), 2.44 (3H, s, CH3-C14), 2.07―2.05 (1H, m, CH2-
C4), 2.04 (1H, dd, J = 19.0, 2.5 Hz, CH2-C5), 1.39 (1H, ddd, J = 12.9, 12.5, 4.0 Hz, CH2-C4); 
13C NMR (101 MHz, CDCl3): δ 199.6 (C-C6), 148.3 (C-C11), 143.1 (C-C8), 132.2 (C-C7a), 
128.8 (CH-C10, CH-C12), 126.7 (CH-C9, CH-C13), 44.6 (CH2-C3), 43.1 (CH2-C1), 38.7 (CH2-
C5), 33.9 (CH-C4a), 31.0 (CH2-C4), 20.5 (CH3-C14); HRMS (CI, isobutane) for C15H17N4O3S 
([M+H]+) calculated 333.1021, found 333.1017; LRMS (CI, isobutane) m/z (intensity): 333 
(17), 308 (100), 305 (78), 207 (70), 151 (85).  
 
 
C15H16N4O3S 
Molecular weight: 332.38 g.mol―1 
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N-But-3-enyl-N-(4-hydroxy-but-2-ynyl)-4-methylbenzenesulfonamide 345: 
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A solution of n-butyllithium (0.8 mL of a 2.5 M solution in hexanes, 2.0 mmol) was added 
dropwise to a solution of 242 (0.50 g, 1.9 mmol) in tetrahydrofuran (30 mL) at ―78 ºC. The 
mixture was stirred at this temperature for 1 h and then p-formaldehyde (0.11 g, 3.8 
mmol) was added. The reaction mixture was slowly warmed to rt and stirred for 2 h, then 
water (100 mL) and dichloromethane (100 mL) were added. The phases were separated, 
the aqueous phase was extracted with dichloromethane (3 × 100 mL) and the combined 
organic phases were washed with brine (300 mL), then dried over magnesium sulfate and 
concentrated in vacuo. Purification of the residue by flash column chromatography on silica 
gel (petroleum ether:ethyl acetate, 8:2) provided the product 345 (2.0 g, 6.8 mmol, 59%) 
as a colourless oil. 
Rf: 0.38 (petroleum ether:ethyl acetate, 5:5); IR: νmax 3474, 2926, 1598, 1450, 1341 cm
―1; 
1H NMR (400 MHz, CDCl3): δ 7.73 (2H, d, J = 8.4 Hz, CH-C10, CH-C14), 7.30 (2H, d, J = 8.4 
Hz, CH-C11, CH-C13), 5.72 (1H, dddd, J = 17.1, 10.2, 6.7, 6.7 Hz, CH-C7), 5.11 (1H, ddd, J 
= 17.1, 2.6, 1.5 Hz, CH2-C8), 5.06 (1H, ddd, J = 10.2, 2.6, 1.2 Hz, CH2-C8), 4.14 (2H, t, J = 
1.9 Hz, CH2-C1), 3.98 (2H, dt, J = 6.1, 1.9 Hz, CH2-C4), 3.25 (2H, t, J = 7.8 Hz, CH2-C5), 
2.42 (3H, s, CH3-C15), 2.32―2.27 (2H, m, CH2-C6), 1.20 (1H, t, J = 6.1 Hz, OH); 
13C NMR 
(101 MHz, CDCl3): δ 143.6 (C-C12), 135.8 (CH-C7), 134.5 (C-C9), 129.5 (CH-C11, CH-C13), 
127.8 (CH-C10, CH-C14), 117.3 (CH2-C8), 83.8 (C-C2), 78.3 (C-C3), 50.6 (CH2-C4), 45.8 (CH2-
C5), 36.7 (CH2-C1), 32.2 (CH2-C6), 21.1 (CH3-C15); HRMS (CI, isobutane) for C15H20O3NS 
([M+H]+) calculated 294.1164, found 294.1166; LRMS (CI, isobutane) m/z (intensity): 294.3 
(100), 252.3 (39), 157.2 (21), 140.2 (19); Elemental analysis: C15H19NO3S requires C: 
61.41%, N: 4.77%, H: 6.53%, found C: 61.28%, N: 4.73%, H: 6.56%. 
 
 
 
C15H19NO3S 
Molecular weight: 293.38 g.mol―1 
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N-But-3-enyl-N-[4-(tert-butyl-dimethyl-silanyloxy)-but-2-ynyl]-4-methyl-
benzenesulfonamide 346: 
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4-(Dimethylamino)pyridine (12 mg, 0.095 mmol), triethylamine (0.40 mL, 2.9 mmol) and t-
butyldimethylsilyl chloride (0.22 g, 1.4 mmol) were added to a solution of 345 (0.28 g, 0.95 
mmol) in dichloromethane (15 mL). The mixture was stirred at rt for 5 h, then water (15 
mL) was added and the phases were separated. The aqueous phase was extracted with 
dichloromethane (3 × 15 mL) and the combined organic phases were washed with brine (50 
mL), then dried over magnesium sulfate and concentrated in vacuo. Purification of the 
residue by flash column chromatography on silica gel (petroleum ether:ethyl acetate, 95:5) 
provided the product 346 (0.28 g, 0.69 mmol, 72%) as a colourless oil. 
Rf: 0.33 (petroleum ether:ethyl acetate, 9:1); IR: νmax 2928, 2856, 1472, 1349, 1253, 1160 
cm―1; 1H NMR (400 MHz, CDCl3): δ 7.68 (2H, d, J = 8.2 Hz, CH-C10, CH-C14), 7.24 (2H, d, J 
= 8.2 Hz, CH-C11, CH-C13), 5.73 (1H, ddt, J = 17.1, 10.2, 6.8, Hz, CH-C7), 5.06 (1H, ddd, J 
= 17.1, 2.8, 1.5 Hz, CH2-C8), 5.03 (1H, ddd, J = 10.2, 2.8, 1.5 Hz, CH2-C8), 4.13 (2H, s, CH2-
C1), 4.01 (2H, s, CH2-C4), 3.20 (2H, t, J = 7.2 Hz, CH2-C5), 2.38 (3H, s, CH3-C15), 2.31―2.28 
(2H, m, CH2-C6), 0.82 (9H, s, CH3-C19, CH3-C20, CH3-C21), 0.00 (6H, s, CH3-C16, CH3-C17); 
13C NMR (101 MHz, CDCl3): δ 142.3 (C-C12), 134.9 (CH-C7), 133.5 (C-C9), 128.3 (CH-C11, 
CH-C13), 126.7 (CH-C10, CH-C14), 116.2 (CH2-C8), 83.1 (C-C2), 76.3 (C-C3), 50.3 (CH2-C4), 
44.7 (CH2-C5), 35.7 (CH2-C1), 31.2 (CH2-C6), 24.7 (CH3-C19, CH3-C20, CH3-C21), 20.5 (CH3-
C15), 17.2 (C-C18), ―6.5 (CH3-C16, CH3-C17); HRMS (FAB) for C21H34NO3SSi ([M+H]
+) 
calculated 408.2029, found 408.2031; LRMS (FAB) m/z (intensity): 408 (100), 366 (81), 350 
(99), 276 (44), 155 (24); Elemental analysis: C21H33NO3SSi requires C: 61.87%, N: 3.44%, H: 
8.16%, found C: 62.03%, N: 3.36%, H: 8.34%. 
 
 
 
C21H33NO3SSi 
Molecular weight: 407.64 g.mol―1 
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7-(tert-Butyldimethylsilanyloxymethyl)-2-(toluene-4-sulfonyl)-1,2,3,4,4a,5-hexahydro-
[2]pyrindin-6-one 347: 
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Tetramethylthiourea (19 mg, 0.15 mmol) and dicobalt octacarbonyl (8.4 mg, 0.025 mmol) 
were added in a flask, fitted with a condenser, under argon atmosphere. This apparatus 
was evacuated and refilled with carbon monoxide (× 3), and toluene (7 ml) was added. A 
solution of 346 (0.10 mg, 0.25 mmol) dissolved in toluene (1 mL) was added dropwise to 
the mixture. The reaction mixture was then stirred at 70 C for 6 h, and the solvent was 
removed in vacuo. Purification of the residue by flash column chromatography on silica gel 
(petroleum ether:ethyl acetate, 6:4) provided the product 347 (51 mg, 12 mmol, 48%) as a 
colourless solid. 
Rf: 0.40 (petroleum ether:ethyl acetate, 5:5); m.p.: 89―91 C; IR: νmax 2928, 2855, 1702, 
1663, 1462, 1160 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.66 (2H, d, J = 8.3 Hz, CH-C16, CH-
C20), 7.32  (2H, d, J = 8.3 Hz, CH-C17, CH-C19), 5.31 (1H, d, J = 14.0 Hz, CH2-C1), 
4.45―4.42 (2H, m, CH2-C8), 3.94―3.92 (1H, m, CH2-C3), 3.13 (1H, d, J = 14.0 Hz, CH2-C1), 
2.57 (1H, dd, J = 16.0, 3.5 Hz, CH2-C5), 2.60―2.48 (2H, m, CH2-C3, CH-C4a), 2.43 (3H, s, 
CH3-C21), 2.08 (1H, dddd, J = 12.5, 5.0, 2.4, 2.4 Hz, CH2-C4), 1.96 (1H, d, J = 16.0 Hz, CH2-
C5), 1.44 (1H, ddd, J = 12.5, 12.4, 4.0 Hz, CH2-C4), 0.93 (9H, s, CH3-C12, CH3-C13, CH3-
C14), 0.14 (3H, s, CH3-C9/C10), 0.08 (3H, s, CH3-C9/C10); 
13C NMR (101 MHz, CDCl3): δ 
206.1 (C-C6), 166.4 (C-C7), 143.9 (C-C18), 138.4 (C-C15), 133.2 (C-C7a), 129.8 (CH-C17, 
CH-C19), 127.7 (CH-C16, CH-C20), 57.1 (CH2-C8), 45.8 (CH2-C1), 45.6 (CH2-C3), 40.7 (CH2-
C5), 37.9 (CH-C4a), 31.7 (CH2-C4), 25.9 (CH3-C12, CH3-C13, CH3-C14), 21.6 (CH3-C21), 18.3 
(C-C11), ―5.6 (CH3-C9, CH3-C10); HRMS (FAB) for C22H34NO4SSi ([M+H]
+) calculated 
436.1978, found 436.1974; LRMS (FAB) m/z (intensity): 436 (100), 378 (42), 304 (50), 155 
(92), 138 (56). 
 
 
 
 
C22H33NO4SSi 
Molecular weight: 435.65 g.mol―1 
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4-[But-3-enyl-(toluene-4-sulfonyl)-amino]-but-2-ynoic acid ethyl ester 350: 
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A solution of n-butyllithium (0.15 mL of a 2.5 M solution in hexanes, 0.38 mmol) was added 
dropwise to a solution of 242 (0.10 g, 0.38 mmol) in tetrahydrofuran (6 mL) at 0 C and the 
mixture was cooled to ―78 C and stirred at this temperature for 1 h. Ethylchloroformate 
(0.04 mL, 0.4 mmol) was added dropwise and the reaction was stirred at rt for 5 h. The 
reaction was then quenched by the addition of a saturated aqueous solution of ammonium 
chloride (5 mL), dichloromethane (15 mL) was added and the phases were separated. The 
aqueous phase was extracted with dichloromethane (3 × 10 mL), and the combined organic 
phases were washed with water (30 mL) and brine (30 mL), then dried over magnesium 
sulfate and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether:ethyl acetate, 95:5) provided the product 
350 (45 mg, 0.13 mmol, 35%) as a colourless oil. 
Rf: 0.26 (petroleum ether:ethyl acetate, 8:2); IR: νmax 2995, 2930, 2236, 1710, 1348, 1245 
cm―1; 1H NMR (400 MHz, CDCl3): δ 7.71 (2H, d, J = 8.1 Hz, CH-C12, CH-C16), 7.30 (2H, d, J 
= 8.1 Hz, CH-C13, CH-C15), 5.74 (1H, ddt, J = 17.1, 12.0, 6.9 Hz, CH-C7), 5.13 (1H, d, J = 
17.1 Hz, CH2-C8), 5.08 (1H, d, J = 12.0 Hz, CH2-C8), 4.24 (2H, s, CH2-C4), 4.14 (2H, q, J = 
7.1 Hz, CH2-C9), 3.24 (2H, t, J = 7.2 Hz, CH2-C5), 2.40 (3H, s, CH3-C17), 2.32 (2H, dt, J = 
7.2, 6.9 Hz, CH2-C6), 1.26 (3H, t, J = 7.1 Hz, CH3-C10); 
13C NMR (101 MHz, CDCl3): δ 152.6 
(C-C1), 143.9 (C-C14), 135.3 (CH-C7), 134.2 (C-C11), 129.7 (CH-C13, CH-C15), 127.6 (CH-
C12, CH-C16), 117.6 (CH2-C8), 80.1 (C-C2), 77.2 (C-C3), 62.1 (CH2-C9), 46.2 (CH2-C5), 36.5 
(CH2-C4), 32.2 (CH2-C6), 21.5 (CH3-C17), 14.1 (CH3-C10); HRMS (CI, isobutane) for 
C17H22NO4S ([M+H]
+) calculated 336.1270, found 336.1272; LRMS (CI, isobutane) m/z 
(intensity): 336 (100), 294 (20), 226 (16). 
 
C17H21NO4S 
Molecular weight: 335.42 g.mol―1 
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2-(Toluene-4-sulfonyl)-1,2,3,4,4a,5-hexahydro-[2]pyrindin-6-one oxime 358: 
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Pyridine (0.42 mL, 5.2 mmol) and hydroxylamine hydrochloride (0.24 g, 3.4 mmol) were 
added to a solution of enone 240 (500 mg, 1.72) in ethanol (7 mL) and the mixture was 
stirred for 24 h. The reaction mixture was then concentrated in vacuo and the residue was 
dissolved in dichloromethane (15 mL), washed with water (15 mL) and brine (15 mL), then 
dried over sodium sulfate and concentrated in vacuo. Purification of the residue by flash 
column chromatography on silica gel (heptane:ethyl acetate, 8:2 to 6:4) provided the 
product 358 (304 mg, 0.992 mmol, 58%) as a colourless solid. 
Rf: 0.24 (petroleum ether:ethyl acetate, 5:5); m.p.: 90―92 ºC; IR: νmax 3232, 3109, 2924, 
2854, 1296, 1157 cm―1; 1H NMR (400 MHz, CDCl3): δ 8.37 (1H, s, OH), 7.68 (2H, d, J = 8.1 
Hz, CH-C9, CH-C13), 7.34 (2H, d, J = 8.1 Hz, CH-C10, CH-C12), 6.05 (1H, s, CH-C7), 4.58 
(1H, d, J = 12.9 Hz, CH2-C1), 3.95―3.93 (1H, m, CH2-C3), 3.10 (1H, d, J = 12.9 Hz, CH2-C1), 
2.98 (1H, dd, J = 18.6, 7.4 Hz, CH2-C5), 2.51―2.49 (1H, m, CH2-C3), 2.47―2.44 (1H, m, CH-
C4a), 2.45 (3H, s, CH3-C14), 2.24 (1H, dd, J = 18.6, 2.8 Hz, CH2-C5), 2.07―2.04 (1H, m, 
CH2-C4), 1.42―1.40 (1H, m, CH2-C4); 
13C NMR (101 MHz, CDCl3): δ 166.5 (C-C6), 153.7 (C-
C11), 143.8 (C-C8), 133.3 (C-C7a), 129.7 (CH-C10, CH-C12), 127.7 (CH-C9, CH-C13), 123.2 
(CH-C7), 47.2 (CH2-C1), 45.7 (CH2-C3), 41.4 (CH-C4a), 32.5 (CH2-C4), 31.4 (CH2-C5), 21.5 
(CH3-C14); HRMS (CI, isobutane) for C15H19N2O3S ([M+H]
+) calculated 307.1116, found 
307.1122; LRMS (CI, isobutane) m/z (intensity): 307 (100), 291 (59), 135 (91). 
 
2-Tosyl-3,4,4a,5-tetrahydro-1H-cyclopenta[c]pyridin-6(2H)-one O-tosyl oxime 359 
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p-Toluenesulfonyl chloride (0.42 g, 2.2 mmol) was added to a solution of 358 (300 mg, 
0.979 mmol) in pyridine (2 mL) at 10 C and the mixture was stirred at this temperature for 
2 h. This mixture was then poured into water (10 mL) and dichloromethane (10 mL) was 
C15H18N2O3S 
Molecular weight: 306.38 g.mol―1 
C22H24N2O5S2 
Molecular weight: 460.57 g.mol―1 
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added. The phases were separated and the aqueous phase was extracted with 
dichloromethane (3 × 10 ml). The combined organic phases were washed with brine (30 
mL), then dried over sodium sulfate and concentrated in vacuo. A short filtration on silica 
gel provided the crude product 359 as a brown solid (110 mg, 0.239 mmol, 24%), which was 
used directly in the next step due to its poor stability. 
Rf: 0.51 (heptane:ethyl acetate, 7:3); 
1H NMR (400 MHz, CDCl3): δ 7.85 (2H, d, J = 8.0 Hz, 
CH-C9, CH-C13/CH-C16, CH-C20), 7.64 (2H, d, J = 8.2 Hz, CH-C9, CH-C13/CH-C16, CH-C20), 
7.33 (2H, d, J = 8.0 Hz, CH-C10, CH-C12/CH-C17, CH-C19), 7.31 (2H, d, J = 8.2 Hz, CH-C10, 
CH-C12/CH-C17, CH-C19), 6.02 (1H, s, CH-C7), 4.56 (1H, d, J = 12.6 Hz, CH2-C1), 3.86―2.90 
(1H, m, CH2-C3), 3.07 (1H, dd, J = 12.6, 3.0 Hz, CH2-C1), 2.54―2.41 (3H, m, CH2-C3, CH2-
C5, CH-C4a), 2.44 (3H, s, CH3-C14), 2.43 (3H, s, CH3-C21), 2.31―2.27 (1H, m, CH2-C4), 
2.06-2.00 (1H, m, CH2-C5), 1.34 (1H, ddd, J = 19.0, 12.8, 4.5 Hz, CH2-C4). 
 
7a-Methyl-2-(toluene-4-sulfonyl)-octahydro-[2]pyrindin-6-one oxime 363: 
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Pyridine (0.12 mL, 1.5 mmol) and hydroxylamine hydrochloride (68 mg, 0.98 mmol) were 
added to a solution of ketone 240 (150 mg, 0.488 mmol) in ethanol (1.5 mL) and the 
reaction mixture was stirred at rt for 24 h. The solution was then concentrated in vacuo 
and the residue was dissolved in dichloromethane (5 mL). The solution was  washed with 
water (5 mL) and brine (5 mL), then dried over magnesium sulfate and concentrated in 
vacuo. Purification of the residue by flash column chromatography on silica gel 
(heptane:ethyl acetate, 8:2 to 6:4) provided the product 363 (70 mg, 0.21 mmol, 45%) as a 
colourless solid. 
Rf: 0.24 (petroleum ether:ethyl acetate, 5:5); m.p.: 192―193 ºC; IR: νmax 3269, 2943, 2872, 
1338, 1161 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.62 (2H, d, J = 8.1 Hz, CH-C10, CH-C14), 
7.43 (1H, s, N-OH), 7.32 (2H, d, J = 8.1 Hz, CH-C11, CH-C13), 3.13―3.09 (1H, m, CH2-C3), 
2.90 (1H, d, J = 11.8 Hz, CH2-C1), 2.79―2.74 (1H, m, CH2-C3), 2.65 (1H, d, J = 18.7 Hz, CH2-
C7), 2.59 (1H, d, J = 11.8 Hz, CH2-C1), 2.53 (1H, ddd, J = 17.1, 7.2, 1.5 Hz, CH2-C5), 2.43 
(3H, s, CH3-C15), 2.27 (1H, d, J = 18.7 Hz, CH2-C7), 2.17 (1H, ddd, J = 17.1, 7.2, 1.5 Hz, 
CH2-C5), 1.86―1.81 (1H, m, CH2-C4), 1.72 (1H, ddd, J = 12.7, 7.2, 7.2 Hz, CH-C4a), 
C16H22N2O3S 
Molecular weight: 322.42 g.mol―1 
129 
 
1.49―1.44 (1H, m, CH2-C4), 1.09 (3H, s, CH3-C8); 
13C NMR (101 MHz, CDCl3): δ 163.9 (C-C6), 
143.5 (C-C12), 133.3 (C-C9), 129.7 (CH-C11, CH-C13), 127.6 (CH-C10, CH-C14), 52.1 (CH2-
C1), 43.4 (CH2-C3), 40.3 (CH-C4a), 39.4 (C-C7a), 36.8 (CH2-C7), 33.8 (CH2-C5), 26.0 (CH2-
C4), 24.2 (CH3-C8), 21.5 (CH3-C15); HRMS (EI) for C16H22N2O3S ([M]
+) calculated 322.1351, 
found 322.1349; LRMS (EI) m/z (intensity): 322 (14), 305 (24), 167 (100), 151 (40), 91 (54). 
 
3-methyl-1,2-butadiene 369: 
369
1
4
5
3
2
C
 
Calcium chloride (27 g, 0.24 mol) was added in portions to a mixture of concentrated 
hydrochloric acid (120 ml), 2-methyl-3-butyn-2-ol (20 g, 0.24 mol) and hydroquinone (0.2 g) 
at 0 ºC. The mixture was stirred at rt for 1 h. The top layer was separated, dried over 
sodium carbonate, and distilled under reduced pressure. All the material that distilled up 
to 40 °C under 110 mmHg was collected and distilled again. 3-Chloro-3-methyl-1-butyne 
was thus collected as a colourless liquid (18 g, 0.18 mol, 73%) which was used directly 
through the next step. 
Zinc powder (23 g, 0.35 mol) was washed with aqueous 3% hydrochloric acid solution (2×20 
ml), aqueous copper sulfate solution (30 ml), ethanol (30 ml), and nbutanol (30 ml). 3-
Chloro-3-methyl-1-butyne (18 g; 0.18 mol) was added dropwise to a mixture of the treated 
zinc in nbutanol (45 mL). The mixture heated cautiously, with stirring, until the reaction 
started. Slow addition of the remaining propargyl chloride allowed the distillation of the 
desired 3-methyl-1,2-butadiene 369 at 37―45 ºC. The collected material was redistilled, 
providing the desired product 369 (3.3 g, 48 mmol, 27%) as a coulorless liquid. 
b.p: 38―42 ºC (lit: 38―41 ºC); 1H NMR (400 MHz, CDCl3): 4.59 (2H, m, CH2-C1); 1.71 (6H, t, 
J = 3.2, CH3-C4, CH3-C5). The data observed are in accordance with literature values.
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C5H8 
Molecular weight: 68.06 g.mol―1 
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2-Isopropylidene-7-(toluene-4-sulfonyl) octahydro-7-aza-cyclobuta[c]inden-3-one 374 
and its regioisomers 380 and 381: 
1
7
16
17
18
15
N
S
O
O
4a
3
4
5
6
8
9
10
12
13
14
11
7a
374
O
19
H
       
N
S
O
O
4a
3
4 5
6
8
9
10
12
13
11
7a
380
O
17
16
1518
1
19
7
H
       
N
S
O
O
4a
3
4 5
6
8
9
10
12
13
14
11
7a
381
O
17
1615
18
1
19
7
H
 
 
 
3-Methyl-1,2-butadiene (0.13 mL, 1.3 mmol) was added to a solution of enone 240 (75 mg, 
0.25 mmol) in degassed acetronitrile (5 mL). This mixture was then irradiated using a 125 
W Hanovia mercury lamp for 6 h at rt, and then concentrated in vacuo. Purification of the 
residue by flash column chromatography (petroleum ether:ethyl acetate, 8:2) provided the 
product as an inseparable mixture of regioisomers (63% overall yield). The ratio was 
determined by NMR; 3.5:1.4:1 of 374:380:381 
Rf: 0.72 (petroleum ether:ethyl acetate, 5:5); IR: νmax 2926, 1735, 1336, 1161 cm
―1; 1H NMR 
(400 MHz, CDCl3): Partial characterisation of 374, δ 7.65 (2H, m, CH-C9, CH-C13), 7.33 (2H, 
d, J = 7.9 Hz, CH-C10, CH-C12), 3.87 (1H, dd, J = 12.1, 1.8 Hz, CH2-C1), 3.26 (1H, s, CH-
C7), 1.63 (3H, s, CH3-C18/C19), 1.50 (3H, s, CH3-C18/C19). Partial characterisation of 380, 
δ 7.65 (2H, m, CH-C9, CH-C13), 7.33 (2H, d, J = 7.9 Hz, CH-C10, CH-C12), 4.93 (1H, dd, J = 
2.5, 1.1 Hz, CH2-C17), 4.91 (1H, dd, J = 3.0, 1.1 Hz, CH2-C17), 3.62 (1H, dd, J = 12.7, 0.9 
Hz, CH2-C1), 3.18 (1H, s, CH-C7), 1.30 (3H, s, CH3-C18/C19), 1.22 (3H, s, CH3-C18/C19). 
Partial characterisation of 381, δ 7.65 (2H, m, CH-C9, CH-C13), 7.33 (2H, d, J = 7.9 Hz, CH-
C10, CH-C12), 5.00 (1H, d, J = 1.4 Hz, CH2-C17), 4.90 (1H, d, J = 1.4 Hz, CH2-C17), 4.05 
(1H, dd, J = 12.6, 1.7 Hz, CH2-C1), 1.38 (3H, s, CH3-C18/C19), 1.01 (3H, s, CH3-C18/C19); 
HRMS (CI, isobutane) for C20H26NO3S ([M+H]
+) calculated 360.1633, found 360.1632; LRMS 
(CI, isobutane) m/z (intensity): 360 (100), 206 (8), 69 (12).  
C20H25NO3S 
Molecular weight: 359.48 g.mol―1 
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2-(Toluene-4-sulfonyl)-2,3,4,4a,5,6-hexahydro-1H-[2]pyrindin-6-ol 392: 
                 
N
S
O
O
1
4a3
4 5
6
78
9
10
12
13
14
11
7a
392
OH
H
    
Sodium borohydride (0.78 g, 2.1 mmol) was added portionwise to a solution of 240 (300 
mg, 1.03 mmol) and cerium(III) chloride heptahydrate (0.38 g, 1.0 mmol) in methanol (5 
mL), at 0 C. The mixture was stirred at this temprature for 1 h prior to the addition of 
water (5 mL). Diethyl ether (5 mL) was added and the phases were separated. The aqueous 
phase was extracted with diethyl ether (3 × 10 ml), the combined organic phases were 
washed with brine (30 mL), then dried over sodium sulfate and concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel (petroleum 
ether:ethyl acetate, 5:5) provided the product 392 (301 mg, 1.03 mmol, 100%) as a 
colourless solid. 
Rf: 0.30 (petroleum ether:ethyl acetate, 3:7); IR: νmax 3356, 2920, 1354, 1334, 1159 cm
―1; 
1H NMR (400 MHz, CDCl3): δ 7.66 (2H, d, J = 8.1 Hz, CH-C9, CH-C13), 7.32 (2H, d, J = 8.1 
Hz, CH-10, CH-C12), 5.58 (1H, s, CH-C7), 4.79―4.78 (1H, m, CH-C6), 4.40 (1H, d, J = 12.9 
Hz, CH2-C1), 3.89―3.86 (1H, m, CH2-C3), 2.92 (1H, d, J = 12.9 Hz, CH2-C1), 2.59 (1H, ddd, J 
= 13.2, 7.7, 7.7 Hz, CH2-C5), 2.43 (3H, s, CH3-C14), 2.37 (1H, ddd, J = 12.4, 12.3, 2.3 Hz, 
CH2-C3), 2.32―2.22 (1H, m, CH-C4a), 1.95―1.89 (1H, m, CH2-C4), 1.40 (1H, ddd, J = 12.8, 
12.3, 3.8 Hz, CH2-C4), 1.20 (1H, ddd, J = 13.2, 6.3, 6.3 Hz, CH2-C5); 
13C NMR (101 MHz, 
CDCl3): δ 143.6 (C-C11), 141.0 (C-C7a), 133.3 (C-C8), 129.6 (CH-C7), 128.3 (CH-C10, CH-
C12), 127.8 (CH-C9, CH-C13), 77.0 (CH-C6), 47.0 (CH2-C1), 46.0 (CH2-C3), 41.7 (CH-C4a), 
40.9 (CH2-C5), 33.3 (CH2-C4), 21.5 (CH3-C14); HRMS (CI, isobutane) for C15H18NO2S ([M-
OH]+) calculated 276.1058, found 276.1062; LRMS (CI, isobutane) m/z (intensity): 276 
(100), 122 (13), 71 (22). 
C15H19NO3S 
Molecular weight: 293.38 g.mol―1 
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6-(tertButyldimethylsilanyloxy)-2-(toluene-4-sulfonyl)-2,3,4,4a,5,6-hexahydro-1H-
[2]pyrindine 396: 
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t-Butyldimethylsilyl trifluoromethanesulfonate (0.17 mL, 0.78 mmol) was added to a 
solution of 2,6-lutidine (0.19 mL, 1.6 mmol) and 392 (190 mg, 0.647 mmol) in 
dichloromethane (15 mL) at 0 C. The resulting mixture was warmed to rt and stirred for 17 
h before a saturated aqueous solution of ammonium chloride (15 ml) was added. The 
phases were separated and the aqueous phase was extracted with dichloromethane (3 × 15 
ml). The combined organic phases were washed brine (45 mL), then dried over magnesium 
sulfate and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (heptane:ethyl acetate, 8:2) provided the product 396 (262 
mg, 0.645 mmol, 100%) as a colourless oil. 
Rf: 0.48 (petroleum ether:ethyl acetate, 8:2); IR: νmax 2955, 1462, 1354, 1251, 1161 cm
―1; 
1H NMR (400 MHz, CDCl3): δ 7.65 (2H, d, J = 8.1 Hz, CH-C9, CH-C13), 7.31 (2H, d, J = 8.1 
Hz, CH-C10, CH-C12), 5.48 (1H, d, J = 1.6 Hz, CH-C7), 4.84―4.80 (1H, m, CH-C6), 4.40 (1H, 
d, J = 12.9 Hz, CH2-C1), 3.86―3.83 (1H, m, CH2-C3), 2.91 (1H, d, J = 12.9 Hz, CH2-C1), 
2.48―2.45 (1H, m, CH-C4a), 2.42 (3H, s, CH3-C14), 2.36 (1H, ddd, J = 12.5, 12.3, 2.3 Hz, 
CH2-C3), 2.26―2.19 (1H, m, CH2-C5), 1.86 (1H, dddd, J = 10.2, 5.1, 2.4, 2.3 Hz, CH2-C4), 
1.40 (1H, ddd, J = 10.2, 12.3, 3.9 Hz, CH2-C4), 1.24 (1H, ddd, J = 12.4, 7.3, 7.3 Hz, CH2-
C5), 0.88 (9H, s, CH3-C18, CH3-C19, CH3-C20), 0.06 (3H, s, CH3-C15/C16), 0.04 (3H, s, CH3-
C15/C16); 13C NMR (101 MHz, CDCl3): δ 143.5 (C-C11), 139.0 (C-C8), 133.4 (C-C7a), 129.6 
(CH-C10, CH-C12), 129.1 (CH-C7), 127.5 (CH-C9, CH-C13), 76.8 (CH-C6), 46.8 (CH2-C1), 45.9 
(CH2-C3), 41.9 (CH-C4a), 41.8 (CH2-5), 32.8 (CH2-4), 25.9 (CH3-C18, CH3-C19, CH3-C20), 21.5 
(CH3-C14), 18.9 (C-C17), ―4.6 (CH3-C15, CH3-C16); HRMS (CI, isobutane) for C21H34NO3SSi 
([M+H]+) calculated 408.2029, found 408.2030; LRMS (CI, isobutane) m/z (intensity): 408 
(76), 350 (66), 276 (100), 133 (30). 
C21H33NO3SSi 
Molecular weight: 407.64 g.mol―1 
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6-Methoxy-2-(toluene-4-sulfonyl)-2,3,4,4a,5,6-hexahydro-1H-[2]pyrindine 400: 
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Sodium hydride (27 mg of a 60% dispersion in mineral oil, 0.68 mmol) was added 
portionwise to a solution of the alcohol 392 (100 mg, 0.341 mmol) in tetrahydrofuran (7 
mL) at 0 C. The mixture was stirred at this temperature for 10 min and methyl iodide 
(0.06 mL, 1 mmol) was added dropwise. This solution was then stirred at rt for 2 h and a 
saturated aqueous solution of ammonium chloride (7 mL) and ethyl acetate (10 mL) were 
added. The phases were separated and the aqueous phase was extracted with ethyl acetate 
(3 × 10 ml). The combined organic phases were washed with water (30 mL) and brine (30 
mL), then dried over magnesium sulfate and concentrated in vacuo. Purification of the 
residue by flash column chromatography on silica gel (heptane:ethyl acetate, 8:2) provided 
the product 400 (97 mg, 0.32 mmol, 93%) as a colourless solid. 
Rf: 0.34 (petroleum ether:ethyl acetate, 6:4); m.p.: 88―91 C; IR: νmax 2924, 2823, 1450, 
1342, 1157 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.66 (2H, d, J = 8.1 Hz, CH-C9, CH-C13), 7.31 
(2H, d, J = 8.1 Hz, CH-C10, CH-C12), 5.62 (1H, d, J = 1.6 Hz, CH-C7), 4.44―4.40 (1H, m, 
CH-C6), 4.41 (1H, d, J = 13.1 Hz, CH2-C1), 3.87―3.82 (1H, m, CH2-C3), 3.30 (3H, s, CH3-
C15), 2.94 (1H, d, J = 13.1 Hz, CH2-C1), 2.47 (1H, d, J = 13.1 Hz, CH2-C5), 2.42 (3H, s, CH3-
C14), 2.38 (1H, ddd, J = 12.5, 12.1, 2.3 Hz, CH2-C3), 2.27―2.19 (1H, m, CH-C4a), 
1.94―1.82 (1H, m, CH2-C4), 1.40 (1H, ddd, J = 12.6, 12.6, 12.1, 4.0 Hz, CH2-C4), 1.28 (1H, 
ddd, J = 13.1, 6.6, 6.6 Hz, CH2-C5); 
13C NMR (101 MHz, CDCl3): δ 143.5 (C-C11), 141.2 (C-
C8), 133.4 (C-C7a), 129.6 (CH-C10, CH-C12), 127.8 (CH-C9, CH-C13), 125.4 (CH-C7), 85.1 
(CH-C6), 56.0 (CH3-C15), 46.9 (CH2-C1), 45.9 (CH2-C3), 41.3 (CH-C4a), 36.8 (CH2-C5), 33.0 
(CH2-C4), 21.5 (CH3-C14); HRMS (CI, isobutane) for C16H22NO3S ([M+H]
+) calculated 
308.1320, found 308.1315; LRMS (CI, isobutane) m/z (intensity): 308 (22), 276 (100), 122 
(18); Elemental analysis: C16H21NO3S: requires C: 62.51%, N: 4.56%, H: 6.89%, found C: 
62.66%, N: 4.62%, H: 6.93%. 
C16H21NO3S 
Molecular weight: 307.41 g.mol―1 
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Tricyclic protected enone 398 
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2,2-Dimethyl-1,3-propanediol (1.78 g, 17.2 mmol) and oxalic acid (62 mg, 0.68 mmol) were 
added to a solution of enone 240 (1.00 g, 34.3 mmol), in toluene (50 mL). The flask was 
fitted with a Dean-Stark apparatus and the mixture was heated at 110 C for 4 h. The 
resulting solution was then concentrated in vacuo, and the residue was dissolved in ethyl 
acetate (50 mL), washed with water (50 mL) and brine (50 mL), then dried on magnesium 
sulfate and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether:ethyl acetate, 9:1) provided the product 
398 (705 mg, 1.86 mmol, 54%) as a colourless solid. 
Rf: 0.38 (petroleum ether:ethyl acetate, 7:3); m.p.: 100―102 C IR: νmax 2952, 1472, 1344, 
1163 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.64 (2H, d, J = 8.1 Hz, CH-C9, CH-C13), 7.29 (2H, 
d, J = 8.1 Hz, CH-C10, CH-C12), 6.51 (1H, s, CH-C7), 3.87 (1H, ddd, J = 12.4, 3.0, 2.4 Hz, 
CH2-C3), 3.48―3.44 (4H, m, CH2-C15, CH2-C17), 2.82 (1H, ddd, J = 12.8, 12.4, 2.6 Hz, CH2-
C3), 2.74 (1H, dd, J = 16.3, 2.4 Hz, CH2-C1), 2.57 (1H, d, J = 16.3 Hz, CH2-C1), 2.43 (3H, s, 
CH3-C14), 2.39―2.29 (2H, m, CH-C4a, CH2-C5), 1.98 (1H, dddd, J = 12.8, 3.0, 2.6, 2.7 Hz, 
CH2-C4), 1.28―1.23 (1H, m, CH2-C5), 1.17―1.07 (1H, m, CH2-C4), 1.01 (3H, s, CH3-
C18/C19), 0.92 (3H, s, CH3-C18/C19); 
13C NMR (101 MHz, CDCl3): δ 143.5 (C-C11), 134.7 (C-
C8), 129.6 (CH-C10, CH-C12), 127.6 (CH-C9, CH-13, 123.0 (C-C7a), 117.9 (CH-C7), 107.4 (C-
C6), 72.5 (CH2-C15/C17), 71.8 (CH2-C15/C17), 43.5 (CH2-C3), 41.9 (CH2-C5), 37.8 (CH2-C1), 
34.9 (CH-C4a), 30.0 (C-C16), 26.7 (CH2-C4), 22.4 (CH3-C18, CH3-C19), 21.5 (CH3-C14); HRMS 
(CI, isobutane) for C20H28NO4S ([M+H]
+) calculated 378.1739, found 378.1743; LRMS (CI, 
isobutane) m/z (intensity): 378 (100), 224 (48), 157 (8); Elemental analysis C20H27NO4S 
requires C: 63.63%, N: 3.71%, H: 7.21%, found C: 63.91%, N: 3.79%, H: 7.63%. 
C20H27NO4S 
Molecular weight: 377.50 g.mol―1 
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6-Hydroxy-7a-methyl-2-(toluene-4-sulfonyl)-1,2,3,4,4a,7a-hexahydro-[2]pyrindin-7-one 
323: 
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Dess-Martin periodinane (1.40 g, 3.30 mmol) was added to a solution of 316 (822 mg, 2.54 
mmol), in dichloromethane (100 mL) at 0 C and the solution was stirred for 2 h at rt. A 
saturated aqueous solution of sodium hydrogencarbonate (50 mL) and diethyl ether (50 mL) 
were added and the phases were separated. The aqueous phase was extracted with diethyl 
ether (3 × 50 ml), and the combined organic phases were washed with water (150 mL) and 
brine (150 mL), then dried over magnesium sulfate and concentrated in vacuo. Purification 
of the residue by flash column chromatography on silica gel (petroleum ether:ethyl 
acetate, 8:2 to 6:4) provided the product 323 (810 mg, 2.52 mmol, 99%) as a colourless 
crystaline solid allowing a crystal structure to be obtained (appendix 2).  
Rf: 0.37 (petroleum ether:ethyl acetate, 5:5); m.p.: 140―143 C; IR: νmax 3340, 2926, 1699, 
1334, 1159 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.61 (2H, d, J = 8.1 Hz, CH-C10, C-C14), 7.28 
(2H, d, J = 8.1 Hz, CH-C11, C-C13), 6.33 (1H, d, J = 3.0 Hz, CH-C5), 5.50 (1H, br s, OH), 
3.33―3.31 (1H, m, CH2-C3), 3.30 (1H, d, J = 12.4 Hz, CH2-C1), 3.09 (1H, d, J = 12.4 Hz, CH2-
C1), 3.09―3.07 (1H, m, CH2-C3), 2.56 (1H, ddd, J = 5.5, 5.4, 3.0 Hz, CH-C4a), 2.41 (3H, s, 
CH3-C15), 2.02 (1H, dddd, J = 14.4, 10.7, 5.4, 5.4 Hz, CH2-C4), 1.65 (1H, dddd, J = 14.4, 
10.7, 5.5, 5.5 Hz, CH2-C4), 1.15 (3H, CH3-C8); 
13C NMR (101 MHz, CDCl3): δ 205.9 (C-C7), 
151.7 (C-C6), 143.4 (C-C12), 134.6 (C-C9), 130.3 (CH-C5), 129.6 (CH-C11, CH-C13), 127.2 
(CH-C10, CH-C14), 48.1 (CH2-C1), 46.5 (C-C7a), 40.8 (CH-C4a), 40.6 (CH2-C3), 25.0 (CH2-
C4), 21.5 (CH3-C15), 21.1 (CH3-C8); HRMS (CI, isobutane) for C16H20NO4S ([M+H]
+) 
calculated 322.1113, found 322.1115; LRMS (CI, isobutane) m/z (intensity): 322 (40), 266 
(29), 172 (100),157 (89).  
 
C16H19NO4S 
Molecular weight: 321.39 g.mol―1 
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6-(tertButyldimethylsilanyloxy)-7a-methyl-2-(toluene-4-sulfonyl)-1,2,3,4,4a,7a-
hexahydro-[2]pyrindin-7-one 409: 
                
N
S
O
O
1
4a
3
4
5
67
8
9
10
12
13
16
18
19
20
14
11
7a
409
21
17
O
O Si
15
H
 
t-Butyldimethylsilyl trifluoromethanesulfonate (0.67 mL, 3.1 mmol) was added to a solution 
of 2,6-lutidine (0.83 mL, 7.2 mmol) and 323 (920 mg, 2.86 mmol) in dichloromethane (150 
mL), at 0 C. The mixture was stirred at rt for 17 h prior to the addition of a saturated 
aqueous solution of ammonium chloride (100 ml). The phases were separated and the 
aqueous phase was extracted with dichloromethane (3 × 100 ml), the combined organic 
phases were washed with brine (300 mL), then dried over magnesium sulfate and 
concentrated in vacuo. Purification of the residue by flash column chromatography on silica 
gel (petroleum ether:ethyl acetate, 9:1 to 8:2) provided the product 409 (971 mg, 2.22 
mmol, 78%) as a colourless solid. 
Rf: 0.35 (petroleum ether:ethyl acetate, 8:2); m.p.: 134―136 C; IR: νmax 2929, 2856, 1711, 
1616, 1330, 1157 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.62 (2H, d, J = 8.1 Hz, CH-C10, CH-
C14), 7.28 (2H, d, J = 8.1 Hz, CH-C11, CH-C13), 6.40 (1H, d, J = 3.0 Hz, CH-C5), 3.31 (1H, 
ddd, J = 11.3, 5.9, 5.6 Hz, CH2-C3), 3.15 (1H, d, J = 12.2 Hz, CH2-C1), 3.07 (1H, d, J = 12.2 
Hz, CH2-C1), 3.06―3.00 (1H, m, CH2-C3), 2.42 (1H, ddd, J = 5.5, 5.0, 3.0 Hz, CH-C4a), 2.40 
(3H, s, CH3-C15), 2.00 (1H, dddd, J = 14.3, 9.1, 5.6, 5.5 Hz, CH2-C4), 1.55 (1H, dddd, J = 
14.3, 6.2, 5.9, 5.0 Hz, CH2-C4), 1.12 (3H, s, CH3-C8), 0.92 (9H, s, CH3-C19, CH3-C20, CH3-
C21), 0.16 (6H, s, CH3-16, CH3-C17); 
13C NMR (101 MHz, CDCl3): δ 206.0 (C-C7), 152.9 (C-
C12), 143.3 (CH-C5), 137.6 (C-C6), 134.5 (C-C9), 129.6 (CH-C11, CH-C13), 127.3 (CH-C10, 
CH-C14), 48.2 (CH2-C1), 46.3 (C-C7a), 41.1 (CH2-C3), 40.2 (CH-C4a), 25.6 (CH2-C4), 25.5 
(CH3-C19, CH3-C20, CH3-C21), 21.7 (CH3-C8), 21.5 (CH3-C15), 18.3 (C-C18), ―4.6 (CH3-16, 
CH3-C17); HRMS (CI, isobutane) for C22H34NO4SSi ([M+H]
+) calculated 436.1978, found 
436.1981; LRMS (CI, isobutane) m/z (intensity): 436 (100), 320 (26), 113 (48), 71 (94). 
C22H33NO4SSi 
Molecular weight: 435.65 g.mol―1 
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6-(tertButyldimethylsilanyloxy)-7a-methyl-2-(toluene-4-sulfonyl)-1,2,3,4,4a,7a-
hexahydro-[2]pyrindin-7-one oxime 410: 
                15
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Hydroxylamine hydrochloride (11 mg, 0.16 mmol) was added to a solution of 409 (35 mg, 
0.080 mmol) in pyridine (2 mL). The mixture was stirred at 40 C and a further portion of 
hydroxylamine hydrochloride (11 mg, 0.16 mmol) was added every 24 h over a period of 7 
days. The reaction mixture was then concentrated in vacuo and the residue was dissolved 
in ethyl acetate (10 mL), washed with water (10 mL) and brine (10 mL), then dried over 
sodium sulfate and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether:ethyl acetate, 9:1) provided the product as 
a mixture of isomers 410 (26 mg, 0.057 mmol, 72%) as a colourless solid. 
Rf: 0.58 (petroleum ether:ethyl acetate, 8:2); m.p.: 179―181 C; IR: νmax 3240, 3109, 2931, 
2862, 1620, 1465, 1342, 1157 cm―1; 1H NMR (400 MHz, CDCl3): δ 8.90 (0.75H, br s, OH), 
8.62 (0.25H, br s, OH), 7.65 (2H, d, J = 8.5 Hz, CH-C10, CH-C13), 7.27 (2H, d, J = 8.5 Hz, 
CH-C11, CH-C14), 5.30 (1H, d, J = 2.9 Hz, CH-C5), 3.88 (1H, d, J = 12.7 Hz, CH2-C1), 3.37 
(1H, ddd, J = 10.5, 10.2, 5.6 Hz, CH2-C3), 3.23 (1H, d, J = 12.7 Hz, CH2-C1), 3.04 (1H, ddd, 
J = 10.5, 10.5, 5.3 Hz, CH2-C3), 2.40 (3H, s, CH3-C15), 2.26―2.20 (1H, m, CH-C4a), 1.86 
(1H, ddd, J = 10.5, 10.1, 5.6, 5.2 Hz, CH2-C4), 1.41 (3H, s, CH3-C8), 1.34―1.27 (1H, m, CH2-
C4), 0.95 (9H, s, CH3-C19, CH3-C20, CH3-C21), 0.18 (3H, s, CH3-C16/C17), 0.16 (3H, s, CH3-
C16/C17); 13C NMR (101 MHz, CDCl3): δ 162.2 (C-C7), 149.3 (C-C6), 143.0 (C-C12), 135.0 (C-
C9), 129.5 (CH-C11, CH-C14), 127.3 (CH-C10, CH-C13), 119.9 (CH-C5), 46.6 (CH2-C1), 44.9 
(C-C7a), 44.0 (CH-C4a), 41.6 (CH2-C3), 26.9 (CH2-C4), 25.5 (CH3-C19, CH3-C20, CH3-C21), 
22.0 (CH3-C8), 21.5 (CH3-C15), 18.2 (C-C17), ―4.7 (CH3-C16, CH3-C17); HRMS (CI, 
isobutane) for C22H35N2O4SSi ([M+H]
+) calculated 451.2087, found 451.2089; LRMS (CI, 
isobutane) m/z (intensity): 451 (32), 435 (58), 279 (36), 133 (74). 
C22H34N2O4SSi 
Molecular weight: 450.67 g.mol―1 
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N-[7a-Methyl-6-oxo-2-(toluene-4-sulfonyl)-octahydro-[2]pyrindin-7-yl]-propionamide 
412: 
                       18
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Palladium on carbon (16 mg, 0.15 mmol) was added to a solution of 410 (684 mg, 1.52 
mmol) and hydrochloric acid (1.5 mL) in ethanol (15 mL) under hydrogen atmosphere 
ballon. The mixture was stirred at rt for 3 h, then filtered through Celite and concentrated 
in vacuo. The amine hydrochloric salt was obtained by trituration with ethanol, 
hydrochloric acid and diethyl ether, filtration, and subsequent driyng under vaccum. This 
product 411 was used directly in the next step (360 mg, 0.951 mmol, 62%). 
N-Methyl morpholine (0.07 mL, 0.6 mmol) and propanoyl chloride (0.03 mL, 0.3 mmol) 
were added to a solution of 411 (90 mg, 0.25 mmol) in tetrahydrofuran (3 mL) at 0 C The 
resulting mixture was warmed to rt and stirred for 24 h. Ethyl acetate (5 mL) and water (5 
mL) were added and the phases were separated. The aqueous phase was extracted with 
ethyl acetate (3 × 5 ml) and the combined organic phases were washed with a saturated 
aqueous solution of sodium hydrogencarbonate (5 mL) and brine (5 mL), then dried over 
magnesium sulfate and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (diethyl ether:ethyl acetate, 5:5) provided the product 412 
(47 mg, 0.12 mmol, 50%) as a colourless crystalline solid allowing a crystal structure to be 
obtained (Appendix 3).  
Rf: 0.47 (ethyl acetate, 10); m.p.: 189―182 C; IR: νmax 3410, 3286, 1751, 1681, 1512, 1327, 
1157 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.62 (2H, d, J = 8.1 Hz, CH-C10, CH-C14), 7.31 (2H, 
d, J = 8.1 Hz, CH-C11, CH-C13), 5.45 (1H, d, J = 7.8 Hz, NH), 4.59 (1H, d, J = 7.8 Hz, CH-
C7), 3.61 (1H, ddd, J = 11.5, 4.9, 2.5 Hz, CH2-C3), 3.21 (1H, d, J = 12.2 Hz, CH2-C1), 2.44 
(3H, s, CH3-C15), 2.42―2.26 (5H, CH2-C3, CH2-C5, CH-C4a, CH2-C17), 2.13―2.21 (1H, m, 
CH2-C4), 1.96 (1H, dd, J = 19.1, 9.8 Hz, CH2-C5), 1.64―1.62 (1H, m, CH2-C4), 1.87 (1H, d, J 
= 12.2 Hz, CH2-C1), 1.39 (3H, s, CH3-C8), 1.95 (3H, t, J = 7.5 Hz, CH3-C18); 
13C NMR (101 
MHz, CDCl3): δ 212.8 (C-C6), 174.8 (C-C16), 143.9 (C-C12), 133.1 (C-C9), 129.9 (CH-C11, 
CH-C13), 127.4 (CH-C10, CH-C14), 66.3 (CH-C7), 47.4 (CH2-C1), 42.5 (C-C7a), 41.1 (CH2-
C3), 35.6 (CH2-C5), 34.3 (CH-C4a), 29.4 (CH2-C17), 23.4 (CH2-C4), 21.7 (CH2-C8), 21.5 (CH2-
C15), 9.6 (CH3-C18); HRMS (CI, isobutane) for C19H27N2O4S ([M+H]
+) calculated 379.1692, 
C19H26N2O4S 
Molecular weight: 378.49 g.mol―1 
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found 379.1696; LRMS (CI, isobutane) m/z (intensity): 379 (10), 225 (9), 113 (14), 89 
(100). 
7a-Allyl-2-(toluene-4-sulfonyl)-octahydro-[2]pyrindin-6-one 243 and 2-Allyl-6-(toluene-
4-sulfonyl)-octahydro-1-oxa-6-aza-cyclopropa[c]inden-2-ol 420: 
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Allylmagnesium chloride (2.7 mL of a 1.0 M solution in tetrahydrofuran, 2.7 mmol) was 
added dropwise to a solution of copper (I) iodide (0.26 g, 1.4 mmol), in tetrahydrofuran (20 
mL) at rt. This was followed by the dropwise addition of a solution of ketone 240 (200 g, 
0.69 mmol) and chlorotrimethylsilane (0.21 mL, 1.7 mmol) in tetrahydrofuran (5 mL). After 
1 h, the mixture was quenched by the addition of saturated aqueous ammonium chloride 
solution (10 mL), saturated aqueous ammonium hydroxide solution (10 mL) and water (20 
mL), then diethyl ether (50 mL) was added. The phases were separated and the aqueous 
phase was extracted with diethyl ether (3 × 50 ml). The combined organic phases were 
washed with water (150 mL) and brine (150 mL), then dried over sodium sulfate and 
concentrated in vacuo. Dimethyldioxirane (0.085 M in acetone, 9.6 mL) was added to a 
solution of the crude mixture, in dichloromethane (7.5 mL), at 0 ºC. After 5 min, the 
solution was concentrated in vacuo and the residue was dissolved in a mixture of 
tetrahydrofuran (10 mL), water (4 mL) and acetic acid (4 mL). The mixture was stirred at rt 
for 3 h. Solid sodium hydrogencarbonate was added until gas evolution ceased. Ethyl 
acetate (20 mL) and water (20 mL) were added and the phases were separated. The 
aqueous phase was extracted with ethyl acetate (3 × 20 ml), the combined organic phases 
were successively washed with a saturated aqueous solution of sodium hydrogencarbonate 
(30 mL), water (30 mL), and brine (30 mL). The solution was then dried over magnesium 
sulfate, and concentrated in vacuo. Purification of the residue by flash column 
chromatography (petroleum ether-ethyl acetate, 8:2 to 3:7) provided the product 243 (119 
mg, 0.357 mmol, 52%) and 420 (56 mg, 0.16 mmol, 23%) as colourless solids. 
 
 
C18H23NO3S 
Molecular weight: 333.45 g.mol―1 
C18H23NO4S 
Molecular weight: 349.44 g.mol―1 
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Data for 243: 
Rf: 0.29 (petroleum ether:ethyl acetate, 5:5); m.p.: 133―136 ºC (lit: 136―139 ºC); IR: νmax 
2901, 1728, 1334, 1157 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.61 (2H, d, J = 7.8 Hz, CH-C12, 
CH-C16), 7.32 (2H, d, J = 7.8 Hz, CH-C13, CH-C15), 5.72 (1H, dddd, J = 17.8, 10.3, 7.4, 7.4 
Hz, CH-C9), 5.17―5.11 (2H, m, CH2-C10), 3.13―3.08 (1H, m, CH2-C3), 3.00 (1H, d, J = 11.5 
Hz, CH2-C1), 2.89―2.83 (1H, m, CH2-C3), 2.58 (1H, d, J = 11.5 Hz, CH2-C1), 2.43 (3H, s, 
CH3-C17), 2.48―2.38 (1H, m, CH2-C8), 2.31 (1H, dd, J = 18.5, 7.9 Hz, CH2-C5), 2.26―2.19 
(1H, m, CH2-C8), 2.21 (2H, s, CH2-C7), 2.15―2.10 (1H, m, CH-C4a), 2.05―1.97 (2H, m, CH2-
C4, CH2-C5), 1.55 (1H, dddd, J = 14.2, 6.2, 6.1, 3.6 Hz, CH2-C4); 
13C NMR (101 MHz, CDCl3): 
δ 216.7 (C-C6), 143.9 (C-C11), 133.0 (C-14), 132.6 (CH-C9), 129.9 (CH-C12, CH-C16), 127.7 
(CH-C13 CH-C15), 119.8 (CH2-C10), 49.6 (CH2-C1), 46.5 (CH2-C7), 42.7 (CH2-C3), 41.6 (C-
C7a), 41.2 (CH2-C5), 40.5 (CH2-C8), 37.0 (CH-C4a), 25.4 (CH2-C4), 21.6 (CH3-C17); HRMS 
(CI, isobutane) for C18H24NO3S ([M+H]
+) calculated 346.1477, found 346.1479; LRMS (CI, 
isobutane) m/z (intensity): 346 (100), 192 (29), 71 (30); Elemental analysis: C18H23NO3S 
requires C: 64.84%, N: 4.20%, H: 6.95%, found C: 64.75%, N: 4.33%, H: 6.98%. The data 
observed are in accordance with literature values.84 
Data for 420:     
Rf: 0.31 (petroleum ether:ethyl acetate, 3:7); IR: νmax 3485, 2926, 2854, 1749), 1597, 1338, 
1159 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.68 (2H, d, J = 8.2 Hz, CH-C9, CH-C13), 7.32 (2H, 
d, J = 8.2 Hz, CH-C10, CH-C12), 5.82 (1H, ddt, J = 17.2, 10.3, 7.3 Hz, CH-C16), 5.13 (1H, d, 
J = 10.3 Hz, CH2-C17), 5.08 (1H, dd, J = 17.2, 1.5 Hz, CH2-C17), 3.92―3.89 (1H, m, CH2-C3), 
3.71 (1H, d, J = 12.3 Hz, CH2-C1), 3.41 (1H, s, CH-C7), 2.98 (1H, d, J = 12.3 Hz, CH2-C1), 
2.43 (3H, s, CH3-C14), 2.44 (1H, m, CH2-C3), 2.27 (1H, dd, J = 13.7, 7.0 Hz, CH2-C5), 2.22 
(1H, dd, J = 13.7, 7.0 Hz, CH2-C5), 1.79―1.64 (4H, CH2-C4, CH-C4a, CH2-C15), 1.10―1.05 
(1H, m, CH2-C4); 
13C NMR (101 MHz, CDCl3): δ 143.5 (C-C11), 133.5 (C-C8), 132.1 (CH-C16), 
129.6 (CH-C10, CH-C12), 127.5 (CH-C9, CH-C13), 118.8 (CH2-C17), 79.1 (C-C6), 65.7 (CH-
C7), 63.8 (C-C7a), 48.8 (CH2-C1), 45.8 (CH2-C3), 40.6 (CH2-C5), 37.4 (CH2-C4), 37.1 (CH-
C4a), 27.2 (CH2-C15), 21.4 (CH3-C14); HRMS (CI, isobutane) for C18H24NO4S ([M+H]
+) 
calculated 350.1426, found 350.1429; LRMS (CI, isobutane) m/z (intensity): 350 (19), 316 
(36), 89 (100).  
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2-(Tetrahydropyran-2-yloxy)-propionic acid isopropyl ester 430: 
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Pyridinium p-toluenesulfonate  (0.19 g, 0.76 mmol) and 3,4-dihydro-2H-pyran (0.95 mL, 11 
mmol) were added to a solution of L-isopropyl lactate (1.0 mL, 7.6 mmol) in 
dichloromethane (20 mL). The solution was stirred at rt for 3 h, then was washed with 
brine (20 mL), dried over magnesium sulfate and concentrated in vacuo. Purification of the 
residue by flash column chromatography on silica gel (petroleum ether:ethyl acetate, 9:1) 
provided the product 430 (1.6 g, 7.5 mmol, 98%) as a colourless oil. The product was 
isolated as an inseparable diastereomeric mixture (4:3) with respect to the stereogenic 
centre in the tetrahydropyranyl ring. 
Rf: 0.57 (petroleum ether:ethyl acetate, 9:1); IR: νmax 2940, 1743, 1454, 1374 cm
―1; 1H NMR 
for the major isomer (400 MHz, CDCl3): δ 5.01 (1H, hept, J = 12.5, CH-C10), 4.68 (1H, t, J 
= 3.6 Hz, CH-C4), 4.34 (1H, q, J = 7.0 Hz, CH-C2), 3.95 (1H, ddd, J = 3.3, 5.9, 25.5, CH2-
C6), 3.37―3.52 (1H, m, CH2-C6), 1.90―1.45 (6H, m, CH2-C7, CH2-C8, CH2-C9), 1.40 (3H, d, J 
= 7.0, CH3-C3), 1.23―1.20 (6H, m, CH3-C11, CH3-C12);
 13C NMR for the major isomer (101 
MHz, CDCl3): 172.9 (C-C1), 97.6 (CH-C4), 70.1 (CH-C2), 68.3 (CH-C10), 62.4 (CH2-C6), 30.4 
(CH2-C9), 25.5 (CH2-C7), 21.9 (CH3-C11, CH3-C12), 19.2 (CH3-C8), 18.7 (CH2-C3); 
1H NMR for 
the minor isomer (400 MHz, CDCl3): δ 5.01 (1H, hept, J = 12.5, CH-C10), 4.65 (1H, t, J = 
3.6 Hz, CH-C4), 4.09 (1H, q, J = 7.0 Hz, CH-C2), 3.85 (1H, ddd, J = 3.3, 5.9, 25.5, CH2-C6), 
3.37―3.52 (1H, m, CH2-C6), 1.90―1.45 (6H, m, CH2-C7, CH2-C8, CH2-C9), 1.34 (3H, d, J = 
7.0, CH3-C3), 1.23―1.20 (6H, m, CH3-C11, CH3-C12);
 13C NMR for the minor isomer (101 
MHz, CDCl3): 172.8 (C-C1), 98.3 (CH-C4), 72.7 (CH-C2), 68.1 (CH-C10), 62.3 (CH2-C6), 30.5 
(CH2-C9), 25.4 (CH2-C7), 21.8 (CH3-C11, CH3-C12), 19.1 (CH3-C8), 18.1 (CH2-C3); HRMS (CI, 
isobutane) for C11H21O4 ([M+H]
+) calculated 217.1440, found 217.1437; LRMS (CI, 
isobutane) m/z (intensity): 217 (8), 133 (18), 85 (100); Elemental analysis: C11H20O4 
requires C: 61.09%, H: 9.32% found, C: 61.23%, H: 9.40%.These data observed are in 
accordance with literature values.152 
 
 
 
C11H20O4 
Molecular weight: 216.27 g.mol―1 
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2-(Tetrahydropyran-2-yloxy)-propionaldehyde 431: 
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Diisobutylaluminum hydride (7.5 mL of a 1.0 M solution in dichloromethane, 7.5 mmol) was 
added dropwise to a solution of 430 (1.6 g, 7.5 mmol) in dichloromethane (200 mL) at ―78 
ºC. The mixture was stirred at this temperature for 1 h and then quenched by the addition 
of a saturated aqueous solution of sodium potassium tartrate (200 mL), diluted with ethyl 
acetate (500 mL) and warmed to rt. The phases were separated and the aqueous phase was 
extracted with ethyl acetate (3 × 500 mL), the combined organic phases were washed with 
washed with water (1 L), and brine (1 L), then dried over magnesium sulfate and 
concentrated in vacuo. Purification of the residue by flash column chromatography on silica 
gel (petroleum ether:ethyl acetate, 9:1) provided the title compound 431 (0.75 g, 4.8 
mmol, 63%) as a colourless oil. The product was isolated as an inseparable diastereomeric 
mixture (1:0.86) with respect to the stereogenic centre in the tetrahydropyranyl ring. 
Rf: 0.47 (petroleum ether:ethyl acetate, 8:1); IR: νmax 2940, 1743, 1454, 1374 cm
―1; 1H NMR 
for the major isomer (400 MHz, CDCl3): δ 9.64 (1H, s, CHO-C1), 4.64 (1H, dd, J = 4.9, 2.5 
Hz, CH-C4), 3.98 (1H, dq, J = 7.0, 2.5 Hz, CH-C2), 3.45―3.57 (1H, m, and m, CH2-C6), 
1.45―1.90 (6H, m, CH2-C7, CH2-C8, CH2-C9), 1.31 (3H, d, J = 7.0 Hz, and d, J = 7.0, Hz CH3-
C3); 13C NMR for the major isomer (101 MHz, CDCl3): δ 203.7 (C-C1), 99.5 (CH-C4), 76.8 
(CH-C2), 63.7 (CH2-C6), 30.8 (CH2-C9), 25.3 (CH2-C7), 20.1 (CH2-C8), 15.3 (CH3-C3); 
1H NMR 
for the minor isomer (400 MHz, CDCl3): δ 9.64 (1H, s, CHO-C1), 4.71 (1H, dd, J = 4.9, 2.5 
Hz, CH-C4), 4.23 (1H, dq, J = 7.0, 2.5 Hz, CH-C2), 3.83―3.93 (1H, m, and m, CH2-C6), 
1.45―1.90 (6H, m, CH2-C7, CH2-C8, CH2-C9), 1.35 (3H, d, J = 7.0 Hz, and d, J = 7.0, Hz CH3-
C3); 13C NMR for the minor isomer (101 MHz, CDCl3): δ 203.3 (C-C1), 98.5 (CH-C4), 78.7 
(CH-C2), 62.9 (CH2-C6), 30.7 (CH2-C9), 25.4 (CH2-C7), 19.5 (CH2-C8), 15.5 (CH3-C3); HRMS 
(CI, isobutane) for C8H15O3 ([M+H]
+) calculated 159.1021, found 159.1023; LRMS (CI, 
isobutane) m/z (intensity): 159 (18), 85 (100), 75 (61). These data observed are in 
accordance with literature values.152 
 
 
 
C8H14O3 
Molecular weight: 158.19 g.mol―1 
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7-(tertButyldimethylsilanyloxy)-7a-methyl-2-(toluene-4-sulfonyl)-octahydro-
[2]pyrindin-6-one 440: 
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Imidazole (1.7 g, 25 mmol) and t-butyldimethylsilyl chloride (1.0 g, 6.8 mmol) were added 
to a solution of 316 (1.5 g, 4.5 mmol) in N,N-dimethylformamide (25 mL) and the mixture 
was stirred at 30 ºC for 17 h. Diethyl ether (50 mL) and water (50 mL) were added, the 
phases were separated and the organic phase was washed with water (3 × 50 mL), and 
brine (50 mL), then dried over magnesium sulfate and concentrated in vacuo. Purification 
of the residue by flash column chromatography on silica gel (petroleum ether:ethyl 
acetate, 95:5) provided the product 440 (1.7 g, 3.8 mmol, 83%) as a colourless solid. 
Rf: 0.40 (petroleum ether:ethyl acetate, 6:4); mp: 171―172 ºC; IR: νmax 2929, 2856, 1749, 
1462, 1340, 1161 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.64 (2H, d, J = 8.2 Hz, CH-C16, CH-
C20), 7.34 (2H, d, J = 8.2 Hz, CH-C17, CH-C19), 4.39 (1H, s, CH-C7), 3.75―3.73 (1H, m, 
CH2-C3), 3.64 (1H, dd, J = 11.9, 1.7 Hz, CH2-C1), 2.47 (1H, dd, J = 19.4, 8.3 Hz, CH2-C5), 
2.43 (3H, s, CH3-C21), 2.16 (1H, ddd, J = 12.4, 12.0, 2.5 Hz, CH2-C3), 2.01 (1H, d, J = 11.9 
Hz, CH2-C1), 1.93 (1H, d, J = 19.4 Hz, CH2-C5), 1.87―1.81 (1H, m, CH2-C4), 1.81―1.73 (1H, 
m, CH-C4a), 1.57 (1H, ddd, J = 15.9, 12.4, 4.3 Hz, CH2-C4), 0.93 (9H, s, CH3-C12, CH3-C13, 
CH3-C14), 0.81 (3H, s, CH3-C8), 0.20 (3H, s, CH3-C9/C10), 0.19 (3H, s, CH3-C9/C10); 
13C 
NMR (101 MHz, CDCl3): δ 215.2 (C-C6), 143.7 (C-C18), 132.6 (C-C15), 129.7 (CH-C17, CH-
C19), 127.9 (CH-C16, CH-C20), 76.4 (CH-C7), 51.1 (CH2-C1), 46.0 (CH2-C3), 41.6 (C-C7a), 
39.7 (CH2-C5), 34.8 (CH-C4a), 29.5 (CH2-C4), 25.9 (CH3-C12, CH3-C13, CH3-C14), 21.6 (CH3-
C21), 19.4 (CH3-C8), 18.3 (C-C11), ―5.1 (CH3-C9, CH3-C10); HRMS (CI, isobutane) for 
C21H36NO4SSi ([M+H]
+) calculated 438.2134, found 438.2138; LRMS (CI, isobutane) m/z 
(intensity): 438.5 (100), 284.5 (22), 107.2 (38); Elemental analysis: C21H35NO4SSi requires 
C: 60.37%, N: 3.20%, H: 8.06%, found C: 60.50%, N: 3.37 %, H: 8.10%. 
C22H35NO4SSi 
Molecular weight: 437.67 g.mol―1 
144 
 
7-(tertButyldimethylsilanyloxy)-5-[1-hydroxy-2-(tetrahydropyran-2-yloxy)propyl]-7a-
methyl-2-(toluene-4-sulfonyl)octahydro-[2]pyrindin-6-one 441: 
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A solution of n-butyllithium (0.23 mL of a 2.5 M solution in hexanes, 0.57 mmol) was added 
dropwise to a solution of diisopropyl amine (77 µL, 0.55 mmol) in tetrahydrofuran (5 mL), 
at ―78 ºC. The solution was stirred at ―78 ºC for 10 min, then warmed to 0 ºC for 10 min 
and finally cooled back to ―78 ºC. This solution of lithium diisopropyl amide was then 
added dropwise to a solution of 431 (0.20 g, 0.46 mmol) in tetrahydrofuran (10 mL) at ―78 
ºC. The resulting mixture was stirred at this temperature for 30 min and a solution of zinc 
chloride (0.14 g, 1.1 mmol) in tetrahydofuran (2 mL) was added. After a further 5 min, a 
solution of 440 (0.14 g, 0.92 mmol) in tetrahydrofuran (2 mL) was added. The mixture was 
stirred at ―78 ºC for 2 h, then slowly warmed to rt, and stirred for a further 16 h. Diethyl 
ether (20 mL) and a saturated aqueous solution of ammonium chloride (20 mL) were added, 
the phases were separated and the aqueous phase was extracted with diethyl ether (2 × 
20).  The combined organic phases were washed with washed brine (50 mL) then dried over 
magnesium sulfate and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether:ethyl acetate, 9:1 to 6:4) provided the 
product 441 (0.18 g, 0.30 mmol, 67%) as an inseparable mixture of diastereoisomers, which 
was used without further separation. 
HRMS (FAB) for C30H49NO7SSiNa ([M+Na]
+) calculated 618.2897, found 618.2899; LRMS (FAB) 
m/z (intensity): 618 (100), 530 (21), 87 (60). 
C30H49NO7SSi 
Molecular weight: 595.86 g.mol―1 
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2-(4-Methoxy-benzyloxy)-propionic acid isopropyl ester 443: 
                    443O
O
O O
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A solution of L-isopropyl lactate (2.0 mL, 15 mmol) in N,N-dimethylformamide (4 mL) was 
added dropwise to a solution of sodium hydroxide (0.67 g, 60% in mineral oil, 17 mmol) in 
N,N-dimethylformamide (50 mL) at 0 ºC. The mixture was stirred for 1 h at rt and a solution 
of tetrabutylammonium iodide (0.28 g, 0.76 mmol) in N,N-dimethylformamide (8 mL) was 
added, followed by 4-methoxybenzyl chloride (2.5 mL, 18 mmol). The mixture was stirred 
at rt for 16 h, and diethyl ether (50 mL) and water (50 mL) were added. The organic phase 
was washed with water (3 × 50 mL) and brine (50 mL), then dried over magnesium sulfate 
and concentrated in vacuo. Purification of the residue by flash column chromatography on 
silica gel (petroleum ether:ethyl acetate, 95:5) provided the product 443 (1.8 g, 7.2 mmol, 
48%) as a colourless oil. 
Rf: 0.65 (petroleum ether:ethyl acetate, 6:4); IR: νmax 2982, 2937, 2837, 1737, 1587, 1514, 
1246 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.29 (2H, d, J = 8.7 Hz, CH-C6, CH-C10), 6.87 (2H, 
d, J = 8.7 Hz, CH-C7, CH-C9), 5.09 (1H, hept, J = 6.2 Hz, CH-C12), 4.61 (1H, d, J = 11.2 Hz, 
CH2-C4), 4.36 (1H, d, J = 11.2 Hz, CH2-C4), 3.98 (1H, q, J = 6.8 Hz, CH-C2), 3.79 (3H, s, 
CH3-C11), 1.39 (3H, d, J = 6.8 Hz, CH3-C3), 1.27 (3H, d, J = 6.2 Hz, CH3-C13/C14), 1.26 (3H, 
d, J = 6.2 Hz, CH3-C13/C14); 
13C NMR (101 MHz, CDCl3): δ 172.9 (C-C1), 159.6 (C-C8), 129.6 
(C-C5), 129.3 (CH-C6, CH-C10), 113.9 (CH-C7, CH-C9), 73.8 (CH-C2), 71.6 (CH2-C4), 66.1 
(CH-C12), 55.6 (CH3-C11), 22.1 (CH3-C13, CH3-C14), 18.7 (CH3-C3).  
 
2-(4-Methoxy-benzyloxy)propionaldehyde 444: 
                            444O
O
O H
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  A solution of diisobutylaluminum hydride (6.8 mL of a 1.0 M solution in dichloromethane, 
6.8 mmol) was added dropwise to a solution of 443 (1.7 g, 6.8 mmol), in dichloromethane 
(200 mL) at ―78 ºC. The mixture was stirred at this temperature for 1 h, quenched with a 
saturated aqueous solution of sodium potassium tartrate (300 mL), diluted with ethyl 
acetate (500 mL) and warmed to rt. The phases were separated and the aqueous phase was 
C14H20O3 
Molecular weight: 252.31 g.mol―1 
C11H14O4 
Molecular weight: 194.23 g.mol―1 
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extracted with ethyl acetate (3 × 500 mL). The combined organic phases were washed with 
water (500 mL) and brine (500 mL), then dried over magnesium sulfate and concentrated in 
vacuo. Purification of the residue by column chromatography on silica gel (petroleum 
ether:ethyl acetate, 95:5) provided the title compound 444 (1.0 g, 5.2 mmol, 77%) as a 
colourless oil.  
Rf: 0.65 (petroleum ether:ethyl acetate, 6:4); IR: νmax 2982, 2908, 2837, 1737, 1464, 1514  
cm―1; 1H NMR (400 MHz, CDCl3): δ 9.63 (1H, d, J = 1.8 Hz, CHO-C1), 7.28 (2H, d, J = 8.5 Hz, 
CH-C6, CH-C10), 6.89 (2H, d, J = 8.5 Hz, CH-C7, CH-C9), 4.55 (1H, d, J = 3.7 Hz, CH2-C4), 
4.55 (1H, d, J = 3.7 Hz, CH2-C4), 3.87 (1H, qd, J = 6.9, 1.8 Hz, CH-C2), 3.80 (3H, s, CH3-
C11), 1.30 (3H, d, J = 6.9 Hz, CH3-C3); 
13C NMR (101 MHz, CDCl3): δ 203.3 (CHO-C1), 159.5 
(C-C8), 130.4 (CH-C6, CH-C10), 129.4 (C-C5), 114.2 (CH-C7, CH-C9), 79.1 (CH-C2), 71.7 
(CH2-C4), 55.3 (CH3-C11), 15.3 (CH3-C3); HRMS (EI) for C11H14O3 ([M]
+) calculated 194.0943, 
found 194.0945; LRMS (EI) m/z (intensity): 194 (8), 121 (100), 91 (10), 77 (19). 
 
7-(tertButyldimethylsilanyloxy)-5-[1-hydroxy-2-(4-methoxybenzyloxy)propyl]-7a-
methyl-2-(toluene-4-sulfonyl)octahydro-[2]pyrindin-6-one 445: 
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A solution of n-butyllithium (1.8 mL of a 2.5 M solution in hexanes, 4.4 mmol) was added 
dropwise to a solution of diisopropyl amine (0.58 mL, 4.1 mmol) in tetrahydrofuran (5 mL) 
at ―78 ºC. The solution was stirred at ―78 ºC for 10 min, then warmed to 0 ºC for 10 min 
and finally cooled back to ―78 ºC. This solution of lithium diisopropyl amide was then 
added dropwise to a solution of 444 (1.13 g, 2.58 mmol) in tetrahydrofuran (50 mL) at ―78 
ºC. The resulting mixture was stirred at this temperature for 30 min and a solution of zinc 
chloride (0.81 g, 5.9 mmol) in tetrahydofuran (10 mL) was added. After a further 5 min, a 
solution of 440 (1.0 g, 5.2 mmol) in tetrahydrofuran (10 mL) was added. The mixture was 
stirred at ―78 ºC for 2 h, then slowly warmed to rt and stirred for a further 16 h. Diethyl 
ether (50 mL) and a saturated aqueous solution of ammonium chloride (50 mL) were added 
C33H49NO7SSi 
Molecular weight: 631.90 g.mol―1 
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and the phases were separated. The aqueous phase was extracted with diethyl ether (2 × 
50 ml), the combined organic phases were washed with brine (100 mL), then dried over 
magnesium sulfate and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether:ethyl acetate 9:1 to 6:4) provided the 
product 445 (1.1 g, 1.8 mmol, 69%) as a mixture of isomers, which was used without 
further separation. For data purposes, a fraction of the major isomer (16% of the mixture) 
was isolated and characterised. 
Rf: 0.51 (petroleum ether:ethyl acetate, 6:4); 
1H NMR (400 MHz, CDCl3): δ 7.61 (2H, d, J = 
8.1 Hz, CH-C27, CH-C31), 7.33 (2H, d, J = 8.1 Hz, CH-C28, CH-C30), 7.15 (2H, d, J = 8.6 Hz, 
CH-C14, CH-C18), 6.79 (2H, d, J = 8.6 Hz, CH-C15, CH-C17), 4.45 (1H, d, J = 11.4 Hz, CH2-
C12), 4.34 (1H, d, J = 11.4 Hz, CH2-C12), 4.14 (1H, s, CH-C7), 3.78 (3H, s, CH3-C19), 
3.63―3.51 (2H, m, CH-C9, CH-C10), 3.29―3.24 (1H, m, CH2-C3), 3.13 (1H, d, J = 12.0 Hz, 
CH2-C1), 2.46―2.44 (1H, m, CH2-C3), 2.44 (3H, s, CH3-C32), 2.28 (1H, d, J = 12.0 Hz, CH2-
C1), 2.22 (1H, ddd, J = 6.6, 5.1, 1.5 Hz, CH-C5), 1.90 (1H, dddd, J = 12.8, 5.6, 5.7, 3.3 Hz 
CH2-C4), 1.81 (1H, ddd, J = 10.2, 5.6, 5.1 Hz, CH-C4a), 1.60 (1H, dddd, J = 12.8, 10.2, 9.4, 
4.0 Hz, CH2-C4), 1.19 (3H, d, J = 6.1 Hz, CH3-C11), 0.93 (9H, s, CH3-C23, CH3-C24, CH3-
C25), 0.88 (3H, s, CH3-C8), 0.15 (3H, s, CH3-C2/C210), 0.14 (3H, s, CH3-C20/C21); 
13C NMR 
(101 MHz, CDCl3): δ 217.9 (C-C6), 159.2 (C-C16), 143.8 (C-C29), 132.7 (C-C13), 130.5 (C-
C26), 129.8 (CH-C14, CH-C18), 129.4 (CH-C15, CH-C17), 127.8 (CH-Car, CH-Car), 113.8 (CH-
Car, CH-Car), 77.8 (CH-C7), 76.4 (CH-C9), 75.5 (CH-C10), 70.5 (CH2-C12), 55.3 (CH3-C19), 
51.0 (CH-C5), 50.5 (CH2-C1), 44.8 (CH2-C3), 40.8 (C-C7a), 38.6 (CH-C4a), 28.4 (CH2-C4), 
25.9 (CH3-C23, CH3-C24, CH3-C25), 21.6 (CH3-C32), 20.1 (CH3-C8), 18.3 (C-C22), 15.5 (CH3-
C11), ―4.1 (CH3-C20/C21), ―5.0 (CH3-C20/C21); HRMS (FAB) for C33H50NO7SSi ([M+H]
+) 
calculated 632.3077, found 632.3071; LRMS (FAB) m/z (intensity): 632 (22), 530 (49), 380 
(60), 122 (100). 
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7-(tertButyldimethylsilanyloxy)-5-(2-hydroxypropylidene)-7a-methyl-2-(toluene-4-
sulfonyl)octahydro-[2]pyrindin-6-one 447: 
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Ceric ammonium nitrate (0.95 g, 1.7 mmol) was added to a solution of 445 (0.55 g, 0.87 
mmol) in acetonitrile (20 mL) and water (2 mL). The mixture was stirred at rt for 3 h and 
ethyl acetate (20 mL) and water (20 mL) were added. The phases were separated and the 
aqueous phase was extracted with ethyl acetate (3 × 20 mL), the combined organic phases 
were washed with water (20 mL), and brine (50 mL), dried over magnesium sulfate and 
concentrated in vacuo. Purification of the residue by flash column chromatography on silica 
gel (petroleum ether: ethyl acetate 95:5 to 6:4) provided the product 447 (0.32 g, 0.65 
mmol, 75%) as an inseparable mixture of E/Z isomers (2.3:1).  
Rf: 0.37 (petroleum ether:ethyl acetate, 5:5); IR: νmax 3700―3300, 2956, 2929, 2855, 1735, 
1657, 1356, 1246 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.63 (2H, d, J = 8.1 Hz, CH-C19, CH-
C23), 7.33 (2H, d, J = 8.1 Hz, CH-C20, CH-C22), 6.53―6.49 (1H, m, CH-C9), 4.54 (1H, s, CH-
C7), 4.47―4.45 (1H, m, CH-C10), 3.74 (1H, d, J = 11.8 Hz, CH2-C3), 3.74 (1H, d, J = 12.1 
Hz, CH2-C1), 2.35―2.33 (1H, m, CH-C4a), 2.43 (3H, s, CH3-C24), 2.13―2.11 (1H, m, CH2-C3), 
2.01―1.99 (1H, m, CH2-C4), 2.00 (3H, s, CH3-C8), 1.95 (1H, d, J = 12.1 Hz, CH2-C1), 
1.55―1.53 (1H, m, CH2-C4), 1.25 (3H, d, J = 7.2 Hz, CH3-C11), 0.94 (9H, s, CH3-C15, CH3-
C16, CH3-C17), 0.22 (3H, s, CH3-C12/C13), 0.19 (3H, s, CH3-C12/C13); 
13C NMR (101 MHz, 
CDCl3): δ 204.3 (C-C6), 143.8 (C-C21), 138.8 (CH-C9), 136.9 (C-C5), 132.5 (C-C18), 129.8 
(CH-C20, CH-C22), 127.9 (CH-C19, CH-C23), 76.6 (CH-C7), 65.7 (CH-C10), 50.8 (CH2-C1), 
45.9 (CH2-C3), 40.1 (CH-C4a), 40.1 (C-C7a), 28.8 (CH2-C4), 25.9 (CH3-C15, CH3-C16, CH3-
C17), 23.4 (CH3-C11), 21.6 (CH3-C24), 20.1 (CH3-C8), 18.3 (C-C14), ―3.8 (CH3-C12/C13), 
―5.0 (CH3-C12/C13); HRMS (CI, isobutane) for C25H40NO5SSi ([M+H]
+) calculated 494.2396, 
found 494.2403; LRMS (CI, isobutane) m/z (intensity): 494 (8), 478 (15), 133 (100).  
 
C25H39NO5SSi 
Molecular weight: 493.73 g.mol―1 
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7a-Methyl-5-(2-oxo-propyl)-2-(toluene-4-sulfonyl)-1,2,3,4,6,7a-hexahydro-[2]pyrindin-
7-one 448: 
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p-Toluenesulfonic acid monohydrate (3 mg, 0.01 mmol) was added to a solution of 447 (80 
mg, 0.16 mmol) in chloroform (2 mL) and the solution was stirred at rt for 17 h. Analysis by 
TLC showed only starting material present, therefore sulphuric acid (0.2 mL) was added 
and the mixture was stirred at 70 C for 2 h. At this time, TLC analysis showed complete 
consumption of 447 so dichloromethane (3 mL) and a saturated aqueous solution of sodium 
hydrogenocarbonate (3 mL) were added. The phases were separated and the aqueous phase 
was extracted with dichloromethane (3 × 5 mL). The combined organic phases were washed 
with water (15 mL), and brine (15 mL), then dried over magnesium sulfate and 
concentrated in vacuo. Purification of the residue by flash column chromatography on silica 
gel (petroleum ether:ethyl acetate 5:5 to 7:3 provided the product 448 (33 mg, 0.092 
mmol, 58%) as a colourless oil.  
Rf: 0.46 (petroleum ether:ethyl acetate, 3:7); IR: νmax 2961, 2926, 1705, 1659, 1344, 1114 
cm―1; 1H NMR (400 MHz, CDCl3): δ 7.61 (2H, d, J = 8.1 Hz, CH-C13, CH-C17), 7.31 (2H, d, J 
= 8.1 Hz, CH-C14, CH-C16), 4.08 (1H, dddd, J = 11.0, 6.1, 1.9, 1.9 Hz, CH2-C3), 3.87 (1H, 
dd, J = 11.0, 1.9 Hz, CH2-C1), 3.36 (1H, d, J = 16.9 Hz, CH2-C9), 3.13 (1H, d, J = 16.9 Hz, 
CH2-C9), 2.71 (1H, ddd, J = 13.5, 12.8, 6.1 Hz, CH2-C4), 2.54 (1H, ddd, J = 13.5, 2.9, 1.9 
Hz, CH2-C4), 2.42 (3H, s, CH3-C18), 2.36―2.26 (2H, m, CH2-C3, CH-C6), 2.16 (1H, d, J = 11.0 
Hz, CH2-C1), 2.16 (3H, s, CH3-C11), 2.18―2.11 (1H, m, CH2-C6), 1.43 (3H, s, CH3-C8); 
13C 
NMR (101 MHz, CDCl3): δ 204.8 (C-CO), 203.9 (C-CO), 176.8 (C-C4a), 143.9 (C-C15), 133.4 
(C-C5), 131.4 (C-C12), 129.9 (CH-C14, CH-C16), 127.3 (CH-C13, CH-C17), 57.5 (CH2-C1), 
46.7 (CH2-C3), 46.6 (CH2-C6), 42.0 (C-C7a), 37.0 (CH2-C9), 30.1 (CH3-C11), 25.7 (CH2-C4), 
23.8 (CH3-C8), 21.5 (CH3-C18); HRMS (CI, isobutane) for C19H24NO4S ([M+H]
+) calculated 
362.1426, found 362.1423; LRMS (CI, isobutane) m/z (intensity): 362 (8), 157 (30), 89 (95), 
79 (100). 
 
 
C19H23NO4S 
Molecular weight: 361.46 g.mol―1 
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7a-Methyl-5-[2-oxoprop-(E)-ylidene]-2-(toluene-4-sulfonyl)-octahydro-[2]pyrindin-7-one 
451: 
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Acetic acid (0.2 mL) was added to a solution of 447 (40 mg, 0.08 mmol) in methanol (2 mL) 
and the solution was stirred at rt for 3 h. Analysis by TLC showed that only starting material 
was present, therefore hydrochloric acid (0.2 mL) was added and the mixture was stirred at 
50 C for 2 h. At this time, TLC analysis showed complete consumption of 447, so the 
solution was concentrated in vacuo and the residue was dissolved in ethyl acetate (10 mL). 
The solution was washed with a saturated aqueous solution of sodium hydrogenocarbonate 
(5 mL) and brine (15 mL), then dried over magnesium sulfate and concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel (petroleum 
ether:ethyl acetate 8:2) provided the product 449 (19 mg, 0.05 mmol, 68%) as a colourless 
oil.  
Rf: 0.54 (petroleum ether:ethyl acetate, 6:4); IR: νmax 2924, 1732, 1690, 1339, 1163 cm
―1; 
1H NMR (400 MHz, CDCl3): δ 7.64 (2H, d, J = 8.1 Hz, CH-C13, CH-C17), 7.35 (2H, d, J = 8.1 
Hz, CH-C14, CH-C16), 6.82 (1H, d, J = 1.5 Hz, CH-C9), 3.81 (1H, dddd, J = 11.9, 4.4, 2.2, 
1.8 Hz, CH2-C3), 3.67 (1H, dd, J = 12.1, 1.8 Hz, CH2-C1), 3.08 (1H, dd, J = 11.9, 4.2 Hz, CH-
C4a), 2.91 (1H, d, J = 18.2, CH2-C6), 2.45 (3H, s, CH3-C18), 3.32 (3H, s, CH3-C11), 2.28 (1H, 
ddd, J = 11.9, 12.7, 2.5 Hz, CH2-C3), 2.15 (1H, d, J = 12.1 Hz, CH2-C1), 2.16―2.11 (1H, m, 
CH2-C4), 2.07 (1H, dd, J = 18.2, 1.5 Hz, CH2-C6), 1.44―1.36 (1H, m, CH2-C4), 0.87, (3H, s, 
CH3-C8); 
13C NMR (101 MHz, CDCl3): δ 206.3 (C-CO), 199.1 (C-CO), 151.7 (C-C5), 143.8 (C-
C15), 133.0 (C-C12), 129.8 (CH-C14, CH-C16), 127.6 (CH-C13, CH-C17), 124.7 (CH-C9), 52.4 
(CH2-C1), 45.5 (CH2-C3), 45.1 (CH-C4a), 44.8 (CH2-C6), 36.5 (C-C7a), 32.2 (CH3-C11), 26.7 
(CH3-C8), 26.2 (CH2-C4), 21.5 (CH3-C18); HRMS (CI, isobutane) for C19H24NO4S ([M+H]
+) 
calculated 362.1426, found 362.1424; LRMS (CI, isobutane) m/z (intensity): 362 (5), 89 
(100), 79 (29).  
C19H23NO4S 
Molecular weight: 361.46 g.mol―1 
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2,2-Dimethylpropionic acid 7a-methyl-6-oxo-2-(toluene-4-sulfonyl)octahydro-
[2]pyrindin-7-yl ester 456: 
                   
1
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Trimethylacetyl chloride (0.46 mL, 3.7 mmol) was added to a solution of 316 (0.60 g, 1.6 
mmol) in pyridine (3 mL). The mixture was stirred at rt for 16 h, then warmed to 40 ºC and 
stirred for a further 4 h. The mixture was then concentrated in vacuo and the residue was 
dissolved in diethyl ether (5 mL). An aqueous solution of hydrochloric acid (3 mL, 1 M) was 
added and the phases were separated. The aqueous phase was extracted with diethyl ether 
(3 × 5 mL) and the combined organic phases were washed with a saturated aqueous solution 
of sodium bicarbonate (3 mL) and brine (3 mL), then dried over magnesium sulfate and 
concentrated in vacuo. Purification of the residue by flash column chromatography on silica 
gel (petroleum ether: ethyl acetate, 9:1 to 7:3) provided the product 456 (0.65 g, 1.6 
mmol, 86%) as a colourless solid.  
Rf: 0.38 (petroleum ether:ethyl acetate, 4:6); m.p.: 157―160 ºC; IR: νmax 2966, 2934, 2846, 
1763, 1735, 1344  cm―1; 1H NMR (400 MHz, CDCl3): δ 7.64 (2H, d, J = 8.2 Hz, CH-C15, CH-
C19), 7.31 (2H, d, J = 8.2 Hz, CH-C16, CH-C18), 5.56 (1H, s, CH-C7), 3.76―3.74 (1H, m, 
CH2-C3), 3.47 (1H, dd, J = 12.2, 1.7 Hz, CH2-C1), 2.50 (1H, dd, J = 19.5, 7.8 Hz, CH2-C5), 
2.41 (3H, s, CH3-C20), 2.33 (1H, ddd, J = 12.1, 12.1, 3.5 Hz, CH2-C3), 2.21 (1H, d, J = 12.2 
Hz, CH2-C1), 2.01 (1H, d, J = 19.5 Hz, CH2-C5), 1.92―1.84 (2H, m, CH-C4a, CH2-C4), 1.65 
(1H, ddd, J = 12.4, 3.5, 1.8 Hz, CH2-C4), 1.22 (9H, s, CH3-C11, CH3-C12, CH3-C13), 0.98 (3H, 
s, CH3-C8); 
13C NMR (101 MHz, CDCl3): δ 209.8 (C-C6), 176.9 (C-C9), 143.8 (C-C17), 133.3 
(C-C14), 129.9 (CH-C16, CH-C18), 127.8 (CH-C15, CH-C19), 76.1 (CH-C7), 50.5 (CH2-C1), 
45.3 (CH2-C3), 40.8 (CH2-C5), 40.2 (C-C7a), 39.1 (C-C10), 35.5 (CH-C4a), 29.7 (CH2-C4), 
27.1 (CH3-C11, CH3-C12, CH3-C13), 21.0 (CH3-C20), 19.6 (CH3-C8); HRMS (CI, isobutane) for 
C21H30NO5S ([M+H]
+) calculated 408.1845, found 408.1843; LRMS (CI, isobutane) m/z 
(intensity): 408 (46), 308 (100), 103 (32); Elemental analysis: C21H29NO5S requires C: 
61.89%, N: 3.44%, H: 7.17%, found C: 61.94%, N: 3.50%, H: 7.20%. 
  
C21H29NO5S 
Molecular weight: 407.52 g.mol―1 
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2,2-Dimethyl-propionic acid 5-[2-(4-methoxybenzyloxy)propylidene]-7a-methyl-6-oxo-
2-(toluene-4-sulfonyl)-octahydro-[2]pyrindin-7-yl ester 457. 
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A solution of n-butyllithium (1.1 mL of a 2.5 M solution in hexanes, 2.7 mmol) was added 
dropwise to a solution of diisopropyl amine (0.36 mL, 2.6 mmol) in tetrahydrofuran (7 mL), 
at ―78 ºC. The solution was stirred at ―78 ºC for 10 min, then warmed to 0 ºC for 10 min 
and finally cooled to ―78 ºC. This solution of lithium diisopropyl amide was then added 
dropwise to a solution of 443 (0.65 g, 1.6 mmol), in tetrahydrofuran (35 mL) at ―78 ºC. The 
resulting mixture was stirred at this temperature for 30 min, and a solution of zinc chloride 
(0.50 g, 3.7 mmol), in tetrahydofuran (7 mL) was added. After a further 5 min, a solution of 
456 (0.65 g, 3.4 mmol) in tetrahydrofuran (7 mL) was added. The mixture was stirred at 
―78 ºC for 2 h, then slowly warmed to rt, and stirred for a further 16 h. Diethyl ether (50 
mL) and a saturated aqueous solution of ammonium chloride (50 mL) were added and the 
phases were separated. The aqueous phase was extracted with diethyl ether (2 × 50), and 
the combined organic phases were washed with brine (100 mL), then dried over magnesium 
sulfate and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether:ethyl acetate 9:1 to 6:4) provided the 
product 457 (0.69 g, 1.2 mmol, 74%) as a mixture of diastereoisomers (0.73:1), which was 
used without further separation. For characterisation purposes, a fraction of the major 
isomer was isolated and characterised. 
Rf: 0.42 (petroleum ether:ethyl acetate, 7:3); IR: νmax 2978, 2932, 2855, 1748, 1732, 1654, 
1342, 1247, 1161 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.64 (2H, d, J = 8.1 Hz, CH-C26, CH-
C30), 7.31 (2H, d, J = 8.1 Hz, CH-C27, CH-C29), 7.14 (2H, d, J = 8.6 Hz, CH-C14, CH-C18), 
6.81 (2H, d, J = 8.6 Hz, CH-C15, CH-C17), 6.59 (1H, dd, J = 8.2, 1.4 Hz, CH-C9), 5.67 (1H, 
s, CH-C7), 4.36 (1H, d, J = 11.3 Hz, CH2-C12), 4.20 (1H, d, J = 11.3 Hz, CH2-C12), 4.12―4.05 
(1H, m, CH-C10), 3.82―3.76 (1H, m, CH2-C3), 3.75 (3H, s, CH3-C19), 3.57 (1H, d, J = 12.3 
Hz, CH2-C1), 2.41 (3H, s, CH3-C31), 2.40―2.35 (1H, m, CH-C4a), 2.25 (1H, ddd, J = 12.5, 
12.4, 2.0 Hz, CH2-C3), 2.17 (1H, d, J = 12.3 Hz, CH2-C1), 1.81―1.73 (1H, m, CH2-C4), 1.63 
C32H41NO7S 
Molecular weight: 583.74 g.mol―1 
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(1H, ddd, J = 13.5, 12.4, 4.3 Hz, CH2-C4), 1.26 (3H, d, J = 6.6 Hz, CH3-C11), 1.24 (9H, s, 
CH3-C22, CH3-C23, CH3-C24), 0.89 (3H, s, CH3-C8); 
13C NMR (101 MHz, CDCl3): δ 198.3 (C-
C6), 176.8 (C-C20), 159.2 (C-C16), 143.8 (C-C5), 139.4 (CH-C9), 137.9 (C-C28), 133.2 (C-
C25), 129.9 (C-C13), 129.8 (CH-C27, CH-C29), 129.2 (CH-C26, CH-C30), 127.8 (CH-C14, CH-
C18), 113.8 (CH-C15, CH-C17), 75.8 (CH-C7), 70.5 (CH-C10), 70.3 (CH2-C12), 55.2 (CH3-
C19), 50.1 (CH2-C1), 44.8 (CH2-C3), 41.2 (CH-C4a), 39.1 (C-C7a), 38.9 (C-C21), 28.8 (CH2-
C4), 27.2 (CH3-C22, CH3-C23, CH3-C24), 21.5 (CH3-C11), 20.9 (CH3-31), 20.4 (CH3-C8); HRMS 
(FAB) for C32H42NO7S ([M+H]
+) calculated 584.2682, found 584.2674; LRMS (FAB) m/z 
(intensity): 584 (19), 362 (20), 121 (100). 
  
2,2-Dimethylpropionic acid 5-(2-hydroxypropylidene)-7a-methyl-6-oxo-2-(toluene-4-
sulfonyl)-octahydro-[2]pyrindin-7-yl ester 458: 
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Ceric ammonium nitrate (0.34 g, 0.62 mmol) was added to a solution of 457 (0.18 g, 0.31 
mmol) in acetonitrile (7 mL) and water (0.7 mL). The mixture was stirred at rt for 3 h, and 
ethyl acetate (7 mL) and water (7 mL) were added.  The phases were separated and the 
aqueous phase was extracted with ethyl acetate (3 × 7 ml), and the combined organic 
phases were washed with brine (20 mL), then dried over magnesium sulfate and 
concentrated in vacuo. Purification of the residue by flash column chromatography on silica 
gel (petroleum ether:ethyl acetate 9.5:0.5 to 6:4 provided the product 458 (0.10 g, 0.22 
mmol, 71%) as an inseparable mixture of E/Z isomers (0.23:1). 
Rf: 0.24 (petroleum ether:ethyl acetate, 5:5); IR: νmax 3453, 2972, 1746, 1721, 1279, 1158 
cm―1; 1H NMR (400 MHz, CDCl3): δ 7.64 (2H, d, J = 8.1 Hz, CH-C18, CH-C22), 7.31 (2H, d, J 
= 8.1 Hz, CH-C19, CH-C21), 6.57-6.55 (1H, m, CH-C9), 5.67 (1H, s, CH-C7), 4.52―4.46 (1H, 
m, CH-C10), 3.81―3.77 (1H, m, CH2-C3), 3.56 (1H, dd, J = 12.3, 1.6 Hz, CH2-C1), 2.63 (1H, 
dd, J = 12.8, 6.3 Hz, CH2-C4a), 2.41 (3H, s, CH3-C23), 2.30 (1H, ddd, J = 12.7, 12.8, 2.5 Hz, 
CH2-C3), 2.17 (1H, d, J = 12.3 Hz, CH2-C1), 2.13―2.08 (1H, m, CH2-C4), 1.65 (1H, ddd, J = 
17.1, 12.8, 4.5 Hz, CH2-C4), 1.27 (3H, d, J = 7.0 Hz, CH3-C11), 1.23 (9H, s, CH3-C14, CH3-
C15, CH3-C16), 0.84 (3H, s, CH3-C8); 
13C NMR (101 MHz, CDCl3): δ 199.2 (C-C6), 177.2 (C-
C24H33NO6S 
Molecular weight: 463.59 g.mol―1 
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C12), 143.9 (C-C20), 140.5 (CH-C9), 136.1 (C-C5), 133.2 (C-C17), 129.8 (CH-C19, CH-C21), 
127.8 (CH-C18, CH-C22), 76.0 (CH-C7), 65.7 (CH-C10), 50.2 (CH2-C1), 45.1 (CH2-C3), 41.0 
(C-C7a), 39.0 (CH-C4a), 38.9 (C-C13), 28.7 (CH2-C4), 27.2 (CH3-C14, CH3-C15, CH3-C16), 
23.3 (CH3-C11), 21.6 (CH3-23), 20.3 (CH3-C8); HRMS (FAB) for C24H34NO6S([M+H]
+) calculated 
464.2107, found 464.2101; LRMS (FAB) m/z (intensity): 463 (63), 361 (100), 153 (68), 57 
(81). 
 
3-(tertButyldimethylsilanyloxy)propan-1-ol 476: 
                               476
HO O
Si
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t-Butyldimethylsilyl chloride (6.9 g, 46 mmol) and triethylamine (9.6 mL, 69 mmol) were 
added to a solution of 1,3-propanediol (5.2 g, 69 mmol), in dichloromethane (300 mL). The 
mixture was stirred at rt for 20 h, and the reaction was then quenched with a saturated 
aqueous solution of ammonium chloride (200 mL). The phases were separated and the 
aqueous phase was extracted with dichloromethane (3 × 200 ml). The combined organic 
phases were washed with brine (500 mL) then dried over magnesium sulfate and 
concentrated in vacuo. Purification of the residue by flash column chromatography on silica 
gel (petroleum ether:ethyl acetate, 8:2 to 6:4) provided the product 476 (7.8 g, 41 mmol, 
90%) as a colourless oil.  
Rf: 0.26 (petroleum ether:ethyl acetate, 8:2); IR: νmax 3357, 2929, 2857, 1472, 1255, 1084 
cm―1; 1H NMR (400 MHz, CDCl3): δ 3.82 (2H, t, J = 5.6 Hz, CH2-C3), 3.78 (2H, dt, J = 5.2, 
5.6 Hz, CH2-C1), 2.56 (1H, t, J = 5.2 Hz, OH), 1.77 (2H, tt, J = 5.6, 5.2 Hz, CH2-C2), 0.89 
(9H, s, CH3-C7, CH3-C8, CH3-C9), 0.07 (6H, s, CH3-C4, CH3-C5); 
13C NMR (101 MHz, CDCl3): δ 
63.0 (CH2-C1), 62.5 (CH2-C3), 34.3 (CH2-C2), 26.0 (CH3-C7, CH3-C8, CH3-C9), 18.3 (C-C6), 
―5.3 (CH3-C4, CH3-C5); HRMS (CI, isobutane) for C9H23O2Si ([M+H]
+) calculated 191.1467, 
found 191.1468; LRMS (CI, isobutane) m/z (intensity):191.3 (100), 133.2 (26).  
C9H22O2Si 
Molecular weight: 190.14 g.mol―1 
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N-(3-(tertButyldimethylsilyloxy)propyl)-4-methyl-N-(prop-2-ynyl)benzenesulfonamide 
474: 
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Diisopropyl azodicarboxylate (16.7 mL, 86.2 mmol) was added dropwise to a solution of 476 
(10.4 g, 49.5 mmol), 242 (8.20 g, 43.0 mmol) and triphenylphosphine (22.6 g, 86.2 mmol) 
in tetrahydrofuran (500 mL), at 0 C. The mixture was stirred at rt for 17 h, and then 
concentrated in vacuo. Purification of the residue by flash column chromatography on silica 
gel (petroleum ether:ethyl acetate, 9:1 to 8:2) provided the product 474 (15.8 g, 41 mmol, 
96%)  as a pink solid.  
Rf: 0.60 (heptane:ethyl acetate, 7:3); m.p.: 36―39 C; IR: νmax 3308, 2928, 2884, 1446, 
1348, 1160 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.71 (2H, d, J = 8.2 Hz, CH-C14, CH-C18), 
7.26 (2H, d, J = 8.2 Hz, CH-C15, CH-C17), 4.12 (2H, d, J = 1.9 Hz, CH2-C4), 3.63 (2H, t, J = 
5.8 Hz, CH2-C3), 3.27 (2H, t, J = 5.8 Hz, CH2-C1), 2.40 (3H, s, CH3-C19), 1.99 (1H, t, J = 1.9 
Hz, CH-C6), 1.76 (2H, tt, J = 5.8, 5.8 Hz, CH2-C2), 0.86 (9H, s, CH3-C10, CH3-C11, CH3-C12), 
0.02 (6H, s, CH3-C7, CH3-C8); 
13C NMR (101 MHz, CDCl3): δ 143.5 (C-C16), 136.1 (C-C13), 
129.5 (CH-C15, CH-C17), 127.9 (CH-C14, CH-C18), 77.1 (C-C5), 73.6 (CH-C6), 60.3 (CH-C3), 
43.9 (CH-C1), 36.9 (CH2-C4), 31.2 (CH2-C2), 26.0 (CH3-C10, CH3-C11, CH3-C12), 21.6 (CH3-
C19), 18.3 (C-C9), ―5.2 (CH3-C7, CH3-C8); HRMS (CI, isobutane) for C19H32NO3SSi ([M+H]
+) 
calculated 382.1872, found 382.1871; LRMS (CI, isobutane) m/z (intensity): 382 (100), 324 
(16), 252 (12); Elemental analysis: C19H31NO3SSi requires C: 59.80%, N: 3.67%, H: 8.19%, 
found C: 59.77%, N: 3.79%, H: 8.20%. 
C19H31NO3SSi 
Molecular weight: 381.60 g.mol―1 
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N-(3-Hydroxypropyl)-4-methyl-N-prop-2-ynyl-benzenesulfonamide 475: 
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A solution of tetrabutylammonium fluoride (62.9 mL of a 1 M solution in tetrahydrofuran, 
62.9 mmol) was added dropwise to a solution of 474 (20.2 g, 52.9 mmol) in tetrahydrofuran 
(200 mL), at 0 ºC. The reaction was allowed to warm at rt and stirred for 17 h. Diethyl 
ether (100 mL) and a saturated aqueous solution of ammonium chloride (100 mL) were 
added and the phases were separated. The aqueous phase was extracted with diethyl ether 
(3 × 1000 ml) and the combined organic phases were washed with brine (150 mL), then 
dried over magnesium sulfate and concentrated in vacuo. Purification of the residue by 
flash column chromatography on silica gel (petroleum ether:ethyl acetate, 8:2 to 6:4) 
provided the product 475 (13.8 g, 51.6 mmol, 98%) as a colourless solid. 
Rf: 0.28 (heptane:ethyl acetate, 5:5); m.p.: 57―60 C; IR: νmax 3493, 3232, 2956, 2827, 
1597, 1328 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.75 (2H, d, J = 8.0, CH-C8, CH-C12), 7.31 
(2H, d, J = 8.0, CH-C9, CH-C11), 4.16 (2H, d, J = 2.4, CH2-C4), 3.75 (2H, dt, J = 6.2, J = 
5.8, CH2-C3), 3.35 (2H, t, J = 6.4, CH2-C1), 2.44 (3H, s, CH3-C13), 2.28 (1H, t, J = 6.2, OH), 
2.05 (1H, t, J = 2.4, CH2-C6), 1.79 (2H, tt, J = 6.4, J = 5.8, CH2-C2); 
13C NMR (101 MHz, 
CDCl3): δ 143.8 (C-C10), 135.7 (C-C7), 129.7 (CH-C9, CH-C11), 127.8 (CH-C8, CH-C12), 77.1 
(C-C5), 74.0 (CH-C6), 58.8 (CH2-C3), 42.8 (CH2-C1), 36.6 (CH2-C4), 29.8 (CH2-C2), 21.6 (CH3-
C13); HRMS (CI, isobutane) for C13H18NO3S ([M+H]
+) calculated 268.1007, found 268.1007; 
LRMS (CI, isobutane) m/z (intensity): 268 (100), 233 (11), 157 (32), 114 (49); Elemental 
analysis: C13H17NO3S requires C: 58.40%, N: 5.24%, H: 6.41%, found C: 58.49%, N: 5.28%, H: 
6.40%. 
C13H17NO3S 
Molecular weight: 267.34 g.mol―1 
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4-Methyl-N-(3-oxo-propyl)-N-prop-2-ynyl-benzenesulfonamide 476: 
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A solution of dimethyl sulfoxide (11.7 mL, 165 mmol) in dichloromethane (100 mL) was 
added dropwise by canula to a solution of oxalyl chloride (3.9 mL, 43 mmol), in 
dichloromethane (500 mL) at ―78 C and the mixture was stirred at for 30 min. A solution 
of 475 (11.6 g, 43.4 mmol) in dichloromethane (100 mL) was then added by canula and the 
resulting solution was stirred at ―78 C for 2 h. Triethylamine (30.1 mL, 217 mmol) was 
added and the reaction mixture was allowed to warm at rt. Water (500 mL) was added and 
the phases were separated. The aqueous phase was extracted with dichloromethane (3 × 
500 mL) and the combined organic phases were washed with brine (1 L), then dried over 
magnesium sulfate and concentrated in vacuo. Filtration through silica gel provided the 
product 476 (11.5 g, 43.3 mmol, 88%) as a colourless oil, which was used without further 
purification. 
1H NMR (400 MHz, CDCl3): δ 9.80 (1H, s, CH-C3), 7.74 (2H, d, J = 8.0 Hz, CH-C8, CH-C12), 
7.32 (2H, d, J = 8.0 Hz, CH-C9, CH-C11), 4.14 (2H, d, J = 2.6 Hz, CH2-C4), 3.52 (2H, t, J = 
7.1 Hz, CH2-C1), 2.87 (2H, t, J = 7.1 Hz, CH2-C2), 2.44 (3H, s, CH3-C13), 2.07 (1H, t, J = 2.6 
Hz, CH-C6). 
 
(E)-5-[Prop-2-ynyl-(toluene-4-sulfonyl)-amino]pent-2-enoic acid methyl ester 477: 
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Methyl (triphenylphosphoranylidene)acetate (18.0 g, 53.8 mmol) was added to a solution of 
476 (10.2 g, 38.4 mmol) in dichloromethane (300 mL), and the resulting mixture was 
stirred for 17 h. The reaction mixture was then concentrated in vacuo. Purification of the 
residue by flash column chromatography on silica gel (heptane:ethyl acetate, 8:2 to 7:3) 
provided the product 477 (11.0 g, 34.2 mmol, 89%)  as a colourless solid.  
C13H15NO3S 
Molecular weight: 265.33 g.mol―1 
C16H19NO4S 
Molecular weight: 321.39 g.mol―1 
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Rf: 0.26 (heptane:ethyl acetate, 7:3); m.p.: 54―56 C; IR: νmax 3255, 2957, 1708, 1659, 
1327, 1159 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.71 (2H, d, J = 8.2 Hz, CH-C11, CH-C15), 
7.29 (2H, d, J = 8.2 Hz, CH-C12, CH-C14), 6.88 (1H, dt, J = 15.7, 7.0 Hz, CH-C3), 5.91 (1H, 
dt, J = 15.7, 1.4 Hz, CH-C4), 4.11 (2H, d, J = 2.4 Hz, CH2-C7), 3.72 (3H, s, CH3-C6), 3.31 
(2H, t, J = 7.0 Hz, CH2-C1), 2.54―2.48 (2H, m, CH2-C2), 2.42 (3H, s, CH3-C16), 2.06 (1H, t, J 
= 2.4 Hz, CH-C9); 13C NMR (101 MHz, CDCl3): δ 166.6 (C-C5), 144.6 (CH-C3), 143.8 (C-C13), 
135.6 (C-C10), 129.7 (CH-C12, CH-C14), 127.8 (CH-C11, CH-C15), 123.3 (CH-C4), 76.4 (C-
C8), 74.1 (CH-C9), 51.6 (CH3-C6), 45.1 (CH2-C1), 36.9 (CH2-C7), 30.9 (CH2-C2), 21.6 (CH3-
C16); HRMS (FAB) for C16H20NO4S ([M+H]
+) calculated 322.1113, found 322.1111; LRMS 
(FAB) m/z (intensity): 322 (100), 289 (57), 221 (98), 154 (28); Elemental analysis: 
C16H19NO4S requires C: 59.79%, N: 4.36%, H: 5.96%, found C: 59.73%, N: 4.52%, H: 5.61%. 
 
N-((E)-5-Hydroxypent-3-enyl)-4-methyl-N-prop-2-ynyl benzenesulfonamide 478: 
N
S
O
O
478
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7
8
9
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A solution of diisobutylaluminum hydride (71 mL of a 1 M solution in dichloromethane, 71 
mmol) was added dropwise to a solution of 477 (9.1 g, 28 mmol) in dichloromethane (600 
mL) at ―78 ºC. The mixture was stirred at this temperature for 1 h and then quenched by 
the addition of a saturated solution of sodium potassium tartrate (500 mL), diluted with 
ethyl acetate (1 L) and warmed to rt. The phases were separated and the aqueous phase 
was extracted with ethyl acetate (2 × 700 mL).  The combined organic phases were washed 
with water (1 L) and brine (1 L), then dried over magnesium sulfate and concentrated in 
vacuo. Purification of the residue by flash column chromatography on silica gel (petroleum 
ether:ethyl acetate, 95:5) provided the title compound 478 (7.5 g, 25 mmol, 90%) as a 
colourless oil.  
Rf: 0.28 (petroleum ether:ethyl acetate, 5:5); IR: νmax 3514, 3281, 1599, 1448, 1346 cm
―1; 
1H NMR (400 MHz, CDCl3): δ 7.72 (2H, d, J = 8.1 Hz, CH-C10, CH-C14), 7.28  (2H, d, J = 8.1 
Hz, CH-C11, CH-C13), 5.73 (1H, dt, J = 15.4, 5.2 Hz, CH-C4), 5.64 (1H, dt, J = 15.4, 6.9 Hz, 
CH-C3), 4.12 (2H, d, J = 2.5 Hz, CH2-C6), 4.09 (2H, d, J = 5.2 Hz, CH2-C5), 3.27 (2H, t, J = 
7.1 Hz, CH2-C1), 2.42 (3H, s, CH3-C15), 2.34 (2H, td, J = 7.1, 6.9 Hz, CH2-C2), 2.03 (1H, t, J 
= 2.5 Hz, CH-C8), 1.42 (1H, s, OH); 13C NMR (101 MHz, CDCl3): δ 143.5 (C-C12), 135.8 (C-
C15H19NO3S 
Molecular weight: 293.38 g.mol―1 
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C9), 131.7 (CH-C4), 129.5 (CH-C11, CH-C13), 128.3 (CH-C3), 127.6 (CH-C10, CH-C14), 76.5 
(C-C7), 73.8 (CH-C8), 63.4 (CH2-C5), 45.8 (CH2-C1), 36.5 (CH2-C6), 30.5 (CH2-C2), 21.5 (CH3-
C15); HRMS (CI, isobutane) for C15H20NO3S ([M+H]
+) calculated 294.1164, found 294.1167; 
LRMS (CI, isobutane) m/z (intensity): 294 (15), 276 (56), 22 (56), 79 (100); Elemental 
analysis: C15H19NO3S requires C: 61.41%, N: 4.77%, H: 6.53%, found C: 60.96%, N: 4.83%, H: 
6.56%. 
 
N-[(E)-5-(tertButyldimethylsilanyloxy)-pent-3-enyl]-4-methyl-N-prop-2-ynyl 
benzenesulfonamide 479: 
  
N
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O
O
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Imidazole (6.25 g, 91.9 mmol) and t-butyldimethylsilyl chloride (4.53 g, 30.1 mmol) were 
added to a solution of 478 (4.9 g, 17 mmol) in dichloromethane (150 mL) and the mixture 
was stirred at rt for 17 h. Water (150 mL) was added and the phases were separated. The 
organic phase was washed with water (150 mL), and brine (150 mL) then dried over 
magnesium sulfate and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (heptane:ethyl acetate, 9:1) provided the product 479 (5.9 g, 
14 mmol, 85%) as a colourless oil. 
Rf: 0.44 (heptane:ethyl acetate, 7:3); IR: νmax 3275, 2928, 2854, 1462, 1350, 1161 cm
―1; 1H 
NMR (400 MHz, CDCl3): δ 7.73 (2H, d, J = 8.2 Hz, CH-C10, CH-C14), 7.30 (2H, d, J = 8.2 Hz, 
CH-C11, CH-C13), 5.68―5.55 (2H, m, CH-C3, CH-C4), 4.14 (2H, d, J = 2.5 Hz, CH2-C6), 4.11 
(2H, d, J = 3.7 Hz, CH2-C5), 3.26 (2H, t, J = 7.9 Hz, CH2-C1), 2.43 (3H, s, CH3-C15), 2.34 
(2H, td, J = 7.9, 6.3 Hz, CH2-C2), 2.05 (1H, t, J = 2.5 Hz, CH-C8), 0.92 (9H, s, CH3-C19, CH3-
C20, CH3-C21), 0.08 (6H, s, CH3-C16, CH3-C17); 
13C NMR (101 MHz, CDCl3): δ 143.5 (C-C12), 
136.0 (C-C9), 132.1 (CH-C4), 129.5 (CH-C11, CH-C13), 127.7 (CH-C10, CH-C14), 126.4 (CH-
C3), 77.1 (C-C7), 73.7 (CH-C8), 63.7 (CH2-C5), 46.0 (CH2-C1), 36.5 (CH2-C6), 30.8 (CH2-C2), 
26.0 (CH3-C19, CH3-C20, CH3-C21), 21.6 (CH3-C15), 18.5 (C-C18), ―5.0 (CH3-C16, CH3-C17); 
HRMS (CI, isobutane) for C21H34NO3SSi ([M+H]
+) calculated 408.2029, found 408.2025; LRMS 
(CI, isobutane) m/z (intensity): 408 (69), 276 (52), 157 (55), 79 (100); Elemental analysis: 
C21H33NO3SSi requires C: 61.87%, N: 3.44%, H: 8.16%, found C: 61.94%, N: 3.57%, H: 8.24%. 
 
C21H33NO3SSi 
Molecular weight: 407.64 g.mol―1 
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5-(tertButyldimethylsilanyloxymethyl)-2-(toluene-4-sulfonyl)-1,2,3,4,4a,5-hexahydro-
[2]pyrindin-6-one 480: 
                   
N
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O
O
O
O
Si
1
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3
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Dicobalt octacarbonyl (0.47 g, 1.4 mmol) was added to a solution of 479 (0.47 g, 1.2 
mmol), in dichloromethane (20 mL) at 0 ºC. The mixture was warmed to rt and stirred for 2 
h. A solution of 4-methylmorpholine N-oxide (1.35 g, 1.15 mmol) in dichloromethane (10 
mL) was added dropwise at 0 ºC, and the resulting mixture was stirred at rt for 30 min 
before being filtrated through Celite and concentrated in vacuo. Purification of the residue 
by flash column chromatography on silica gel (petroleum ether:ethyl acetate, 9:1 to 7:3) 
provided the product 480 (0.39 g, 0.90 mmol, 78%) as a colourless foam.  
Rf: 0.47 (heptane:ethyl acetate, 7:3); IR: νmax 2951, 2854, 1708, 1635, 1354, 1165 cm
―1; 1H 
NMR (400 MHz, CDCl3): δ 7.68 (2H, d, J = 8.2 Hz, CH-C16, CH-C20), 7.34 (2H, d, J = 8.2 Hz, 
CH-C17, CH-C19), 5.96 (1H, s, CH-C7), 4.73 (1H, d, J = 13.4 Hz, CH2-C1), 3.98―3.95 (1H, m, 
CH2-C3), 3.82 (1H, dd, J = 10.1, 4.0 Hz, CH2-C8), 3.76 (1H, dd, J = 10.1, 5.9 Hz, CH2-C8), 
3.19 (1H, d, J = 13.4 Hz, CH2-C1), 2.63―2.51 (2H, m, CH2-C3, CH-C4a ), 2.43 (3H, s, CH3-
C21), 2.09―2.18 (2H, m, CH2-C4, CH-C5), 1.49 (1H, dddd, J = 12.6, 12.6, 12.6, 4.0 Hz, CH2-
C4), 0.79 (9H, s, CH3-C12, CH3-C13, CH3-C14), 0.02 (3H, s, CH3-C9/C10), 0.01 (3H, s, CH3-
C9/C10); 13C NMR (101 MHz, CDCl3): δ 207.0 (C-C6), 171.6 (C-C7a), 144.1 (C-C18), 133.2 (C-
C15), 129.9 (CH-C17, CH-C19), 128.6 (CH-C7), 127.8 (CH-C16, CH-C20), 61.3 (CH2-C8), 55.2 
(CH-C5), 47.6 (CH2-C1), 45.8 (CH2-C3), 43.1 (CH-C4a), 31.5 (CH2-C4), 25.8 (CH3-C12, CH3-
C13, CH3-C14), 21.6 (CH3-C21), 18.2 (C-C11), ―5.3 (CH3-C9/C10), ―5.4 (CH3-C9/C10); HRMS 
(CI, isobutane) for C22H34NO4SSi  ([M+H]
+) calculated 436.1978, found 436.1977; LRMS (CI, 
isobutane) m/z (intensity): 436 (100), 280 (22), 198 (45), 133 (32). 
C22H33NO4SSi 
Molecular weight: 435.65 g.mol―1 
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5-(tertButyldimethylsilanyloxymethyl)-7a-methyl-2-(toluene-4-sulfonyl)-octahydro-
[2]pyrindin-6-one 482: 
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Methyl magnesium bromide (5.6 mL of a 1.4 M solution in tetrahydrofuran/toluene, 7.9 
mmol) was added dropwise to a solution of copper iodide (0.75 g, 3.9 mmol), in 
tetrahydrofuran (50 mL) at rt. This was followed by the dropwise addition of a solution of 
ketone 480 (0.855 g, 1.96 mmol), in tetrahydrofuran (10 mL). After 1h, the mixture was 
quenched with a mixture of a saturated aqueous solution of ammonium chloride (20 mL), 
saturated aqueous solution of ammonium hydroxide (20 mL) and water (40mL). The phases 
were separated and the aqueous phase was extracted with diethyl ether (3 × 80 ml), the 
combined organic phases were washed with water (150 mL), and brine (150 mL), then dried 
over sodium sulfate and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (heptane:ethyl acetate, 9:1 to 7:3) provided the product 482 
(0.455 g, 1.01 mmol, 53%) as a colourless foam. 
Rf: 0.47 (heptane:ethyl acetate, 7:3); IR: νmax 2931, 2854, 1743, 1465, 1334, 1157 cm
―1; 1H 
NMR (400 MHz, CDCl3): δ 7.58 (2H, d, J = 8.1 Hz, CH-C17, CH-C21), 7.29 (2H, d, J = 8.1 Hz, 
CH-C18, CH-C20), 3.83 (1H, dd, J = 10.5, 4.0 Hz, CH2-C8), 3.65―3.69 (1H, m, CH2-C3), 3.55 
(1H, dd, J = 10.5, 3.0 Hz, CH2-C8), 3.32 (1H, d, J = 11.9 Hz, CH2-C1), 2.41 (3H, s, CH3-C22), 
2.26―2.24 (1H, m, CH-C4a), 2.24―2.20 (1H, m, CH2-C3), 2.13―2.18 (1H, m, CH2-C4), 2.04 
(2H, s, CH2-C7), 2.00 (1H, ddd, J = 11.2, 4.0, 3.0 Hz, CH-C5), 1.94 (1H, d, J = 11.9 Hz, CH2-
C1), 1.71―1.65 (1H, m, CH2-C4), 1.36 (3H, s, CH3-C15), 0.82 (9H, s, CH3-C12, CH3-C13, CH3-
C14), ―0.01 (3H, s, CH3-C9/C10), ―0.02 (3H, s, CH3-C9/C10); 
13C NMR (101 MHz, CDCl3): δ 
216.4 (C-C6), 143.5 (C-C19), 133.0 (C-C16), 129.7 (CH-C18, CH-C20), 127.4 (CH-C17, CH-
C21), 60.3 (CH2-C8), 51.8 (CH2-C1), 51.7 (CH2-C7), 51.1 (CH-C5), 41.2 (CH2-C3), 40.1 (CH-
C4a), 38.1 (C-C7a), 25.7 (CH3-C12, CH3-13, CH3-14), 23.5 (C-C11), 22.4 (CH3-C22), 21.4 
(CH2-C4), 18.0 (CH3-C15), ―5.7 (CH3-C9, CH3-C10); HRMS (CI, isobutane) for C23H38NO4SSi 
([M+H]+) calculated 452.2291, found 452.2295; LRMS (CI, isobutane) m/z (intensity): 452 
(5), 320 (100), 133 (28). 
 
C23H37NO4SSi 
Molecular weight: 451.69 g.mol―1 
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5,7a-Dimethyl-2-(toluene-4-sulfonyl)-1,2,3,4,7,7a-hexahydro-[2]pyrindin-6-one 484: 
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p-Toluenesulfonic acid (22 mg, 0.12 mmol) and ethylene glycol (54 mg, 0.86 mmol) were 
added to a solution of 482 (260 mg, 0.576 mmol) in toluene (7 mL). The flask was fitted 
with a Dean-Stark apparatus and the mixture was heated to 110 C for 6 h. The solution 
was cooled to rt and a saturated aqueous solution of sodium hydrogenocarbonate (5 mL) 
was added. The phases were separated and the organic phase was washed with brine (5 
mL) then dried over sodium sulfate and concentrated in vacuo. Purification of the residue 
by flash column chromatography on silica gel (heptane:ethyl acetate, 5:5) provided the 
product 484 (184 mg, 0.58 mmol, 100%) as a colourless solid. 
Rf: 0.35 (petroleum ether:ethyl acetate, 5:5); m.p.: 128―129 ºC; IR: νmax 2924, 2847, 1705, 
1658, 1334, 1157 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.61 (2H, d, J = 8.1 Hz, CH-C11, CH-
C15), 7.31 (2H, d, J = 8.1 Hz, CH-C12, CH-C14), 4.12―4.08 (1H, m, CH2-C3), 3.84 (1H, dd, J 
= 9.2, 2.0 Hz, CH2-C1), 2.69 (2H, m, CH2-C7), 2.42 (3H, s, CH3-C16), 2.27―2.24 (2H, m, CH2-
C4), 2.11―2.05 (1H, m, CH2-C3), 2.05 (1H, d, J = 9.2 Hz, CH2-C1), 1.62 (3H, s, CH3-C8), 1.40 
(3H, s, CH3-C9); 
13C NMR (101 MHz, CDCl3): δ 206.2 (C-C6), 172.4 (C-C4a), 143.8 (C-C5), 
137.0 (C-C13), 133.3 (C-C10), 130.1 (CH-C12, CH-C14), 127.3 (CH-C11, CH-C15), 57.6 (CH2-
C1), 46.8 (CH2-C3), 46.6 (CH2-C7), 41.5 (C-C7a), 24.9 (CH2-C4), 23.7 (CH3-C9), 21.5 (CH3-
C16), 7.7 (CH3-C8); HRMS (EI) for C17H21NO3S ([M]
+) calculated 319.1242, found 319.1245; 
LRMS (EI) m/z (intensity): 319 (80), 198 (28), 164 (100), 91 (44).  
C17H21NO3S 
Molecular weight: 319.42 g.mol―1 
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4-Methyl-N-prop-2-ynyl-N-((E)-5-triethylsilanyloxypent-3-enyl)benzenesulfonamide 485: 
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Imidazole (1.2 g, 17 mmol) and chlorotriethylsilane (1.1 mL, 6.8 mmol) were added to a 
solution of 478 (1.00 g, 3.41 mmol) in dichloromethane (30 mL) and the mixture was 
stirred at rt for 17 h. Water (30 mL) was added and the phases were separated. The organic 
phase was washed with brine (30 mL), dried over magnesium sulfate and then concentrated 
in vacuo. Purification of the residue by flash column chromatography on silica gel 
(petroleum ether:ethyl acetate, 9:1) provided the product 485 (1.40 g, 3.43 mmol, 100%) 
as a colourless oil. 
Rf: 0.28 (petroleum ether:ethyl acetate, 9:1); IR: νmax 3279, 2955, 2877, 1458, 1350, 1157 
cm―1; 1H NMR (400 MHz, CDCl3): δ 7.70 (2H, d, J = 8.1 Hz, CH-C10, CH-C14), 7.27 (2H, d, J 
= 8.1 Hz, CH-C11, CH-C13), 5.67―6.55 (2H, m, CH-C3, CH-C4), 4.12 (2H, d, J = 2.4 Hz, CH2-
C6), 4.09―4.08 (2H, m, CH2-C5), 3.23 (2H, t, J = 7.6 Hz, CH2-C1), 2.41 (3H, s, CH3-C15), 
2.34―2.29 (2H, m, CH2-C2), 2.01 (1H, t, J = 2.4 Hz, CH-C8), 0.95 (9H, t, J = 7.9 Hz, CH3-
C17, CH3-C19, CH3-C21), 0.60 (6H, q, J = 7.9 Hz, CH2-C16, CH2-C18, CH2-C20); 
13C NMR (101 
MHz, CDCl3): δ 143.5 (C-C12), 135.9 (C-C9), 132.0 (CH-C4), 129.4 (CH-C11, CH-C13), 127.7 
(CH-C10, CH-C14), 126.7 (CH-C3), 76.6 (C-C7), 73.8 (CH-C8), 63.4 (CH2-C5), 46.0 (CH2-C1), 
36.5 (CH2-C6), 30.8 (CH2-C2), 21.6 (CH3-C15), 6.8 (CH3-C17, CH3-C19, CH3-C21), 4.5 (CH2-
C16, CH2-C18, CH2-C20); HRMS (CI, isobutane) for C21H34NO3SSi ([M+H]
+) calculated 
408.2029, found 408.2025; LRMS (CI, isobutane) m/z (intensity): 408 (100), 276 (75), 222 
(85), 133 (53); Elemental analysis: C21H33NO3SSi requires C: 61.87%, N: 3.44%, H: 8.16% 
found, C: 61.84%, N: 3.52%, H: 8.12%. 
 
C21H33NO3SSi 
Molecular weight: 407.64 g.mol―1 
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2-(Toluene-4-sulfonyl)-5-triethylsilanyloxymethyl-1,2,3,4,4a,5-hexahydro-[2]pyrindin-
6-one 486: 
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Dicobalt octacarbonyl (2.5 g, 7.4 mmol) was added to a solution of 485 (2.51 g, 6.16 
mmol), in dichloromethane (50 mL) at 0 ºC. The resulting mixture was warmed to rt and 
stirred for 2 h. A solution of 4-methylmorpholine N-oxide (7.21 g, 61.5 mmol), in 
dichloromethane (15 mL) was added dropwise at 0 ºC, and the resulting mixture was stirred 
at rt for 30 min before being filtrated through Celite and concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel (petroleum 
ether:ethyl acetate, 9:1 to 7:3) provided the product 486 (1.72 g, 39.4 mmol, 64%) as a 
colourless solid. 
Rf: 0.47 (petroleum ether:ethyl acetate, 8:2); m.p.: 75―77 C IR: νmax 2955, 1712, 1342, 
1165 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.67 (2H, d, J = 8.0 Hz, CH-C16, CH-C20), 7.34 (2H, 
d, J = 8.0 Hz, CH-C17, CH-C19), 5.96 (1H, s, CH-C7), 4.73 (1H, d, J = 13.4 Hz, CH2-C1), 
3.98―3.95 (1H, m, CH2-C3), 3.82 (1H, dd, J = 10.1, 4.0 Hz, CH2-C8), 3.79 (1H, dd, J = 10.1, 
6.0 Hz, CH2-C8), 3.21 (1H, d, J = 13.4 Hz, CH2-C1), 2.65―2.63 (1H, m, CH-C4a), 2.55 (1H, 
ddd, J = 12.4, 12.4, 3.0 Hz, CH2-C3), 2.43 (3H, s, CH3-C21), 2.17―2.09 (2H, m, CH2-C4, CH-
C5), 1.49 (1H, dddd, J = 12.6, 12.6, 12.4, 4.0 Hz, CH2-C4), 0.86 (9H, t, J = 7.9 Hz, CH3-C10, 
CH3-C12, CH3-C14), 0.51 (6H, q, J = 7.9 Hz, CH2-C9, CH2-C11, CH2-C13); 
13C NMR (101 MHz, 
CDCl3): δ 207.1 (C-C6), 171.6 (C-C7a), 144.2 (C-C18), 133.2 (C-C15), 130.0 (CH-C17, CH-
C19), 128.6 (CH-C7), 127.8 (CH-C16, CH-C20), 61.1 (CH2-C8), 55.3 (CH-C5), 47.6 (CH2-C1), 
45.9 (CH2-C3), 43.0 (CH-C4a), 31.5 (CH2-C4), 21.6 (CH3-C21), 6.8 (CH3-C10, CH3-C12, CH3-
C14), 4.3 (CH2-C9, CH2-C11, CH2-C13); HRMS (EI) for C22H33NO4SSi ([M]
+) calculated 
435.1900, found 435.1893; LRMS (EI) m/z (intensity): 406 (100), 250 (98), 91 (66); 
Elemental analysis: C22H33NO4SSi requires C: 60.65%, N: 3.22%, H: 7.63%, found C: 60.57%, 
N: 3.31%, H: 7.65%. 
 
 
C22H33NO4SSi 
Molecular weight: 435.65 g.mol―1 
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7a-Methyl-2-(toluene-4-sulfonyl)-5-triethylsilanyloxymethyloctahydro-[2]pyrindin-6-one 
487: 
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Methyl magnesium bromide (7.7 mL of a 1.4 M solution in tetrahydrofuran/toluene, 11 
mmol) was added dropwise to a solution of copper iodide (1.0 g, 5.4 mmol) in 
tetrahydrofuran (75 mL) at rt. This was followed by the dropwise addition of a solution of 
ketone 486 (1.17 g, 2.69 mmol), in tetrahydrofuran (15 mL). The mixture was quenched by 
the addition of a mixture of saturated aqueous solution of ammonium chloride (40 mL), 
saturated aqueous ammonium hydroxide solution (40 mL) and water (80 mL). The phases 
were separated and the aqueous phase was extracted with diethyl ether (3 × 100 ml). The 
combined organic phases were washed with water (200 mL), and brine (200 mL), then dried 
over sodium sulfate and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether:ethyl acetate, 9:1) provided the product 
487 (782 mg, 1.73 mmol, 64%) as a colourless oil. 
Rf: 0.47 (petroleum ether:ethyl acetate, 8:2); IR: νmax 2931, 2839, 1735, 1350, 1165, 1087 
cm―1; 1H NMR (400 MHz, CDCl3): δ 7.58 (2H, d, J = 8.2 Hz, CH-C17, CH-C21), 7.29 (2H, d, J 
= 8.2 Hz, CH-C18, CH-C20), 3.83 (1H, dd, J = 10.0, 4.2 Hz, CH2-C8), 3.69―3.65 (1H, m, CH2-
C3), 3.58 (1H, dd, J = 10.0, 3.1 Hz, CH2-C8), 3.32 (1H, d, J = 11.9 Hz, CH2-C1), 2.42 (3H, s, 
CH3-C22), 2.29―2.10 (3H, m, CH2-C3, CH-C4, CH-C4a), 2.06―2.05 (2H, m, CH2-C7), 2.02 
(1H, ddd, J = 11.0, 4.2, 3.1 Hz, CH-C5), 1.94 (1H, d, J = 11.9 Hz, CH2-C1), 1.72―1.68 (1H, 
m, CH2-C4), 1.37 (3H, s, CH3-C15), 0.89 (9H, t, J = 7.8 Hz, CH3-C10, CH3-C12, CH3-C14), 
0.54 (6H, q, J = 7.8 Hz, CH2-C9, CH2-C11, CH2-C13); 
13C NMR (101 MHz, CDCl3): δ 216.8 (C-
C6), 143.7 (C-C19), 133.0 (C-C16), 129.8 (CH-C18, CH-C20), 127.6 (CH-C17, CH-C21), 60.3 
(CH2-C8), 52.0 (CH-C5), 51.9 (CH2-C1), 51.2 (CH2-C7), 41.4 (CH2-C3), 40.3 (CH-C4a), 36.6 
(C-C7a), 23.6 (CH2-C15), 22.6 (CH3-C4), 21.6 (CH3-C22), 6.7 (CH3-C10, CH3-C12, CH3-C14), 
4.3 (CH2-C9, CH2-C11, CH2-C13); HRMS (CI, isobutane) for C23H38NO4SSi ([M+H]
+) calculated 
452.2291, found 452.2289; LRMS (CI, isobutane) m/z (intensity): 452 (5), 320 (100), 133 
(30); Elemental analysis: C23H37NO4SSi requires C: 61.16%, N: 3.10%, H: 8.26%, found C: 
61.38%, N: 3.13%, H: 8.39%. 
 
C23H37NO4SSi 
Molecular weight: 451.69 g.mol―1 
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7a-Methyl-2-(toluene-4-sulfonyl)-5-triethylsilanyloxymethyloctahydro-[2]pyrindin-6-ol 
487’: 
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Sodium borohydride (0.19 g, 5.1 mmol) was added portionwise to a solution of 487 (772 
mg, 1.71 mmol) in methanol (15 mL), at 0 C. The mixture was stirred at this temprature 
for 1 h before water (15 mL) was added dropwise. Dichloromethane (20 mL) was added and 
the phases were separated. The aqueous phase was extracted with dichloromethane (3 × 20 
ml) and the combined organic phases were washed with brine (100 mL), then dried over 
magnesium sulfate and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether:ethyl acetate, 9:1 to 8:2) provided the 
product 487’ (456 mg, 1.00 mmol, 86%) as a colourless solid. 
Rf: 0.48 (petroleum ether:ethyl acetate, 6:4); m.p.: 94―96 C; IR: νmax 3525, 2924, 2862, 
1597, 1465, 1327, 1157, 1087 cm―1; 1H NMR (400 MHz, CDCl3): δ 7.62 (2H, d, J = 8.2 Hz, CH-
C17, CH-C21), 7.30 (2H, d, J = 8.2 Hz, CH-C18, CH-C20), 4.04 (1H, ddd, J = 9.1, 6.7, 4.9 Hz, 
CH-C6), 3.72 (1H, dd, J = 8.8, 4.7 Hz, CH2-C8), 3.56―3.51 (1H, m, CH2-C3), 3.46 (1H, d, J = 
8.8, Hz, CH2-C8), 3.24 (1H, dd, J = 11.8, 1.7 Hz, CH2-C1), 2.55 (1H, d, J = 11.8 Hz, CH2-C1), 
2.47 (1H, ddd, J = 12.0, 12.0, 2.9 Hz, CH2-C3), 2.42 (3H, s, CH3-C22), 1.83 (1H, d, J = 9.1 
Hz, CH2-C7), 1.95―1.82 (2H, m, CH-C5, CH2-C4), 1.48 (1H, dddd, J = 14.2, 3.0, 2.9, 2.9 Hz, 
CH2-C4), 1.41―1.36 (2H, m, CH2-C7, CH2-C4a), 1.17 (3H, s, CH3-C15), 0.92 (9H, t, J = 7.9 
Hz, CH3-C10, CH3-C12, CH3-C14), 0.56 (6H, q, J = 7.9 Hz, CH2-C9, CH2-C11, CH2-C13); 
13C 
NMR (101 MHz, CDCl3): δ 143.3 (C-C19), 133.8 (C-C16), 129.6 (CH-C18, CH-20 127.4 (CH-
C17, CH-C21), 75.94 (CH-C6), 65.1 (CH2-C8), 53.0 (CH2-C1), 50.5 (CH-C5), 45.4 (CH2-C7), 
43.1 (CH-C4a), 41.8 (CH2-C3), 39.9 (C-C7a), 25.8 (CH3-15), 22.5 (CH2-C4), 21.5 (CH3-C22), 
6.7 (CH3-C10, CH3-C12, CH3-C14), 4.2 (CH2-C9, CH2-C11, CH2-C13); HRMS (CI, isobutane) for 
C23H40NO4SSi ([M+H]
+) calculated 454.2447, found 454.2445; LRMS (CI, isobutane) m/z 
(intensity): 454 (100), 320 (28), 298 (18), 133 (20); Elemental analysis: C23H39NO4SSi 
requires C: 60.89%, N: 3.09%, H: 8.66%, found C: 60.84%, N: 3.12%, H: 8.68%. 
 
C23H39NO4SSi 
Molecular weight: 453.71 g.mol―1 
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6-(tertButyldimethylsilanyloxy)-7a-methyl-2-(toluene-4-sulfonyl)-5-
triethylsilanyloxymethyloctahydro-[2]pyrindine 488: 
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t-Butyldimethylsilyl trifluoromethanesulfonate (0.05 mL, 0.3 mmol) was added to a solution 
of 2,6-lutidine (0.06 mL, 0.6 mmol) and 487’ (100 mg, 0.22 mmol) in dichloromethane (10 
mL) at 0 C. The mixture was stirred at rt for 17 h, and a saturated aqueous solution of 
ammonium chloride (10 ml) was added. The phases were separated and the aqueous phase 
was extracted with dichloromethane (3 × 10 ml). The combined organic phases were 
washed with brine (30 mL), then dried over magnesium sulfate and concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel (heptane:ethyl 
acetate, 9.5:0.5) provided the product 488 (128 mg, 0.22 mmol, 100%) as a colourless 
solid. 
Rf: 0.46 (petroleum ether:ethyl acetate, 9:1); IR: νmax 2951, 1469, 1354, 1338, 1161, 1091 
cm―1; 1H NMR (400 MHz, CDCl3): δ 7.61 (2H, d, J = 8.1 Hz, CH-C17, CH-C21), 7.28 (2H, d, J 
= 8.1 Hz, CH-C18, CH-C20), 4.01―3.95 (1H, m, CH-C6), 3.57―3.46 (3H, m, CH2-C3, CH2-C8), 
3.17 (1H, d, J = 11.6 Hz, CH2-C1), 2.68 (1H, d, J = 11.6, CH2-C1), 2.41 (3H, s, CH3-C22), 
2.35 (1H, ddd, J = 12.1, 11.8, 2.8 Hz, CH2-C3), 1.97―1.88 (1H, m, CH2-C4), 1.74―1.70 (1H, 
m, CH-C5), 1.66 (1H, dd, J = 13.8, 7.7 Hz, CH2-C7), 1.61―1.50 (2H, m, CH2-C4, CH-C4a), 
1.36 (1H, ddd, J = 13.8, 5.6, 2.8 Hz, CH2-C7), 1.15 (3H, s, CH3-C15), 0.91 (9H, t, J = 7.9 Hz, 
CH3-10, CH3-C12, CH3-C14), 0.85 (9H, s, CH3-C26, CH3-C27, CH3-C28), 0.54 (6H, q, J = 7.9 
Hz, CH2-C9, CH2-C11, CH2-C13), 0.00 (3H, s, CH3-C23/C24), ―0.01 (3H, s, CH3-C23/C24); 
13C 
NMR (101 MHz, CDCl3): δ 143.1 (C-C19), 133.5 (C-C16), 129.5 (CH-C18, CH-C20), 127.5 (CH-
C17, CH-C21), 73.0 (CH-C6), 62.4 (CH2-C8), 52.6 (CH-C5), 52.4 (CH2-C1), 47.7 (CH2-C7), 
43.2 (CH-C4a), 42.1 (CH2-C3), 40.5 (C-C7a), 25.8 (CH3-C26, CH3-C27, CH3-C28), 25.7 (CH3-
C15), 24.8 (C-C25), 22.7 (CH2-C4), 21.5 (CH3-C22), 6.8 (CH3-10, CH3-C12, CH3-C14), 4.7 
(CH2-C9, CH2-C11, CH2-C13), ―5.5 (CH3-C23, CH3-C24); HRMS (CI, isobutane) for 
C29H54NO4SSi2 ([M+H]
+) calculated 568.3312, found 568.3309; LRMS (CI, isobutane) m/z 
(intensity): 569 (100), 413 (10), 113 (19), 71 (35); Elemental analysis: C29H54NO4SSi2 
requires C: 61.33%, N: 2.47%, H: 9.41%, found C: 61.22%, N: 2.54%, H: 9.50%. 
C29H53NO4SSi2 
Molecular weight: 567.97 g.mol―1 
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A solution of n-butyllithium (0.26 mL of a 2.5 M solution in hexanes, 0.66 mmol) was added 
dropwise to a solution of diisopropyl amine (0.09 mL, 0.6 mmol) in tetrahydrofuran (5 mL), 
at ―78 ºC. The solution was stirred at ―78 ºC for 10 min, then warmed to 0 ºC for 10 min 
and finally cooled back to ―78 ºC. The solution of lithium diisopropyl amide was then 
added dropwise to a mixture of 374 and its regioisomers (0.20 g, 0.46 mmol) in 
tetrahydrofuran (10 mL) at ―78 ºC. The resulting mixture was stirred at this temperature 
for 30 min and a solution of zinc chloride (0.14 g, 1.1 mmol) in tetrahydofuran (2 mL) was 
added. After a further 5 min reaction time a solution of 431 (0.14 g, 0.92 mmol) in 
tetrahydrofuran (2 mL) was added. The mixture was stirred at ―78 ºC for 2 h, then warmed 
slowly to rt, and stirred for a further 16 h. Diethyl ether (10 mL) and a saturated aqueous 
solution of ammonium chloride (10 mL) were added and the phases were separated. The 
aqueous phase was extracted with diethyl ether (3 × 10 ml), and the combined organic 
phases were washed with and brine (20 mL), then dried over magnesium sulfate and 
concentrated in vacuo. Purification of the residue by flash column chromatography on silica 
gel (petroleum ether:ethyl acetate 8:2) provided the product 491 (102 mg, 0.184 mmol, 
47%) as a mixture of diastereo and regioisomers, which was used without further 
separation.  
Ceric ammonium nitrate (0.12 g, 0.22 mmol) was added to a solution of crude 491 (102 mg, 
0.184 mmol) in acetonitrile (2 mL) and water (0.2 mL). The mixture was stirred at rt for 3 
h, and ethyl acetate (5 mL) and water (5 mL) were added. The phases were separated and 
the aqueous phase was extracted with ethyl acetate (3 × 5 mL). The combined organic 
phases were washed with brine (10 mL), then dried over magnesium sulfate and 
concentrated in vacuo. After a short filtration on silica gel, the residue was dissolved in 
toluene (5 mL) and camphorsulfonic acid (85 mg, 0.36 mmol) was added. After stirring for 3 
h at 110 ºC, the mixture was quenched with a saturated aqueous solution of sodium 
C23H27NO3S 
Molecular weight: 397.53 g.mol―1 
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hydrogencarbonate (5 mL) and the phases were separated. The aqueous phase was 
extracted with ethyl acetate (3 × 5 ml) and the combined organic phases were washed with 
and brine (10 mL), then dried over magnesium sulfate and concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel (petroleum 
ether:ethyl acetate 95:5 to 6:4) provided the product as a mixture of regioisomers 492-a 
and 492-b (15 mg, 0.38 mmol, 10%).  
Rf: 0.42 (petroleum ether:ethyl acetate, 5:5); IR: νmax 2953, 2922, 1599, 1346, 1161 cm
―1; 
1H NMR (400 MHz, CDCl3): partial interpretation of isomer 492-b; δ 7.68 (2H, d, J = 8.1 Hz, 
CH-C12, CH-C16), 7.31 (2H, d, J = 8.1 Hz, CH-C13, CH-C15), 5.76 (1H, d, J = 0.9 Hz, CH-
C8), 4.95 (1H, d, J = 0.9 Hz, CH2-C20), 4.84 (1H, d, J = 0.9 Hz, CH2-C20), 3.80 (1H, d, J = 
12.8 Hz, CH2-C1), 3.31 (1H, d, J = 12.8 Hz, CH2-C1), 2.43 (3H, s, CH3-C17), 2.25 (3H, s, CH3-
C10), 1.26 (3H, CH3-C21/C22), 0.83 (3H, CH3-C21/C22); HRMS (CI, isobutane) for 
C23H28NO3S ([M+H]
+) calculated 398.1790, found 398.1788; LRMS (CI, isobutane) m/z 
(intensity): 398 (100), 260 (10), 85 (12).  
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Appendices 
 
 
Appendix 1: X-ray crystallography of compound 316  
 
 
Table 1: Crystal data and structure refinement for 316 
 
Empirical formula C16H21NO4S 
Formula weight 323.4 
Temperature 100(2) K 
Wavelength 0.71073 Å 
Crystal system, space group Monoclinic,  P2(1)/c 
Unit cell dimensions a = 14.145(3) Å  α = 90 º 
 
b = 7.8662(16) Å  β = 95.96(3) º 
 
c = 14.172(3) Å  γ = 90 º 
Volume 1568.3(5) A3 
Z, Calculated density 4,  1.370 Mg/m3 
Absorption coefficient 0.224 mm-1 
F(000) 688 
Crystal size 0.40 x 0.30 x 0.25 mm 
Theta range for data collection 2.89 to 30.12 º 
Limiting indices -19≤h≤19, -11≤k≤11, -19≤1<19 
Reflections collected / unique 32641 / 4573 [R(int) = 0.346] 
Completeness to theta = 30.12 99.20% 
Max. and min. transmission 0.9461 and 0.9157 
Refinement method Full-matrix least-squares on F2 
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Data / restraints / parameters 4573 / 0 / 202 
Goodness-of-fit on F2 1.056 
Final R indices [I>2sigma(I)] R1 = 0.0336, wR2 = 0.0852 
R indices (all data) R1 = 0.0412, wR2 = 0.092 
Largest diff. peak and hole 0.501 and -0.422 e.A-3 
 
 
 
Table 2:  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2 
x 103) for 316 U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 
 
x y z U(eq) 
S(1) 7614(1) 2126(1) 4490(1) 15(1) 
O(1) 10197(1) -2879(1) 7509(1) 20(1) 
O(2) 8522(1) -735(1) 7496(1) 17(1) 
O(3) 8322(1) 2971(1) 4009(1) 21(1) 
O(4) 7284(1) 2883(1) 5316(1) 21(1) 
N(1) 8045(1) 263(1) 4814(1) 14(1) 
C(1) 9609(1) -2759(1) 6821(1) 14(1) 
C(2) 8875(1) -1335(1) 6664(1) 13(1) 
C(3) 8105(1) -2117(1) 5948(1) 12(1) 
C(4) 7485(1) -763(1) 5421(1) 14(1) 
C(5) 8452(1) -770(1) 4082(1) 16(1) 
C(6) 9158(1) -2019(1) 4580(1) 15(1) 
C(7) 8703(1) -3150(1) 5291(1) 14(1) 
C(8) 9477(1) -3978(1) 5991(1) 16(1) 
C(9) 7459(1) -3298(1) 6452(1) 17(1) 
C(10) 6617(1) 1794(1) 3653(1) 16(1) 
C(11) 5738(1) 1404(2) 3965(1) 21(1) 
C(12) 4954(1) 1172(2) 3304(1) 23(1) 
C(13) 5026(1) 1334(2) 2333(1) 22(1) 
C(14) 5915(1) 1695(2) 2037(1) 22(1) 
C(15) 6711(1) 1924(2) 2688(1) 19(1) 
C(16) 4160(1) 1191(2) 1620(1) 31(1) 
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Table 3:  Bond lengths [Å] and angles [º] for 316 
 
S(1)-O(3) 1.4317(9) 
S(1)-O(4) 1.4345(9) 
S(1)-N(1) 1.6348(10) 
S(1)-C(10) 1.7654(13) 
O(1)-C(1) 1.2178(14) 
O(2)-C(2) 1.4083(12) 
O(2)-H(2) 0.8400 
N(1)-C(4) 1.4700(13) 
N(1)-C(5) 1.4800(13) 
C(1)-C(8) 1.5143(15) 
C(1)-C(2) 1.5275(14) 
C(2)-C(3) 1.5384(15) 
C(2)-H(2A) 1.000 
C(3)-C(4) 1.5249(15) 
C(3)-C(9) 1.5305(14) 
C(3)-C(7) 1.5516(14) 
C(4)-H(4A) 0.9900 
C(4)-H(4B) 0.9900 
C(5)-C(6) 1.5205(15) 
C(5)-H(5A) 0.9900 
C(5)-H(5B) 0.9900 
C(6)-C(7) 1.5346(15) 
C(6)-H(6A) 0.9900 
C(6)-H(6B) 0.9900 
C(7)-C(8) 1.5429(15) 
C(7)-H(7A) 1.0000 
C(8)-H(8A) 0.9900 
C(8)-H(8B) 0.9900 
C(9)-H(9A) 0.9800 
C(9)-H(9B) 0.9800 
C(9)-H(9C) 0.9800 
C(10)-C(15) 1.3920(16) 
C(10)-C(11) 1.3955(16) 
C(11)-C(12) 1.3879(17) 
C(11)-H(11A) 0.9500 
C(12)-C(13) 1.3960(18) 
C(12)-H(12A) 0.9500 
C(13)-C(14) 1.3951(17) 
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C(13)-C(16) 1.5090(18) 
C(14)-C(15) 1.3912(17) 
C(14)-H(14A) 0.9500 
C(15)-H(15A) 0.9500 
C(16)-H(16A) 0.9800 
C(16)-H(16B) 0.9800 
C(16)-H(16C) 0.9800 
  O(3)-S(1)-O(4) 119.91(6) 
O(3)-S(1)-N(1) 106.92(5) 
O(4)-S(1)-N(1) 106.65(5) 
O(3)-S(1)-C(10) 107.40(5) 
O(4)-S(1)-C(10) 107.73(6) 
N(1)-S(1)-C(10) 107.72(5) 
C(2)-O(2)-H(2) 109.5 
C(4)-N(1)-C(5) 112.42(9) 
C(4)-N(1)-S(1) 116.67(7) 
C(5)-N(1)-S(1) 117.15(7) 
O(1)-C(1)-C(8) 126.31(10) 
O(1)-C(1)-C(2) 124.78(10) 
C(8)-C(1)-C(2) 108.92(9) 
O(2)-C(2)-C(1) 114.72(9) 
O(2)-C(2)-C(3) 113.42(8) 
C(1)-C(2)-C(3) 103.09(8) 
O(2)-C(2)-H(2A) 108.4 
C(1)-C(2)-H(2A) 108.4 
C(3)-C(2)-H(2A) 108.4 
C(4)-C(3)-C(9) 108.14(8) 
C(4)-C(3)-C(2) 112.08(8) 
C(9)-C(3)-C(2) 110.59(8) 
C(4)-C(3)-C(7) 113.16(8) 
C(9)-C(3)-C(7) 110.57(9) 
C(2)-C(3)-C(7) 102.25(8) 
N(1)-C(4)-C(3) 110.66(8) 
N(1)-C(4)-H(4A) 109.5 
C(3)-C(4)-H(4A) 109.5 
N(1)-C(4)-H(4B) 109.5 
C(3)-C(4)-H(4B) 109.5 
H(4A)-C(4)-H(4B) 108.1 
N(1)-C(5)-C(6) 108.33(8) 
N(1)-C(5)-H(5A) 110 
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C(6)-C(5)-H(5A) 110 
N(1)-C(5)-H(5B) 110 
C(6)-C(5)-H(5B) 110 
H(5A)-C(5)-H(5B) 108.4 
C(5)-C(6)-C(7) 112.30(9) 
C(5)-C(6)-H(6A) 109.1 
C(7)-C(6)-H(6A) 109.1 
C(5)-C(6)-H(6B) 109.1 
C(7)-C(6)-H(6B) 109.1 
H(6A)-C(6)-H(6B) 107.9 
C(6)-C(7)-C(8) 110.44(9) 
C(6)-C(7)-C(3) 112.49(8) 
C(8)-C(7)-C(3) 103.28(8) 
C(6)-C(7)-H(7A) 110.1 
C(8)-C(7)-H(7A) 110.1 
C(3)-C(7)-H(7A) 110.1 
C(1)-C(8)-C(7) 104.73(8) 
C(1)-C(8)-H(8A) 110.8 
C(7)-C(8)-H(8A) 110.8 
C(1)-C(8)-H(8B) 110.8 
C(7)-C(8)-H(8B) 110.8 
H(8A)-C(8)-H(8B) 108.9 
C(3)-C(9)-H(9A) 109.5 
C(3)-C(9)-H(9B) 109.5 
H(9A)-C(9)-H(9B) 109.5 
C(3)-C(9)-H(9C) 109.5 
H(9A)-C(9)-H(9C) 109.5 
H(9B)-C(9)-H(9C) 109.5 
C(15)-C(10)-C(11) 120.44(11) 
C(15)-C(10)-S(1) 119.84(9) 
C(11)-C(10)-S(1) 119.72(9) 
C(12)-C(11)-C(10) 119.37(11) 
C(12)-C(11)-H(11A) 120.3 
C(10)-C(11)-H(11A) 120.3 
C(11)-C(12)-C(13) 121.24(11) 
C(11)-C(12)-H(12A) 119.4 
C(13)-C(12)-H(12A) 119.4 
C(14)-C(13)-C(12) 118.36(11) 
C(14)-C(13)-C(16) 120.56(11) 
C(12)-C(13)-C(16) 121.04(12) 
C(15)-C(14)-C(13) 121.30(11) 
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C(15)-C(14)-H(14A) 119.4 
C(13)-C(14)-H(14A) 119.4 
C(14)-C(15)-C(10) 119.26(11) 
C(14)-C(15)-H(15A) 120.4000 
C(10)-C(15)-H(15A) 120.4000 
C(13)-C(16)-H(16A) 109.5000 
C(13)-C(16)-H(16B) 109.5000 
H(16A)-C(16)-H(16B) 109.5000 
C(13)-C(16)-H(16C) 109.5000 
H(16A)-C(16)-H(16C) 109.5000 
H(16B)-C(16)-H(16C) 109.5000 
 
 
Symmetry transformations used to generate equivalent atoms. 
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Table 4: Anisotropic displacement parameters (A2 x 103) for 316. The anisotropic 
displacement factor exponent takes the form: -2 pi2 [ h2 a*2 U11 + ... + 2 h k a* b* U12] 
 
 
 
U11 U22 U33 U23 U13 U12 
       S(1) 18(1) 11(1) 17(1) 1(1) 4(1) 1(1) 
O(1) 22(1) 24(1) 14(1) 1(1) 0(1) 6(1) 
O(2) 23(1) 16(1) 14(1) -5(1) 5(1) 1(1) 
O(3) 22(1) 16(1) 26(1) 4(1) 7(1) -3(1) 
O(4) 29(1) 15(1) 21(1) -4(1) 7(1) 3(1) 
N(1) 17(1) 12(1) 13(1) 1(1) 4(1) 2(1) 
C(1) 18(1) 13(1) 13(1) 1(1) 4(1) 1(1) 
C(2) 16(1) 12(1) 11(1) -1(1) 3(1) 0(1) 
C(3) 14(1) 11(1) 12(1) -1(1) 3(1) -1(1) 
C(4) 14(1) 14(1) 14(1) 1(1) 3(1) -1(1) 
C(5) 21(1) 16(1) 12(1) -1(1) 4(1) 3(1) 
C(6) 18(1) 14(1) 13(1) -1(1) 5(1) 2(1) 
C(7) 18(1) 11(1) 13(1) -2(1) 3(1) 0(1) 
C(8) 21(1) 12(1) 16(1) -1(1) 4(1) 3(1) 
C(9) 19(1) 15(1) 18(1) 1(1) 5(1) -3(1) 
C(10) 18(1) 14(1) 18(1) 3(1) 4(1) 4(1) 
C(11) 20(1) 23(1) 20(1) 4(1) 6(1) 3(1) 
C(12) 19(1) 24(1) 27(1) 5(1) 5(1) 2(1) 
C(13) 23(1) 18(1) 24(1) 1(1) -1(1) 5(1) 
C(14) 26(1) 22(1) 17(1) 2(1) 3(1) 6(1) 
C(15) 20(1) 19(1) 20(1) 2(1) 7(1) 5(1) 
C(16) 29(1) 29(1) 32(1) 2(1) -6(1) 1(1) 
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Appendix 2: X-ray crystallography of compound 409 
 
Table 1: Crystal data and structure refinement for 409 
 
  
 
Empirical formula  C16H19NO4S 
Formula weight  321.38 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C 2/c 
Unit cell dimensions a = 26.9907(4) Å 
 
b = 10.4583(2) Å 
 
c = 12.2099(2) Å 
Volume 3147.67(9) Å3 
Z 8 
Density (calculated) 1.356 Mg/m3 
Absorption coefficient 0.223 mm-1 
F(000) 1360 
Crystal size 0.69 x 0.26 x 0.17 mm3 
Theta range for data collection 2.12 to 29.97°. 
Index ranges -37≤h≤37, -14≤k≤14, -17≤l≤17 
Reflections collected 67065 
Independent reflections 4581 [R(int) = 0.0301] 
Completeness to theta = 29.97° 100.00% 
Absorption correction Gaussian 
Max. and min. transmission 0.9631 and 0.8613 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4581 / 0 / 221 
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Goodness-of-fit on F2 1.053 
Final R indices [I > 2σ(I)] R1 = 0.0289, wR2 = 0.0810 
R indices (all data) R1 = 0.0326, wR2 = 0.0832 
Largest diff. peak and hole 0.409 and -0.369 e.Å-3 
 
Table 2:  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2 
x 103) for 409 U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 
 
 
x y z U(eq) 
S(1) 7775(1) 283(1) 7941(1) 15(1) 
O(8) 9935(1) 2072(1) 9458(1) 22(1) 
O(9) 9492(1) -499(1) 8698(1) 19(1) 
O(11) 7956(1) -988(1) 8365(1) 21(1) 
O(12) 7746(1) 1229(1) 8766(1) 21(1) 
N(1) 8184(1) 825(1) 7376(1) 14(1) 
C(2) 8385(1) -61(1) 6708(1) 15(1) 
C(3) 8926(1) 440(1) 6755(1) 15(1) 
C(4) 8886(1) 1869(1) 6370(1) 17(1) 
C(5) 8310(1) 2403(1) 6005(1) 17(1) 
C(6) 8104(1) 2185(1) 6983(1) 17(1) 
C(7) 9296(1) 2538(1) 7447(1) 21(1) 
C(8) 9549(1) 1750(1) 8377(1) 17(1) 
C(9) 9344(1) 443(1) 8051(1) 15(1) 
C(31) 9127(1) -443(1) 6017(1) 21(1) 
C(111) 7117(1) 155(1) 6776(1) 17(1) 
C(112) 7021(1) -766(1) 5887(1) 20(1) 
C(113) 6496(1) -924(1) 5019(1) 24(1) 
C(114) 6066(1) -189(1) 5034(1) 25(1) 
C(115) 6174(1) 745(1) 5915(1) 26(1) 
C(116) 6699(1) 927(1) 6788(1) 22(1) 
C(117) 5494(1) -423(1) 4125(1) 35(1) 
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Table 3:  Bond lengths [Å] and angles [º] for 409 
 
 
S(1)-O(12)  1.4367(7) 
S(1)-O(11)  1.4390(7) 
S(1)-N(1)  1.6250(7) 
S(1)-C(111)  1.7704(9) 
O(8)-C(8)  1.3499(11) 
O(8)-H(8)  0.8400 
O(9)-C(9)  1.2231(11) 
N(1)-C(2)  1.4752(11) 
N(1)-C(6)  1.4887(11) 
C(2)-C(3)  1.5318(12) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-C(9)  1.5244(12) 
C(3)-C(31)  1.5353(12) 
C(3)-C(4)  1.5570(12) 
C(4)-C(7)  1.5025(13) 
C(4)-C(5)  1.5387(12) 
C(4)-H(4)  1.0000 
C(5)-C(6)  1.5248(12) 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(6)-H(6A)  0.9900 
C(6)-H(6B)  0.9900 
C(7)-C(8)  1.3421(12) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.4676(12) 
C(31)-H(31A)  0.9800 
C(31)-H(31B)  0.9800 
C(31)-H(31C)  0.9800 
C(111)-C(116)  1.3925(13) 
C(111)-C(112)  1.3936(13) 
C(112)-C(113)  1.3920(12) 
C(112)-H(112)  0.9500 
C(113)-C(114)  1.3968(15) 
C(113)-H(113)  0.9500 
C(114)-C(115)  1.3935(16) 
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C(114)-C(117)  1.5106(14) 
C(115)-C(116)  1.3965(13) 
C(115)-H(115)  0.9500 
C(116)-H(116)  0.9500 
C(117)-H(11A)  0.9800 
C(117)-H(11B)  0.9800 
C(117)-H(11C)  0.9800 
  O(12)-S(1)-O(11) 119.42(4) 
O(12)-S(1)-N(1) 107.34(4) 
O(11)-S(1)-N(1) 106.53(4) 
O(12)-S(1)-C(111) 107.05(4) 
O(11)-S(1)-C(111) 107.59(4) 
N(1)-S(1)-C(111) 108.55(4) 
C(8)-O(8)-H(8) 109.5 
C(2)-N(1)-C(6) 117.41(7) 
C(2)-N(1)-S(1) 118.82(6) 
C(6)-N(1)-S(1) 115.81(6) 
N(1)-C(2)-C(3) 108.92(7) 
N(1)-C(2)-H(2A) 109.9 
C(3)-C(2)-H(2A) 109.9 
N(1)-C(2)-H(2B) 109.9 
C(3)-C(2)-H(2B) 109.9 
H(2A)-C(2)-H(2B) 108.3 
C(9)-C(3)-C(2) 109.29(7) 
C(9)-C(3)-C(31) 108.76(7) 
C(2)-C(3)-C(31) 109.41(7) 
C(9)-C(3)-C(4) 104.06(7) 
C(2)-C(3)-C(4) 111.65(7) 
C(31)-C(3)-C(4) 113.47(7) 
C(7)-C(4)-C(5) 112.41(8) 
C(7)-C(4)-C(3) 104.26(7) 
C(5)-C(4)-C(3) 111.97(7) 
C(7)-C(4)-H(4) 109.4 
C(5)-C(4)-H(4) 109.4 
C(3)-C(4)-H(4) 109.4 
C(6)-C(5)-C(4) 111.49(7) 
C(6)-C(5)-H(5A) 109.3 
C(4)-C(5)-H(5A) 109.3 
C(6)-C(5)-H(5B) 109.3 
C(4)-C(5)-H(5B) 109.3 
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H(5A)-C(5)-H(5B) 108 
N(1)-C(6)-C(5) 110.10(7) 
N(1)-C(6)-H(6A) 109.6 
C(5)-C(6)-H(6A) 109.6 
N(1)-C(6)-H(6B) 109.6 
C(5)-C(6)-H(6B) 109.6 
H(6A)-C(6)-H(6B) 108.2 
C(8)-C(7)-C(4) 113.24(8) 
C(8)-C(7)-H(7) 123.4 
C(4)-C(7)-H(7) 123.4 
C(7)-C(8)-O(8) 126.74(9) 
C(7)-C(8)-C(9) 109.68(8) 
O(8)-C(8)-C(9) 123.58(8) 
O(9)-C(9)-C(8) 126.01(8) 
O(9)-C(9)-C(3) 125.27(8) 
C(8)-C(9)-C(3) 108.70(7) 
C(3)-C(31)-H(31A) 109.5 
C(3)-C(31)-H(31B) 109.5 
H(31A)-C(31)-H(31B) 109.5 
C(3)-C(31)-H(31C) 109.5 
H(31A)-C(31)-H(31C) 109.5 
H(31B)-C(31)-H(31C) 109.5 
C(116)-C(111)-C(112) 121.00(9) 
C(116)-C(111)-S(1) 119.89(7) 
C(112)-C(111)-S(1) 119.04(7) 
C(113)-C(112)-C(111) 118.91(9) 
C(113)-C(112)-H(112) 120.5 
C(111)-C(112)-H(112) 120.5 
C(112)-C(113)-C(114) 121.20(10) 
C(112)-C(113)-H(113) 119.4 
C(114)-C(113)-H(113) 119.4 
C(115)-C(114)-C(113) 118.84(9) 
C(115)-C(114)-C(117) 120.66(10) 
C(113)-C(114)-C(117) 120.49(11) 
C(114)-C(115)-C(116) 120.87(10) 
C(114)-C(115)-H(115) 119.6 
C(116)-C(115)-H(115) 119.6 
C(111)-C(116)-C(115) 119.13(10) 
C(111)-C(116)-H(116) 120.4 
C(115)-C(116)-H(116) 120.4 
C(114)-C(117)-H(11A) 109.5 
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C(114)-C(117)-H(11B) 109.5 
H(11A)-C(117)-H(11B) 109.5 
C(114)-C(117)-H(11C) 109.5 
H(11A)-C(117)-H(11C) 109.5 
H(11B)-C(117)-H(11C) 109.5 
 
Symmetry transformations used to generate equivalent atoms. 
 
 
  
Table 4: Anisotropic displacement parameters (A2 x 103) for 409. The anisotropic 
displacement factor exponent takes the form: -2 pi2 [ h2 a*2 U11 + ... + 2 h k a* b* U12] 
 
 
 
U11 U22 U33 U23 U13 U12 
       S(1) 13(1)  19(1) 12(1)  2(1) 4(1)  -1(1) 
O(8) 20(1)  19(1) 20(1)  0(1) -1(1)  -2(1) 
O(9) 19(1)  19(1) 17(1)  2(1) 4(1)  1(1) 
O(11) 19(1)  21(1) 20(1)  7(1) 5(1)  -1(1) 
O(12) 21(1)  27(1) 15(1)  -2(1) 9(1)  -2(1) 
N(1) 14(1)  15(1) 15(1)  1(1) 7(1)  0(1) 
C(2) 13(1)  17(1) 15(1)  -2(1) 5(1)  0(1) 
C(3) 13(1)  19(1) 12(1)  0(1) 4(1)  1(1) 
C(4) 15(1)  21(1) 15(1)  4(1) 6(1)  1(1) 
C(5) 16(1)  20(1) 14(1)  4(1) 5(1)  2(1) 
C(6) 18(1)  16(1) 18(1)  3(1) 9(1)  2(1) 
C(7) 17(1)  20(1) 23(1)  4(1) 5(1)  -3(1) 
C(8) 14(1)  18(1) 18(1)  0(1) 4(1)  -1(1) 
C(9) 12(1)  18(1) 14(1)  0(1) 5(1)  1(1) 
C(31) 18(1)  29(1) 18(1)  -4(1) 7(1)  3(1) 
C(111) 13(1)  20(1) 16(1)  4(1) 4(1)  -2(1) 
C(112) 17(1)  20(1) 19(1)  2(1) 5(1)  -2(1) 
C(113) 22(1)  24(1) 20(1)  3(1) 2(1)  -6(1) 
C(114) 16(1)  29(1) 23(1)  12(1) 1(1)  -5(1) 
C(115) 15(1)  31(1) 31(1)  9(1) 8(1)  2(1) 
C(116) 17(1)  25(1) 24(1)  3(1) 9(1)  0(1) 
C(117) 18(1)  42(1) 33(1)  15(1) -3(1)  -8(1) 
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Appendix 3: X-ray crystallography of compound 412 
 
Table 1: Crystal data and structure refinement for 412 
  
Empirical formula C19H26N2O4S 
Formula weight 378.48 
Temperature 150(2) K 
Wavelength 0.71073 Å 
Crystal system, space group Monoclinic,  P2(1)/c 
Unit cell dimensions a = 11.2667(3) Å  α = 90 º. 
 
b = 15.2906(4) Å  β = 110.9560(10) º . 
 
c = 11.5112(3) Å   γ = 90 º. 
Volume 1851.92(8) Å3 
Z, Calculated density 4,  1.357 Mg/m3 
Absorption coefficient 0.202 mm-1 
F(000) 808 
Crystal size 0.12 x 0.10 x 0.05 mm 
Theta range for data collection 1.94 to 26.00 deg. 
Limiting indices -13≤h≤13, -16≤k≤18, -9≤l≤14 
Reflections collected /unique 14272 / 3621 [R(int) = 0.0294] 
Completeness to theta = 26.00 99.60% 
Absorption correction Empirical 
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Max. and min. Transmission 0.9900 and 0.9761 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3621 / 0 / 238 
Goodness-of-fit on F2 1.042 
Final R indices [I>2sigma(I)] R1 = 0.0338, wR2 =0.082 
R indices (all data) R1 = 0.0407, wR2 = 0.0869 
Extinction coefficient none 
Largest diff. peak and hole 0.32 and -0.34 e.A-3 
 
Table 2:  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2 
x 103) for 412. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
  
 
x y z U(eq) 
C(1) 4003(1) -162(1) 7659(1) 20(1) 
C(2) 3336(1) 723(1) 7239(1) 17(1) 
C(3) 2329(1) 637(1) 5925(1) 17(1) 
C(4) 2742(2) 1070(1) 8141(1) 24(1) 
C(5) 2997(1) 2004(1) 5220(1) 21(1) 
C(6) 4027(2) 2141(1) 6488(2) 23(1) 
C(7) 4465(1) 1285(1) 7190(1) 19(1) 
C(8) 5210(1) 667(1) 6637(2) 24(1) 
C(9) 4885(1) -245(1) 6924(1) 22(1) 
C(10) 3434(1) -1428(1) 8636(1) 18(1) 
C(11) 2578(2) -2218(1) 8443(2) 29(1) 
C(12) 2872(2) -2788(1) 9591(2) 31(1) 
C(13) 809(1) 948(1) 3007(1) 18(1) 
C(14) 679(1) 43(1) 3006(1) 20(1) 
C(15) 970(2) -451(1) 2133(1) 23(1) 
C(16) 1407(2) -57(1) 1276(2) 25(1) 
C(17) 1510(2) 850(1) 1280(2) 28(1) 
C(18) 1217(2) 1355(1) 2137(2) 25(1) 
C(19) 1768(2) -606(1) 367(2) 37(1) 
N(1) 3216(1) -913(1) 7624(1) 22(1) 
N(2) 1930(1) 1515(1) 5390(1) 17(1) 
O(1) 5233(1) -925(1) 6611(1) 33(1) 
O(2) 4267(1) -1265(1) 9631(1) 27(1) 
O(3) -357(1) 1124(1) 4571(1) 22(1) 
O(4) 388(1) 2461(1) 3828(1) 26(1) 
S(1) 582(1) 1562(1) 4205(1) 17(1) 
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Table 3:  Bond lengths [Å] and angles [º] for 412 
 
 
C(1)-N(1) 1.442(2) 
C(1)-C(9) 1.523(2) 
C(1)-C(2) 1.540(2) 
C(2)-C(4) 1.518(2) 
C(2)-C(3) 1.5381(19) 
C(2)-C(7) 1.553(2) 
C(3)-N(2) 1.4783(18) 
C(5)-N(2) 1.4869(19) 
C(5)-C(6) 1.520(2) 
C(6)-C(7) 1.524(2) 
C(7)-C(8) 1.545(2) 
C(8)-C(9) 1.508(2) 
C(9)-O(1) 1.211(2) 
C(10)-O(2) 1.2189(18) 
C(10)-N(1) 1.354(2) 
C(10)-C(11) 1.511(2) 
C(11)-C(12) 1.517(2) 
C(13)-C(18) 1.389(2) 
C(13)-C(14) 1.392(2) 
C(13)-S(1) 1.7616(16) 
C(14)-C(15) 1.387(2) 
C(15)-C(16) 1.388(2) 
C(16)-C(17) 1.392(2) 
C(16)-C(19) 1.506(2) 
C(17)-C(18) 1.383(2) 
N(2)-S(1) 1.6405(12) 
O(3)-S(1) 1.4368(11) 
O(4)-S(1) 1.4351(12) 
  N(1)-C(1)-C(9) 115.78(13) 
N(1)-C(1)-C(2) 117.74(12) 
C(9)-C(1)-C(2) 103.89(12) 
C(4)-C(2)-C(3) 110.58(12) 
C(4)-C(2)-C(1) 112.18(13) 
C(3)-C(2)-C(1) 109.81(12) 
C(4)-C(2)-C(7) 113.50(13) 
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C(3)-C(2)-C(7) 109.73(12) 
C(1)-C(2)-C(7) 100.63(12) 
N(2)-C(3)-C(2) 109.82(12) 
N(2)-C(5)-C(6) 108.57(12) 
C(5)-C(6)-C(7) 112.46(13) 
C(6)-C(7)-C(8) 115.34(13) 
C(6)-C(7)-C(2) 112.36(12) 
C(8)-C(7)-C(2) 104.41(12) 
C(9)-C(8)-C(7) 105.38(13) 
O(1)-C(9)-C(8) 126.74(16) 
O(1)-C(9)-C(1) 125.59(15) 
C(8)-C(9)-C(1) 107.65(13) 
O(2)-C(10)-N(1) 122.07(14) 
O(2)-C(10)-C(11) 122.59(14) 
N(1)-C(10)-C(11) 115.34(13) 
C(10)-C(11)-C(12) 113.69(14) 
C(18)-C(13)-C(14) 120.54(15) 
C(18)-C(13)-S(1) 120.21(12) 
C(14)-C(13)-S(1) 119.03(12) 
C(15)-C(14)-C(13) 119.29(15) 
C(14)-C(15)-C(16) 120.98(15) 
C(15)-C(16)-C(17) 118.71(15) 
C(15)-C(16)-C(19) 120.30(16) 
C(17)-C(16)-C(19) 120.99(16) 
C(18)-C(17)-C(16) 121.22(16) 
C(17)-C(18)-C(13) 119.23(15) 
C(10)-N(1)-C(1) 121.21(12) 
C(3)-N(2)-C(5) 111.82(12) 
C(3)-N(2)-S(1) 116.04(9) 
C(5)-N(2)-S(1) 114.86(10) 
O(4)-S(1)-O(3) 119.19(7) 
O(4)-S(1)-N(2) 106.79(6) 
O(3)-S(1)-N(2) 107.20(6) 
O(4)-S(1)-C(13) 108.82(7) 
O(3)-S(1)-C(13) 108.03(7) 
N(2)-S(1)-C(13) 106.09(7) 
 
             
           Symmetry transformations used to generate equivalent atoms 
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Table 4: Anisotropic displacement parameters (A2 x 103) for 412. The anisotropic 
displacement factor exponent takes the form: -2 pi2 [ h2 a*2 U11 + ... + 2 h k a* b* U12] 
  
 
 
U11 U22 U33 U23 U13 U12 
       
C(1) 19(1) 19(1) 16(1) 2(1) 1(1) 0(1) 
C(2) 19(1) 16(1) 15(1) 0(1) 4(1) -1(1) 
C(3) 19(1) 14(1) 16(1) 1(1) 5(1) 0(1) 
C(4) 26(1) 26(1) 18(1) -1(1) 7(1) 2(1) 
C(5) 23(1) 17(1) 21(1) 4(1) 6(1) -4(1) 
C(6) 22(1) 19(1) 25(1) -1(1) 6(1) -6(1) 
C(7) 18(1) 21(1) 16(1) -2(1) 2(1) -4(1) 
C(8) 17(1) 29(1) 23(1) 2(1) 6(1) 1(1) 
C(9) 18(1) 25(1) 17(1) 1(1) 0(1) 4(1) 
C(10) 18(1) 19(1) 18(1) 2(1) 7(1) 5(1) 
C(11) 28(1) 26(1) 27(1) 5(1) 4(1) -4(1) 
C(12) 39(1) 24(1) 30(1) 6(1) 15(1) -1(1) 
C(13) 17(1) 20(1) 15(1) -1(1) 2(1) 0(1) 
C(14) 20(1) 20(1) 17(1) 2(1) 5(1) 0(1) 
C(15) 23(1) 21(1) 21(1) 0(1) 3(1) 3(1) 
C(16) 20(1) 33(1) 18(1) -2(1) 4(1) 5(1) 
C(17) 30(1) 36(1) 22(1) 2(1) 12(1) -5(1) 
C(18) 30(1) 22(1) 20(1) 1(1) 7(1) -6(1) 
C(19) 38(1) 48(1) 26(1) -3(1) 12(1) 13(1) 
N(1) 24(1) 20(1) 16(1) 3(1) 0(1) -3(1) 
N(2) 18(1) 16(1) 15(1) 1(1) 3(1) -1(1) 
O(1) 36(1) 29(1) 35(1) -1(1) 12(1) 9(1) 
O(2) 29(1) 31(1) 18(1) 4(1) 2(1) -3(1) 
O(3) 19(1) 25(1) 22(1) -1(1) 7(1) 0(1) 
O(4) 30(1) 17(1) 24(1) 2(1) 3(1) 4(1) 
S(1) 18(1) 16(1) 15(1) 0(1) 3(1) 1(1) 
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Appendix 4: Spectrum 
 
1H spectra of 240         199 
13C Spectra of 240         199 
1H spectra of 316         200 
13C Spectra of 316         200 
1H spectra of 323         201 
13C Spectra of 323         201 
1H spectra of 412         202 
13C Spectra of 412         202 
1H spectra of 450         203 
13C Spectra of 450         203 
1H spectra of 451         204 
13C Spectra of 451         204 
 
 
199 
 
 
 
200 
 
 
 
201 
 
 
202 
 
 
203 
 
 
204 
 
 
205 
 
 
 
